{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Cc1cc(CC([NH3+])C(=O)[O-])ccc1O\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from rdkit import Chem, DataStructs\n",
    "from rdkit.Chem import Draw, AllChem, MACCSkeys\n",
    "import matplotlib as mpl\n",
    "import numpy as np\n",
    "\n",
    "smis = [\"CC1=C(C=CC(=C1)C[C@@H](C(=O)[O-])[NH3+])O\",\n",
    "\"CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O)CO)O)O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O\",\n",
    "\"CC(C)(C(=O)[O-])O\",\n",
    "\"CC[C@H](C[C@H]([C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O)C(C)C\",\n",
    "#\"CCCCCCCC/C=C\\\\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OC[C@H](CO)O)OC(=O)CCCCCCC/C=C\\\\CCCCCCCC\",\n",
    "\"C1=CC(=CC=C1CN=C(N)SCCCC2=CN=CN2)Cl.Br.Br\"]\n",
    "\n",
    "mols = [Chem.MolFromSmiles(smi) for smi in smis]\n",
    "#print(DataStructs.TanimotoSimilarity(AllChem.GetMorganFingerprint(mols[1], 2), AllChem.GetMorganFingerprint(mols[3], 2)))\n",
    "\n",
    "print(Chem.MolToSmiles(mols[0], isomericSmiles=False))\n",
    "img = Draw.MolsToGridImage(mols, legends=smis, molsPerRow=2, subImgSize=(700, 500))\n",
    "display(img)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/mnt/luoyz_dair/anaconda3/envs/biomedgpt/lib/python3.9/site-packages/nltk/translate/bleu_score.py:552: UserWarning: \n",
      "The hypothesis contains 0 counts of 4-gram overlaps.\n",
      "Therefore the BLEU score evaluates to 0, independently of\n",
      "how many N-gram overlaps of lower order it contains.\n",
      "Consider using lower n-gram order or use SmoothingFunction()\n",
      "  warnings.warn(_msg)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "75 0.445912029556302 0.3443161726270154 0.5715219575979859 \n",
      " CSCC(=O)O\n",
      "The molecule is a sulfur-containing carboxylic consisting of thioglycolic acid carrying an S-methyl substituent. It has a role as a xenobiotic metabolite. It is a sulfur-containing carboxylic acid, a monocarboxylic acid and a methyl sulfide. It derives from a thioglycolic acid. It is a conjugate acid of a (methylthio)acetate.\n",
      "The molecule is a sulfur-containing carboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a methylsulfanyl group. It is a sulfur-containing carboxylic acid and a thioacetate ester. It derives from an acetic acid. It is a conjugate acid of a (methylthio)acetate.\n",
      " The molecule is a monocarboxylic acid that is (R)-thioglycolic acid substituted by a carboxy group at C-1. It derives from a (R)-thioglycolic acid. It is a conjugate acid of a (1R)-1-carboxylatoethylthioglycolate(1-). \n",
      " The molecule is a sulfur-containing carboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a methylsulfanyl group. It has a role as a human metabolite. It is a sulfur-containing carboxylic acid and a methyl sulfide. It derives from an acetic acid. It is a conjugate acid of a (methylthio)acetate.\n",
      "\n",
      "99 0.18183505191300303 0.20527425815334444 0.3235149434580948 \n",
      " CC1=CC=CC=C1C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C\n",
      "The molecule is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropanoic acid with the secondary amino group of N-methyl-4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridin-3-amine; an antiemetic used in combination with palonosetron hydrochloride (under the trade name Akynzeo) to treat nausea and vomiting in patients undergoing cancer chemotherapy. It has a role as an antiemetic and a neurokinin-1 receptor antagonist. It is a monocarboxylic acid amide, an organofluorine compound, an aminopyridine, a member of toluenes, a N-alkylpiperazine and a N-arylpiperazine.\n",
      "The molecule is a member of the class of pyrrolidines that is pyrrolidine which is substituted by a methyl group at position 2, a 3-(trifluoromethyl)-3-methylphenyl group at position 4, and by a tert-butyl group at position 2, and by a methyl group at position 5. It is a member of pyrrolidines, a N-alkylpiperazine, a N-arylpiperazine, an organofluorine compound and a tertiary carboxamide.\n",
      " The molecule is a member of the class of imidazoles that is 1H-imidazole which is substituted at positions 1, 4 and 5 by 3,5-bis(trifluoromethyl)phenyl, 4,5-dihydro-1H-1,2,4-triazol-1-yl and hex-4-yn-2-ylnitrilo groups, respectively. It has a role as an anxiolytic drug, a serotonergic agonist and a H1-receptor antagonist. It is a N-acylpiperazine, a member of imidazoles, a triazole alkaloid, a member of (trifluoromethyl)benzenes and \n",
      " The molecule is a member of the class of pyrimidines that is pyrimidine which is substituted at positions 2, 3, and 6 by (2-methylphenyl), [4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)phenyl](methyl)aminocarbonyl, and trifluoromethyl groups, respectively. It is a potent and selective inhibitor of the insulin-like growth factor 1 receptor (IGF-1 receptor, IGFR1R) tyrosine kinase. It has a role as an insulin-like growth factor receptor 1 antagonist and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is a N-alkylpiperazine, a member of (trifluoromethyl)benzenes and a N-arylpiperazine.\n",
      "\n",
      "109 0.5405678548627658 0.19572295809437099 1.0 \n",
      " C1C[C@H]([NH2+]C1)C(=O)O\n",
      "The molecule is an optically active form of prolinium having L-configuration. It has a role as a human metabolite. It is a conjugate acid of a L-proline. It is an enantiomer of a D-prolinium.\n",
      "The molecule is the cation resulting from the protonation of the amino group of L-proline. It is a conjugate acid of a L-proline. It is an enantiomer of a D-prolinium.\n",
      " The molecule is the zwitterion formed from L-proline by proton transfer from the carboxy group to the ring nitrogen. It is the predominant species at physiological pH. It is a tautomer of a L-proline. \n",
      " The molecule is an optically active form of prolinium having L-configuration. It has a role as a human metabolite. It is a conjugate acid of a L-proline. It is an enantiomer of a D-prolinium.\n",
      "\n",
      "112 0.5826952048352283 0.3020594973737074 0.7906837962700616 \n",
      " CC(=O)NC1=CC(=C(C=C1)N=NC2=C(C=CC3=CC(=CC(=C32)O)S(=O)(=O)[O-])N)S(=O)(=O)[O-]\n",
      "The molecule is an organosulfonate oxoanion resulting from the removal of a proton from both of the sulfo groups of 5-[(4-acetamido-2-sulfophenyl)diazenyl]-6-amino-4-hydroxynaphthalene-2-sulfonic acid. It is a conjugate base of a lissamine fast red (acid form).\n",
      "The molecule is an organosulfonate oxoanion obtained by deprotonation of the sulfo groups of 5-[(4-acetamido-2-sulfophenyl)diazenyl]-6-amino-4-hydroxynaphthalene-2-sulfonic acid. It is a conjugate base of a 5-[(4-acetamido-2-sulfophenyl)diazenyl]-6-amino-4-hydroxynaphthalene-2-sulfonic acid.\n",
      " The molecule is an organosulfonate oxoanion that is the dianion obtained by removal of both protons from the sulfo groups of Sirius red F3B (acid form). It is a conjugate base of a Sirius red F3B (acid form). \n",
      " The molecule is an organosulfonate oxoanion obtained by deprotonation of the sulfo groups of 5-[(4-acetamido-2-sulfophenyl)diazenyl]-6-amino-4-hydroxynaphthalene-2-sulfonic acid. It is a conjugate base of a Sirius red F3B (acid form).\n",
      "\n",
      "129 0.09225136461786196 0.08245245407588395 0.21052853906690738 \n",
      " C[C@@]1(C[C@H]([C@@]2(C[C@H](C(=O)O2)O)C3=C1C4=C(C(=CC(=C4)OC)O)C(=O)O3)OC)O\n",
      "The molecule is a benzochromene that is benzo[c]chromen-6-one which is substituted by hydroxy groups at positions 1, 4 and 7, methoxy groups at positions 3 and 9, a methyl group at position 1, and a 2-carboxy-2-hydroxyethyl group at position 4, and in which the carboxy group has undergone condensation with the 4-hydroxy group to afford the corresponding spirocyclic lactone. It is active against the pathogenic bacteria Agrobacterium tumefaciens, Bacillus subtilis, Pseudomonas lachrymans, Ralstonia solanacearum, Staphylococcus hemolyticus, and Xanthomonas vesicatoria, with MIC values in the range 25-100 mug/mL. It has a role as an antifungal agent and a fungal metabolite. It is an oxaspiro compound, a benzochromene, a secondary alcohol, a tertiary alcohol and a gamma-lactone.\n",
      "The molecule is a member of the class of aflatoxins that is aflatoxin B1 in which the hydrogen at the pro-3S position is replaced by a hydroxy group. It has a role as a human xenobiotic metabolite and a carcinogenic agent. It is an aflatoxin, an aromatic ether, a delta-lactone, an organic heterotetracyclic compound, a tertiary alcohol, a secondary alcohol and a polyketide. It derives from an aflatoxin B1.\n",
      " The molecule is a member of the class of coumestans that is coumestan-6-one carrying an oxo substituent at position 8 and hydroxy substituents at positions 1, 3 and 5. It has a role as a fungal metabolite. It is a member of coumestans, a gamma-lactone, an aromatic ether, a cyclic hemiketal and a secondary alcohol. \n",
      " The molecule is an organic heterotetracyclic compound that is 11,12-dihydro-2H,6H,10H-dipyrano[2,3-f:2',3'-h]chromen-2-one substituted by hydroxy groups at positions 4 and 7, a methoxy group at position 12, methyl groups at positions 6 and 11 and a methyl group at position 4 (the 3R,4R,5R,6R stereoisomer). Isolated from Chaetomium globosum, it exhibits cytotoxic activity. It has a role as an antineoplastic agent and a Chaetomium metabolite. It is a delta-lactone, an aromatic ether, an organic heterotetracyclic compound, a tertiary alcohol and a secondary alcohol.\n",
      "\n",
      "131 0.6515580039683163 0.438245484169517 1.0 \n",
      " C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)N)CN=C(N)N\n",
      "The molecule is a dipeptide composed of L-aspartic acid and L-arginine joined by a peptide linkage. It has a role as a metabolite. It derives from a L-aspartic acid and a L-arginine.\n",
      "The molecule is a dipeptide composed of L-aspartic acid and L-arginine joined by a peptide linkage. It is a constituent of bacterial cell wall peptidoglycan type A11.14 and A3alpha. It has a role as a bacterial metabolite. It derives from a L-aspartic acid and a L-arginine.\n",
      " The molecule is a dipeptide composed of L-arginine and L-aspartic acid joined by a peptide linkage. It is a conjugate acid of a D-Asp-Arg(1-). \n",
      " The molecule is a dipeptide composed of L-aspartic acid and L-arginine joined by a peptide linkage. It has a role as a metabolite. It derives from a L-aspartic acid and a L-arginine.\n",
      "\n",
      "132 0.4481120353902087 0.34189502989976944 0.6046361064694642 \n",
      " CCCCCC(CC)O\n",
      "The molecule is an aliphatic alcohol that is octane substituted by a hydroxy group at position 3. It has a role as a metabolite. It is an aliphatic alcohol and an octanol.\n",
      "The molecule is a secondary alcohol that is octane substituted by a hydroxy group at position 3. It has a role as a volatile oil component, a plant metabolite and a flavouring agent. It derives from a hydride of an octane.\n",
      " The molecule is an alkyl alcohol that is octane substituted by a carboxy group at position 2. It has a role as a volatile oil component, a plant metabolite and a pheromone. It is an alkyl alcohol and a secondary alcohol. It derives from a hydride of an octane. \n",
      " The molecule is a secondary alcohol that is octane substituted by a hydroxy group at position 3. It has a role as a plant metabolite. It derives from an octane.\n",
      "\n",
      "143 0.7644396790810687 0.7917260398795413 0.9170221312235193 \n",
      " CC1=C(C=CC(=C1)C[C@@H](C(=O)[O-])[NH3+])O\n",
      "The molecule is an amino acid zwitterion resulting from a transfer of a proton from the carboxy to the amino group of 3-methyl-L-tyrosine; major species at pH 7.3. It is a tautomer of a 3-methyl-L-tyrosine.\n",
      "The molecule is an amino acid zwitterion arising from transfer of a proton from the carboxy to the amino group of 4-hydroxy-3-methyl-L-tyrosine; major species at pH 7.3. It is a tautomer of a 4-hydroxy-3-methyl-L-tyrosine.\n",
      " The molecule is a zwitterion obtained by transfer of a proton from the carboxy to the amino group of 3-O-methyl-L-tyrosine; major species at pH 7.3. It is a tautomer of a 3-O-methyl-L-tyrosine. \n",
      " The molecule is an amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 3-methyl-L-tyrosine; major species at pH 7.3. It is a tautomer of a 3-methyl-L-tyrosine.\n",
      "\n",
      "157 0.2842748732550537 0.18419819818039654 0.41103818320908003 \n",
      " CCCCCCCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O\n",
      "The molecule is an beta-D-glucoside in which the anomeric hydrogen of beta-D-glucopyranose is substituted by an octyl group. It has a role as a plant metabolite.\n",
      "The molecule is a beta-D-glucoside resulting from the formal condensation of the hydroxy group of beta-D-glucopyranose with the anomeric hydroxy group of octan-1-ol. It derives from an octan-1-ol.\n",
      " The molecule is a beta-D-glucoside resulting from formal condensation of the hydroxy group of (6R)-6-hydroxyhexanoic acid with the anomeric carboxy group of beta-D-glucose. It is a beta-D-glucoside and a carboxylic ester. It derives from a beta-D-glucose. \n",
      " The molecule is a beta-D-glucoside that is beta-D-glucopyranose in which the anomeric hydroxy hydrogen is replaced by a hexyl group. It derives from a beta-D-glucose.\n",
      "\n",
      "175 0.38070373109215305 0.39851120244299504 0.5098659926216876 \n",
      " C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](OC([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)CO)O)O)O)O\n",
      "The molecule is a trisaccharide that is lactose in which the hydroxy group at position 2 has been converted into the corresponding alpha-D-glucopyranosyl derivative. It derives from a lactose and an alpha-D-Glcp-(1->2)-D-Glcp.\n",
      "The molecule is a trisaccharide that is D-galactopyranose in which the hydroxy groups at positions 2 and 4 have been converted into the corresponding alpha-D-glucopyranosyl and beta-D-glucopyranosyl derivatives, respectively.\n",
      " The molecule is a glucotriose consisting of two alpha-D-glucopyranose residues and a D-glucopyranose residue joined in sequence by (1->2) and (1->3) glycosidic bonds. It derives from an alpha-D-Glcp-(1->3)-D-Glcp. \n",
      " The molecule is a trisaccharide that is D-glucopyranose in which the hydroxy groups at positions 2 and 4 have been converted to the corresponding alpha-D-glucopyranosyl and beta-D-galactopyranosyl derivatives, respectively. It derives from an alpha-D-Glcp-(1->2)-D-Galp.\n",
      "\n",
      "179 0.43004848867634743 0.34571336932133745 0.7457398322915013 \n",
      " CCCCCCCC/C=C\\\\CCCCCCCC(=O)O[C@@H](CO)COC(=O)CCCCCCC/C=C\\\\C/C=C\\\\CCCCC\n",
      "The molecule is a 1,2-diacyl-sn-glycerol where linoleoyl and oleoyl form the 1- and 2-acyl groups respectively. It is a 1-linoleoyl-2-oleoylglycerol and a 1,2-diacyl-sn-glycerol. It is an enantiomer of a 3-linoleoyl-2-oleoyl-sn-glycerol.\n",
      "The molecule is a 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as linoleoyl and oleoyl respectively. It has a role as a mouse metabolite. It is a 1,2-diacyl-sn-glycerol and a diacylglycerol 36:2. It derives from a linoleic acid and an oleic acid.\n",
      " The molecule is a 2,3-diacyl-sn-glycerol in which both acyl groups are specified as (Z)-hexadecenoyl. It is a 2,3-diacyl-sn-glycerol and a dilinoleoylglycerol. It derives from a hexadec-9-enoic acid. It is an enantiomer of a 1,2-di-[(Z)-hexadec-9-enoyl]-sn-glycerol. \n",
      " The molecule is a 1,2-diacyl-sn-glycerol where oleoyl and oleoyl form the 1- and 2-acyl groups respectively. It is a 1,2-diacyl-sn-glycerol and a dilinoleoylglycerol. It is an enantiomer of a 2-oleoyl-3-linoleoyl-sn-glycerol.\n",
      "\n",
      "185 0.17278683942290385 0.08358818691113147 0.319593398781386 \n",
      " CNC(=O)SC1=CC=C(C=C1)OS(=O)(=O)C\n",
      "The molecule is a monothiocarbamic ester that is phenyl methanesulfonate in which the hydrogen at position 4 is replaced by a (methylcarbamoyl)sulfanediyl group. It is a fungicide used for the treatment of a range of fungal diseases in rice. It is a monothiocarbamic ester and a methanesulfonate ester.\n",
      "The molecule is a phenyl sulfide that is phenyl sulfate substituted by a (methylsulfonyl)oxy group at position 4. It is a metabolite of the herbicide sulfathiazole. It has a role as a marine xenobiotic metabolite. It is a member of benzenes, a sulfide and a carbamate ester.\n",
      " The molecule is an organosulfonic acid that is 6-methoxy-1,3-benzothiazol-2-yl hydrogen sulfate in which the hydrogen of the hydroxy group has been replaced by a methyl group. It is used (particularly as the disodium salt) as a sex attractant for fish. It has a role as a sex pheromone and an agrochemical. It is an organosulfonic acid and a 1,3-benzothiazol-2-yl sulfate. It is a conjugate acid of a disodium 4-(methanesulfonyl)-2-methoxy-1,3-benzothiazol-5-olate. \n",
      " The molecule is a monothiocarbamic ester that is phenyl sulfide in which the hydrogen of the thiol group has been replaced by a methyl group. It is an aryl sulfide and a monothiocarbamic ester. It derives from a phenyl sulfide.\n",
      "\n",
      "187 0.42380867363985036 0.3025861648138233 0.7487120172003494 \n",
      " CCCCCCC(CCCC)COS(=O)(=O)O\n",
      "The molecule is an alkyl sulfate that is the mono(2-butyloctyl) ester of sulfuric acid. It has a role as a surfactant. It derives from a 2-butyl-1-octanol. It is a conjugate acid of a 2-butyloctyl sulfate.\n",
      "The molecule is an alkyl sulfate that is the mono(2-ethylhexyl) ester of sulfuric acid. It is a conjugate base of a 2-butyloctyl hydrogen sulfate.\n",
      " The molecule is an organosulfonic acid that is octane-1-sulfonic acid which is substituted by a methyl group at position 2 and by a propyl group at position 3. It has a role as a surfactant. It is an organosulfonic acid and a branched-chain alkane. It derives from an octane-1-sulfonic acid. It is a conjugate acid of a 2-methyloctyl sulfate. \n",
      " The molecule is an alkyl sulfate that is the mono(2-butyloctyl) ester of sulfuric acid. It has a role as a surfactant and a carcinogenic agent. It derives from a 2-butyloctan-1-ol. It is a conjugate acid of a 2-butyloctyl sulfate(1-).\n",
      "\n",
      "195 0.5054446580935181 0.43726404080198705 0.9235927708601809 \n",
      " CCCCCCCC/C=C\\\\CCCCCCCC(=O)O[C@H](CO)COC(=O)CCCCCCC/C=C\\\\C/C=C\\\\CCCCC\n",
      "The molecule is a 2,3-diacyl-sn-glycerol where oleoyl and linoleoyl form the 2- and 3-acyl groups respectively. It is a 1-linoleoyl-2-oleoylglycerol and a 2,3-diacyl-sn-glycerol. It is an enantiomer of a 1-linoleoyl-2-oleoyl-sn-glycerol.\n",
      "The molecule is a 2,3-diacyl-sn-glycerol in which both acyl groups are specified as linoleoyl. It is a 2,3-diacyl-sn-glycerol and a dilinoleoylglycerol. It derives from a linoleic acid. It is an enantiomer of a 1,2-dilinoleoyl-sn-glycerol.\n",
      " The molecule is a 1,2-diacyl-sn-glycerol where both acyl groups are specified as linoleoyl. It has a role as a mouse metabolite. It is a 1,2-diacyl-sn-glycerol and a dilinoleoylglycerol. It derives from a linoleic acid. It is an enantiomer of a 2,3-dilinoleoyl-sn-glycerol. \n",
      " The molecule is a 2,3-diacyl-sn-glycerol where oleoyl and linoleoyl form the 2- and 3-acyl groups respectively. It is a 1-alpha-linolenoyl-2-oleoylglycerol and a 2,3-diacyl-sn-glycerol. It is an enantiomer of a 1-linoleoyl-2-oleoyl-sn-glycerol.\n",
      "\n",
      "205 0.33183524366413597 0.3850590142033803 0.6286322633327974 \n",
      " OP(=S)([O-])[S-]\n",
      "The molecule is a phosphorus oxoanion obtained by selective deprotonation of the SH goup and one of the OH groups of dithiophosphoric acid. It is a phosphorus oxoanion and a divalent inorganic anion. It is a conjugate base of a dithiophosphoric acid.\n",
      "The molecule is a divalent inorganic anion obtained by removal of both protons from phosphorothioic O,O,O-acid. It is a phosphorothioate and a divalent inorganic anion. It is a conjugate base of a phosphorothioic O,O,S-acid.\n",
      " The molecule is a divalent inorganic anion obtained by removal of two protons from thiosulfuric acid. It is a sulfur oxoanion and a divalent inorganic anion. It is a conjugate base of a thiosulfate(1-). \n",
      " The molecule is a phosphorus oxoanion obtained by deprotonation of two of the phosphonate OH groups of thiophosphoric acid. It is a phosphorus oxoanion and a divalent inorganic anion. It is a conjugate base of a phosphorothioic O,O,O-acid.\n",
      "\n",
      "217 0.04090151559166857 9.985640778649112e-79 0.6820157164626129 \n",
      " C/C(=C\\\\C(=O)N(CCC[C@H]1C(=O)N[C@H](C(=O)N1)CCCN(C(=O)/C=C(\\\\C)/CCOC(=O)[C@H](CCCN(C(=O)/C=C(\\\\C)/CCO)[O-])N)[O-])[O-])/CCO\n",
      "The molecule is a hydroxamic acid anion resulting from the removal of a proton from each of the three hydroxamic acid groups of desferricoprogen B. It has a role as a siderophore. It is a conjugate base of a desferricoprogen B.\n",
      "The molecule is a hydroxamic acid anion resulting from the removal of a proton from each of the hydroxamic acid groups of epsilon-amino-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxohex-2-enoyl]-N(5)-hydroxy-N(5)-[(2E)-5-hydroxy-3-methyl-1-oxo\n",
      " The molecule is an iron(III) oxoanion obtained from (2E,5E)-N(5)-hydroxy-N(5)-[(2E)-3-hydroxy-7-methylocta-2,5-dienoyl]-N(5)-{[(2E,5E)-N(5)-hydroxy-N(5)-[(2E)-3-hydroxy-7-methylocta-2,5-dienoyl]-N(5)-acetyl-L-ornithyl]carbonyl}-L-ornithine by removal of the three protons from the \n",
      " The molecule is a hydroxamic acid anion resulting from the removal of a proton from each of the hydroxamic acid groups of desferricoprogen(3-). It is a conjugate base of a desferricoprogen.\n",
      "\n",
      "234 2.3890509865507774e-78 0.23366119020007195 0.4454570011344724 \n",
      " C[C@H]1[C@H]([C@H]([C@@H](C(O1)O)O)O)O\n",
      "The molecule is the pyranose form of L-fucose. It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a L-fucose and a fucopyranose.\n",
      "The molecule is a deoxytalose that is D-fucopyranose in which the hydroxy group at position 6 has been replaced by a hydrogen.\n",
      " The molecule is a fucose that is D-fucopyranose in which the hydroxy group at position 6 has been replaced by a hydrogen. It is a fucose and a D-fucopyranose. \n",
      " The molecule is the L-enantiomer of fucopyranose. It has a role as an Escherichia coli metabolite. It is an enantiomer of a D-fucopyranose.\n",
      "\n",
      "237 0.870857556702545 0.870857556702545 1.0 \n",
      " C[C@H]1[C@@H](C[C@H]([C@@H](O1)OCCCCCCCCC/C=C/C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O)O)O)O)O\n",
      "The molecule is an acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of oscr#19. It derives from an oscr#19. It is a conjugate acid of an oscr#19-CoA(4-).\n",
      "The molecule is an acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of oscr#21. It derives from an oscr#21. It is a conjugate acid of an oscr#21-CoA(4-).\n",
      " The molecule is an acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of oscr#3. It derives from an oscr#3. It is a conjugate acid of an oscr#3-CoA(4-). \n",
      " The molecule is an acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of oscr#19. It derives from an oscr#19. It is a conjugate acid of an oscr#19-CoA(4-).\n",
      "\n",
      "244 0.1934586747555509 0.3870765297678159 0.9678317907712601 \n",
      " CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O)CO)O)O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O\n",
      "The molecule is an alpha-D-Galp-(1->3)-D-GalpNAc in which the anomeric centre at the reducing end has beta-configuration. It is an alpha-D-Galp-(1->3)-D-GalpNAc and a D-Galp-(1->3)-D-GalpNAc.\n",
      "The molecule is an amino disaccharide composed of D-galactose and 2-acetamido-2-deoxy-beta-D-glucopyranosyl residues in (alpha-1->3) linkage. It is an amino disaccharide, a glucosamine oligosaccharide and a glycosylglucose derivative. It derives from a N-acetyl-beta-D-glucosamine and an alpha-D-galactose.\n",
      " The molecule is an alpha-D-Galp-(1->3)-D-GalpNAc in which the anomeric centre at the reducing end has alpha-configuration. It has a role as an epitope. \n",
      " The molecule is an alpha-D-Galp-(1->3)-D-GalpNAc in which the anomeric centre at the reducing end has alpha-configuration. It is an alpha-D-Galp-(1->3)-D-GalpNAc and a D-Galp-(1->3)-D-GalpNAc.\n",
      "\n",
      "275 0.1352748810821068 0.2623924764722929 0.3630867817425484 \n",
      " CC(=O)[O-].CC(=O)[O-].[Co+2]\n",
      "The molecule is a cobalt salt in which the cobalt metal is in the +2 oxidation state and the counter-anion is acetate. It is a cobalt salt and an acetate salt.\n",
      "The molecule is a praseodymium molecular entity in which a praseodymium(3+) cation is associated with three acetate anions. Used as a heavy atom in protein crystallography experiments (multiple-wavelength anomalous dispersion, multiple isomorphous replacement). It is a praseodymium molecular entity and an acetate salt.\n",
      " The molecule is a cobalt coordination entity in which a cobalt(2+) cation is associated with two acetate anions. It has a role as an astringent. It is a cobalt coordination entity and an acetate salt. \n",
      " The molecule is a cobalt salt in which the cobalt metal is coordinated to two acetate ions. It has a role as an insecticide. It contains a cobalt(2+).\n",
      "\n",
      "280 0.29813214019066486 0.20744616049253062 0.46316624190803424 \n",
      " C1=CC=C(C=C1)[N+]2=C3C=C(C=CC3=NC4=C2C=C(C=C4)N)N.[Cl-]\n",
      "The molecule is an organic chloride salt having 3,7-diamino-5-phenylphenazin-5-ium as the counterion. It is commonly used for staining Gram negative bacteria red in smears to contrast with the blue Gram positive organisms. It has a role as a fluorochrome, a histological dye and a photosensitizing agent. It contains a 3,7-diamino-5-phenylphenazin-5-ium.\n",
      "The molecule is an organic chloride salt having 3,6-diamino-10-phenylacridine as the counterion. It has a role as a fluorochrome and a histological dye. It contains a 3,6-diamino-10-phenylacridine.\n",
      " The molecule is an organic chloride salt consisting of 3,7-diamino-4-(pyridin-4-yl)phenazine cation and chloride ions in a 1:1 ratio. It has a role as a histological dye. It contains a pararosanilin(1+). \n",
      " The molecule is an organic chloride salt having 3,6-diamino-10-phenyl-3H-phenyl-3H-phenazin-5-ium as the counterion. It stains nuclei green and is sometimes used as a counterstain to red or purple primary stains. It has a role as a fluorochrome and a histological dye. It contains a 3,6-diamino-10-phenyl-3H-phenazin-5-ium.\n",
      "\n",
      "292 0.14889380787028975 0.2007186574277278 0.31498356031307445 \n",
      " C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3C[C@@H]([C@@H]5[C@@]4(CCC(=O)C5)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C)O)O[C@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)C)O)O)O)O)C)O[C@@]1(CC[C@H](C)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O\n",
      "The molecule is a steroid saponin that is (5alpha,6alpha,22R,25S)-6,22,26-trihydroxyfurostan-3-one in which the hydroxy group at position 6 has been converted into the beta-D-glucopyranosyl-(1->3)-alpha-L-rhamnoside derivative, while that at position 26 has been converted to its beta-D-glucoside. Torvoside H is a natural product found in the fruit of Solanum torvum which shows antiviral activity against herpes simplex virus type 1. It has a role as a metabolite and an antiviral agent. It is a steroid saponin, a disaccharide derivative, a cyclic hemiketal, a pentacyclic triterpenoid and a 3-oxo-5alpha-steroid.\n",
      "The molecule is a steroid saponin that is the 26-O-beta-D-glucoside of chenodeoxycholic acid. It has a role as a plant metabolite. It is a steroid saponin, a trisaccharide derivative, a pentacyclic triterpenoid and a cyclic terpene ketone. It derives from a chenodeoxycholic acid.\n",
      " The molecule is a spirostanyl glycoside that is (25R)-5alpha-spirostan-3beta,7alpha,26-triol attached to a 6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has a role as a metabolite and an allergen. It is a spirostanyl glycoside, a tetrasaccharide derivative, a 6alpha-hydroxy steroid, a 3beta-hydroxy steroid and an oxaspiro compound. It derives from a hydride of a 5alpha \n",
      " The molecule is a steroid saponin that is cholest-20-ene-3,22-dione attached to a alpha-L-rhamnopyranosyl(1->3)-beta-D-xylopyranosyl residue at position 3 via a glycosidic linkage. Isolated from the aerial parts of Lysimachia clethroides, it exhibits antineoplastic activity. It has a role as a plant metabolite and an antineoplastic agent. It is a beta-D-glucoside, a 17alpha-hydroxy steroid, a steroid saponin, a cholestanoid and a 3-oxo-5alpha-steroid. It derives from a hydride of a cholestane.\n",
      "\n",
      "296 0.14850111043009223 0.10292729846544825 0.3274217604232306 \n",
      " C1=NC(=C(N1)C(=O)O)N\n",
      "The molecule is an imidazole-4-carboxylic acid compound having an amino substituent at the 5-position. It is an imidazole-4-carboxylic acid and an aminoimidazole.\n",
      "The molecule is an imidazolyl carboxylic acid that is 1H-imidazole with methyl and carboxylic acid group substituents at positions 5 and 4 respectively. It has a role as a metabolite.\n",
      " The molecule is an organonitrogen heterocyclic compound that is 1H-imidazole substituted by a methyl group at position 5 and a carboxy group at position 4. It has a role as a metabolite. It is an organonitrogen heterocyclic compound and a monocarboxylic acid. \n",
      " The molecule is an imidazole-4-carboxylic acid compound having an amino substituent at the 5-position. It has a role as an Escherichia coli metabolite. It is an imidazole-4-carboxylic acid and a non-proteinogenic alpha-amino acid. It is a conjugate acid of a 5-amino-1H-imidazole-4-carboxylate. It is a tautomer of a 5-amino-1H-imidazole-4-carboxylic acid zwitterion.\n",
      "\n",
      "311 0.2984261960111146 0.7076879804229577 0.898911635555289 \n",
      " O[Mn](=O)(=O)[O-]\n",
      "The molecule is a manganese oxoanion that consists of manganic acid where one of the two OH groups has been deprotonated. It is a manganese oxoanion and a monovalent inorganic anion. It is a conjugate base of a manganic acid. It is a conjugate acid of a manganate.\n",
      "The molecule is a manganese oxoanion. It is a conjugate base of a hydrogen manganate. It is a conjugate acid of a hydrogen manganate(2-).\n",
      " The molecule is a monovalent inorganic anion obtained by deprotonation of one of the two OH groups in manganic acid. It is a manganese oxoanion and a monovalent inorganic anion. It is a conjugate base of a manganic acid. It is a conjugate acid of a manganate. \n",
      " The molecule is a monovalent inorganic anion that consists of manganic acid where one of the two OH groups has been deprotonated. It is a manganese oxoanion and a monovalent inorganic anion. It is a conjugate base of a manganic acid. It is a conjugate acid of a manganate.\n",
      "\n",
      "315 0.6790973533555847 0.7134336543625447 0.8139875177583439 \n",
      " CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)O\n",
      "The molecule is a methyl-branched fatty acid that is tetracosanoic acid (lignoceric acid) substituted by a methyl group at position 22. It is a branched-chain saturated fatty acid, a methyl-branched fatty acid and a very long-chain fatty acid. It derives from a tetracosanoic acid.\n",
      "The molecule is a methyl-branched fatty acid that is tricosanoic acid substituted by a methyl group at position 22. It has a role as a mammalian metabolite. It is a branched-chain saturated fatty acid, a methyl-branched fatty acid and a long-chain fatty acid. It derives from a tricosanoic acid.\n",
      " The molecule is a methyl-branched fatty acid that is heptadecanoic acid (margaric acid) substituted by a methyl group at position 16. It is a branched-chain saturated fatty acid, a long-chain fatty acid and a methyl-branched fatty acid. It derives from a heptadecanoic acid. \n",
      " The molecule is a methyl-branched fatty acid that is tetracosanoic acid substituted by a methyl group at position 22. It has a role as a mammalian metabolite. It is a branched-chain saturated fatty acid, a methyl-branched fatty acid and a long-chain fatty acid. It derives from a tetracosanoic acid.\n",
      "\n",
      "316 0.3865608384723155 0.25137831088258034 0.5487021069628877 \n",
      " C(CC(=O)N[C@@H](CSCCl)C(=O)NCC(=O)[O-])[C@@H](C(=O)[O-])[NH3+]\n",
      "The molecule is a peptide anion obtained by deprotonation of both carboxy groups and protonation of the glutamyl amino group of S-(chloromethyl)glutathione; major species at pH 7.3. It is a conjugate base of a S-(chloromethyl)glutathione.\n",
      "The molecule is conjugate base of S-(chloromethyl)glutathione. It has a role as a human metabolite. It is a conjugate base of a S-(chloromethyl)glutathione.\n",
      " The molecule is conjugate base of S-chloro-L-glutathione having both carboxy groups in anionic form and a protonated primary amino group. It is a conjugate base of a S-chloro-L-glutathione. \n",
      " The molecule is the conjugate base of S-(chloromethyl)glutathione; major species at pH 7.3. It is a conjugate base of a S-(chloromethyl)glutathione.\n",
      "\n",
      "335 0.4637676397123744 0.4506015465040919 0.5648916353484859 \n",
      " C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=O)C=C4[C@@]3(CC[C@@H](C4)O)C)C\n",
      "The molecule is a cholestanoid that consists of cholesterol bearing an oxo substituent at position 7. It has a role as a neuroprotective agent. It is a 3beta-sterol, a cholestanoid, a 7-oxo steroid and a 3beta-hydroxy-Delta(5)-steroid. It derives from a cholesterol.\n",
      "The molecule is the 7-oxo derivative of cholesterol. It has a role as a mouse metabolite. It is a 7-oxo steroid, an oxysterol and a 3beta-hydroxy-Delta(5)-steroid. It derives from a cholesterol.\n",
      " The molecule is a 7alpha-hydroxy steroid resulting from the oxidation of (5R,25R)-cholest-5-en-3beta-ol to the corresponding ketone. It has a role as a human metabolite. It is a 7alpha-hydroxy steroid, a cholestanoid and a 3beta-hydroxy-Delta(5)-steroid. It derives from a cholesterol. \n",
      " The molecule is the 7-oxo steroid resulting from the oxidation of the hydroxy group of cholesterol to the corresponding ketone. It has a role as a human metabolite. It is a 7-oxo steroid, an oxysterol, a 3beta-sterol, a cholestanoid and a 3beta-hydroxy-Delta(5)-steroid. It derives from a cholesterol.\n",
      "\n",
      "339 0.4529213997404853 0.43339663824311053 0.7417304614913462 \n",
      " CC(C)CCCCCCC/C=C/C(=O)O\n",
      "The molecule is an alpha,beta-unsaturated monocarboxylic acid that is trans-dodec-2-enoic acid in which one of the hydrogens at position 11 has been replaced by a methyl group. It is a methyl-branched fatty acid, an alpha,beta-unsaturated monocarboxylic acid and a monounsaturated fatty acid.\n",
      "The molecule is a monounsaturated fatty acid that is trans-2-dodecenoic acid in which one of the hydrogens at position 10 has been replaced by a methyl group. It is a medium-chain fatty acid, a monounsaturated fatty acid and a branched-chain fatty acid.\n",
      " The molecule is a methyl-branched fatty acid that is (2E)-oct-2-enoic acid substituted by a methyl group at position 9. It is an alpha,beta-unsaturated monocarboxylic acid, a methyl-branched fatty acid, a medium-chain fatty acid and a straight-chain fatty acid. \n",
      " The molecule is an alpha,beta-unsaturated monocarboxylic acid that is trans-2-dodecenoic acid in which one of the hydrogens at position 13 has been replaced by a methyl group. It is an alpha,beta-unsaturated monocarboxylic acid, a medium-chain fatty acid and a monounsaturated fatty acid.\n",
      "\n",
      "389 0.5969741170267375 0.3264406677790247 0.8172096953355769 \n",
      " CC(=O)OCCC1=CC=CC=C1\n",
      "The molecule is the acetate ester of 2-phenylethanol. It has a role as a metabolite and a Saccharomyces cerevisiae metabolite. It derives from a 2-phenylethanol.\n",
      "The molecule is the acetate ester of 2-phenylethanol. It has a role as a metabolite and a fragrance. It is a member of benzenes and an acetate ester.\n",
      " The molecule is the methyl ester of 3-phenylprop-1-ene. It has a role as a metabolite and a fragrance. It is a member of benzenes and a methyl ester. \n",
      " The molecule is the acetate ester of 2-phenylethanol. It has a role as a metabolite. It derives from a 2-phenylethanol.\n",
      "\n",
      "393 0.39313907033616025 0.24894738050210108 0.5050305869988034 \n",
      " C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OC(=O)N)O)O)N\n",
      "The molecule is a purine ribonucleoside 5'-monophosphate that is AMP in which one of the phosphate OH groups substituted by a carbamoyl group It derives from an adenosine 5'-monophosphate. It is a conjugate acid of a carbamoyl adenylate(1-).\n",
      "The molecule is a a purine ribonucleoside 5'-monophosphate that is adenosine 5'-monophosphate in which one of the hydroxy groups of the phosphate has been condensed with the carboxylic acid group of adenosine 5'-monophosphate. It has a role as a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a hydroxy monocarboxylic acid and a purine ribonucleoside 5'-monophosphate. It derives from an adenosine 5'-monophosphate. It is a conjugate acid of a carbamoyl adenylate(1-).\n",
      " The molecule is a carbamate ester that is the carbamoyl ester of adenine. It has a role as a protein kinase inhibitor, an EC 2.7.11.1 (adenylate cyclase) inhibitor, an EC 3.5.1.98 (histone deacetylase) inhibitor and an antimicrobial agent. It is a member of adenosines and a carbamate ester. It derives from an adenine. It is a conjugate acid of a carbamoyl adenylate(1-). \n",
      " The molecule is a purine ribonucleoside 5'-monophosphate having a carbamoyl group attached to one of the hydroxy groups. It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a purine ribonucleoside 5'-monophosphate and a monocarboxylic acid amide. It derives from an adenosine 5'-monophosphate. It is a conjugate acid of a carbamoyl adenylate(1-).\n",
      "\n",
      "400 0.8827332105915097 0.8595342787179135 1.0 \n",
      " CC1=CC(=CC=C1)C[C@@H](C(=O)N[C@@H](CC[C@H](CN)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC4=CSC=N4)NC(=O)CN\n",
      "The molecule is a fifteen-membered glycopeptide comprising glycyl, 3-(1,3-thiazol-4-yl)alanyl, alanyl, glycyl, 3-methylphenylalanyl, (5R)-5-(beta-D-galactopyranosyloxy)lysyl, glycyl. alpha-glutamyl, glutaminyl, glycyl, prolyl, lysyl, glycyl, alpha-glutamyl and threonine residues coupled in sequence.\n",
      "The molecule is a fifteen-membered glycopeptide comprising glycyl, 3-methyl-1,3-thiazole, alanyl, glycyl, 3-methylphenylalanyl, (5R)-5-(beta-D-galactopyranosyloxy)lysyl, glycyl. alpha-glutamyl, glutaminyl, glycyl, prolyl, lysyl, glycyl, alpha-glutamyl and threonine residues coupled in sequence.\n",
      " The molecule is a fifteen-membered glycopeptide comprising glycyl, 3-(1,3-thiazol-4-yl)alanyl, alanyl, glycyl, 3-(1,3-thiazol-4-yl)alanyl, (5R)-5-(beta-D-galactopyranosyloxy)lysyl, glycyl. alpha-glutamyl, glutaminyl, glycyl, prolyl, lysyl, glycyl, alpha-glutamyl and threonine residues coupled in sequence. \n",
      " The molecule is a fifteen-membered glycopeptide comprising glycyl, 3-(1,3-thiazol-4-yl)alanyl, alanyl, glycyl, 3-methylphenylalanyl, (5R)-5-(beta-D-galactopyranosyloxy)lysyl, glycyl. alpha-glutamyl, glutaminyl, glycyl, prolyl, lysyl, glycyl, alpha-glutamyl and threonine residues coupled in sequence.\n",
      "\n",
      "408 0.23193375549239162 0.23061320685533973 0.6958531339765073 \n",
      " CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H]([C@@H](O[C@@H]([C@H]3O)CO)O)NC(=O)C)CO)O)CO)O)O\n",
      "The molecule is an amino trisaccharide consisting of 2-acetamido-2-deoxy-alpha-D-galactopyranose, beta-D-galactopyranose and 2-acetamido-2-deoxy-beta-D-glucopyranose residu joined in sequence by (1->3) glycosidic bonds. It is an amino trisaccharide, a member of acetamides and a glucosamine oligosaccharide. It derives from an alpha-D-GalpNAc-(1->3)-beta-D-Galp and a beta-D-Galp-(1->3)-beta-D-GlcpNAc.\n",
      "The molecule is a linear amino trisaccharide comprising N-acetyl-alpha-D-galactosamine, beta-D-galactose and N-acetyl-beta-D-glucosamine residues linked sequentially (1->3) and (1->3). It has a role as an epitope. It is an amino trisaccharide, a glucosamine oligosaccharide and a galactosamine oligosaccharide.\n",
      " The molecule is an amino trisaccharide consisting of N-acetyl-alpha-D-glucosamine having an N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl group attached at the 3-position. It has a role as an epitope. It is an amino trisaccharide and a glucosamine oligosaccharide. \n",
      " The molecule is an aminotrisaccharide consisting of 2-acetamido-2-deoxy-alpha-D-galactose, beta-D-galactopyranose and 2-acetamido-2-deoxy-beta-D-glucopyranose residues joined in sequence by (1->3) and (1->3) glycosidic bonds. It is an amino trisaccharide and a member of acetamides. It derives from a N-acetyllactosamine and an alpha-D-GalpNAc-(1->3)-beta-D-Galp.\n",
      "\n",
      "416 0.6126782846122486 0.6095621512944177 0.9785826525822038 \n",
      " CCCCCCCC/C=C\\\\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OC[C@H](CO)O)OC(=O)CCCCCCC/C=C\\\\CCCCCCCC\n",
      "The molecule is a 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) in which both acyl groups are specified as oleoyl. It is a 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) and a phosphatidylglycerol 36:2(1-). It is a conjugate base of a 1,2-dioleoyl-sn-glycero-3-phospho-(1'-sn-glycerol).\n",
      "The molecule is a 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) in which both acyl groups are specified as oleoyl (9Z-octadecenoyl); major species at pH 7.3. It is a conjugate base of a 1,2-dioleoyl-sn-glycero-3-phospho-(1'-sn-glycerol).\n",
      " The molecule is a 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) obtained by deprotonation of the phosphate group of 1,2-[(1E,3E)-octadecadienoyl]-sn-glycero-3-phospho-(1'-sn-glycerol); major species at pH 7.3. It is a conjugate base of a 1,2-di[(1E,3E)-octadecadienoyl]-sn-glycero-3-phospho-(1'-sn-glycerol). \n",
      " The molecule is a 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) in which both acyl groups are specified as oleoyl. It is a 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) and a phosphatidylglycerol 36:4(1-). It is a conjugate base of a 1,2-dioleoyl-sn-glycero-3-phospho-(1'-sn-glycerol).\n",
      "\n",
      "419 0.3128802052069587 0.3394656587332876 0.6148235352862094 \n",
      " CCCCCC(=O)/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/O2)O\n",
      "The molecule is a prostaglandins I. It derives from a prostaglandin I2. It is a conjugate acid of a 15-dehydro-prostaglandin I2(1-).\n",
      "The molecule is a prostaglandin I that consists of prostaglandin I1 carrying an additional oxo substituent at position 19. It has a role as a human metabolite. It is a prostaglandins I, a secondary allylic alcohol, an oxo monocarboxylic acid and a secondary alcohol. It derives from a prostaglandin I2. It is a conjugate acid of a 19-oxoprostaglandin I2(1-).\n",
      " The molecule is a prostaglandin Falpha obtained by formal oxidation of the 15-hydroxy group of prostaglandin F2alpha. It has a role as a metabolite. It derives from a prostaglandin F2alpha. It is a conjugate acid of a 15-oxoprostaglandin F2alpha(1-). \n",
      " The molecule is a prostaglandins I. It has a role as a mouse metabolite. It is a conjugate acid of a prostaglandin I2(1-).\n",
      "\n",
      "433 0.6743518345880539 0.5227502869439773 0.826500325810986 \n",
      " C1=CC(=CC=C1CCCCCCCCCCCCCCCCCCC(=O)[O-])O\n",
      "The molecule is a monocarboxylic acid anion that is the conjugate base of 19-(4-hydroxyphenyl)nonadecanoic acid; major species at pH 7.3. It is a conjugate base of a 19-(4-hydroxyphenyl)nonadecanoic acid.\n",
      "The molecule is a monocarboxylic acid anion that is the conjugate base of 19-(4-hydroxyphenyl)nonadecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a monocarboxylic acid anion and a member of phenols. It is a conjugate base of a 19-(4-hydroxyphenyl)nonadecanoic acid.\n",
      " The molecule is a monocarboxylic acid anion that is the conjugate base of 10-(p-carboxyethyl)decanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a conjugate base of a 10-(p-carboxyethyl)decanoic acid. \n",
      " The molecule is a monocarboxylic acid anion that is the conjugate base of 19-(4-hydroxyphenyl)nonadecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a conjugate base of a 19-(4-hydroxyphenyl)nonadecanoic acid.\n",
      "\n",
      "449 0.4146544639690649 0.22869089707518292 0.882646435403761 \n",
      " CC[C@H](C[C@H]([C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O)C(C)C\n",
      "The molecule is a 3-oxo steroid that is stigmast-4-en-3-one substituted by a hydroxy group at position 22 (the 22R stereoisomer). Isolated from the whole plants of Haloxylon recurvum, it exhibits chymotrypsin inhibitory activity. It has a role as a metabolite and an EC 3.4.21.1 (chymotrypsin) inhibitor. It is a 22-hydroxy steroid and a 3-oxo-Delta(4) steroid. It derives from a hydride of a stigmastane.\n",
      "The molecule is a 3-oxo steroid that is 3-oxostigmasta-4,22-dien-3-one substituted by an ethyl group at position 3. It has been isolated from Croton gratissimus. It has a role as a metabolite. It is a 3-oxo-Delta(4) steroid and a 20-hydroxy steroid. It derives from a hydride of a stigmastane.\n",
      " The molecule is a 3beta-hydroxy steroid that is ergosta-4,6,8(14),22-tetraen-3beta-ol bearing an additional oxo substituent at position 23. It has a role as a plant metabolite. It is a 23-oxo steroid, a 3beta-hydroxy steroid and a steroid aldehyde. It derives from a hydride of an ergostane. \n",
      " The molecule is a 3-oxo steroid that is sitosterol which has been substituted by an additional hydroxy group at position 22 (the 22R stereoisomer). Isolated from the whole plants of Haloxylon recurvum, it exhibits chymotrypsin inhibitory activity. It has a role as a metabolite and an EC 3.4.21.1 (chymotrypsin) inhibitor. It is a 22-hydroxy steroid and a 3-oxo-Delta(4) steroid. It derives from a hydride of a stigmastane.\n",
      "\n",
      "454 0.41960465534155833 0.28358446286700556 0.5203375305464013 \n",
      " C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C\n",
      "The molecule is a bile acid taurine conjugate of ursocholic acid. It has a role as a human metabolite and a rat metabolite. It derives from an ursocholic acid. It is a conjugate acid of a tauroursocholate.\n",
      "The molecule is a bile acid taurine conjugate of cholic acid that usually occurs as the sodium salt of bile in mammals. It has a role as a human metabolite. It is an amino sulfonic acid and a bile acid taurine conjugate. It derives from a cholic acid. It is a conjugate acid of a taurocholate.\n",
      " The molecule is a bile acid taurine conjugate of ursoodeoxycholic acid that is ursodeoxycholic acid in which the carboxy hydrogen at position 3 has been replaced by a sulfonic acid group. It has a role as a human metabolite and a rat metabolite. It is an organosulfonic acid, a bile acid taurine conjugate, a 3alpha-hydroxy steroid, a 7beta-hydroxy steroid, a 12alpha-hydroxy steroid and a 26-hydroxy steroid. It derives from an ursodeoxycholic acid. It is a conjugate acid of an tauroursodeoxycholate. \n",
      " The molecule is a bile acid taurine conjugate derived from ursoocholic acid. It has a role as a human metabolite, an anti-inflammatory agent, a neuroprotective agent, an apoptosis inhibitor, a cardioprotective agent and a bone density conservation agent. It derives from an ursocholic acid. It is a conjugate acid of a tauroursocholate.\n",
      "\n",
      "470 0.20490115025794886 0.14050148877812788 0.34052557425498753 \n",
      " CC(CC1=CC(=C(C=C1OC)I)OC)N\n",
      "The molecule is an organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4. It is an organoiodine compound, a dimethoxybenzene and a member of amphetamines. It derives from an amphetamine.\n",
      "The molecule is a primary arylamine that is propan-2-amine substituted by iodo groups at positions 2 and 4, an iodo group at position 5 and a methoxy group at position 4. It is a metabolite of the drug verapamil. It has a role as a marine xenobiotic metabolite. It is a member of benzenes, an aromatic ether and an organoiodine compound.\n",
      " The molecule is a phenylethylamine compound having oxo substituents at the 1- and 6-positions and iodo substituents at the 3- and 5-positions. It is a member of phenylethanolamines and an organoiodine compound. \n",
      " The molecule is an organoiodine compound that is 2-aminoethylamine in which the hydrogens at positions 4 and 5 are replaced by iodine and methoxy groups, respectively. It has a role as a metabolite. It is an organoiodine compound, an aromatic ether and a primary amino compound.\n",
      "\n",
      "477 0.5552672570724014 0.22730318860320772 0.7608865373721357 \n",
      " CCOC1=NN2C(=C(C=N2)C3=NC(=NC=C3)NC4=CC(=CC=C4)N5CCOCC5)C=C1\n",
      "The molecule is a pyrazolopyridazine that is pyrazolo[1,5-b]pyridazine substituted by a 2-[3-(morpholin-4-yl)anilino]pyrimidin-4-yl group at position 3 and an ethoxy group at position 6. It is an aminopyrimidine, a member of morpholines, a secondary amino compound, a tertiary amino compound, a pyrazolopyridazine and an aromatic ether.\n",
      "The molecule is a pyrazolopyridazine that is pyrazolo[1,5-b]pyridazine which is substituted by a 2-(ethoxymethyl)phenyl group at position 3 and by a 3-morpholin-4-ylaminophenyl group at position 6. It is a pyrazolopyridazine, an aromatic ether, a member of morpholines and a member of pyrazoles.\n",
      " The molecule is a pyrazolopyridazine that is pyrazolo[1,5-a]pyridazine which is substituted at positions 3, 6, and 9 by (6-oxo-9,10-dihydro-9,10-dihydro-2H-pyrano[3,2-g][1,2,4]triazolo[4,3-a][1,4]diazin-2-yl)nitrilo, hexahydropyrrolo[3,4-b]pyridin-3-yl, and 1,3,5-triazin-2-yl groups, respectively. It is an inhibitor of the tyrosine kinase activity of fibroblast growth factor receptor \n",
      " The molecule is a pyrazolopyridazine that is pyrazolo[1,5-b]pyridazine which is substituted by a 2-[3-(morpholin-4-yl)phenyl]aminopyrimidin-4-yl group at position 3 and by an ethoxy group at position 6. It is a pyrazolopyridazine, an aromatic ether, a member of morpholines, a secondary amino compound and a substituted aniline.\n",
      "\n",
      "482 0.11320908114201265 0.2342243927433166 0.571469497620531 \n",
      " CCCCCCCCCCCCCCCC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@]5([C@H]([C@@H]4CC=C3C2)CC[C@@H]5[C@H](C)CC[C@@H](CC)C(C)C)C)C)O)O)O\n",
      "The molecule is a steroid saponin that is sitosterol attached to a 6-O-hexadecanoyl-beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has been isolated from Breynia fruticosa. It has a role as a plant metabolite. It is a fatty acid ester, a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It derives from a hexadecanoic acid and a sitosterol. It derives from a hydride of a stigmastane.\n",
      "The molecule is a cholesteryl 6-O-acyl-beta-D-galactoside having palmitoyl as the 6-O-acyl group. It is a cholesteryl 6-O-acyl-beta-D-galactoside and a monosaccharide derivative.\n",
      " The molecule is a cholesterol ester resulting from the formal condensation of the hydroxy group of beta-D-galactopyranosyl-(1->4)-3-O-hexacosanoyl-beta-D-glucose with the carboxy group of cholesterol. Isolated from Selaginella doederleinii, it exhibits anti-complement activity. It has a role as a metabolite. It is a monosaccharide derivative, a beta-D-galactoside, a cholesterol ester and a hexacosanoate ester. It derives from a beta-D-galactose and a 3-O-hexacosanoyl-beta-D-glucose. \n",
      " The molecule is a steroid saponin that is beta-sitosterol substituted by a 6-O-hexadecanoyl-beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has a role as a plant metabolite. It is a steroid saponin, a monosaccharide derivative and a beta-D-glucoside. It derives from a sitosterol and a pentadecanoic acid.\n",
      "\n",
      "488 0.3901870910072376 0.3356369076806806 0.5455815081680836 \n",
      " C[C@@]1(CC[C@@H]([C@@]2([C@]13[C@@H]([C@@H](C[C@H]2OC(=O)C4=CC=CC=C4)C(O3)(C)C)OC(=O)C5=CN=CC=C5)C)OC(=O)C6=CC=CC=C6)O\n",
      "The molecule is a sesquiterpene alkaloid that is isolated from the stem of Tripterygium regelii. It has a role as a plant metabolite. It is a sesquiterpene alkaloid, a benzoate ester, an organic heterotricyclic compound, an oxacycle, a bridged compound, a tertiary alcohol, a pyridine alkaloid and a dihydroagarofuran sesquiterpenoid. It derives from a nicotinic acid.\n",
      "The molecule is a dihydroagarofuran sesquiterpenoid that is the 15-acetoxy derivative of orbiculin G. It is isolated from Microtropis japonica and exhibits antitubercular activity. It has a role as a metabolite and an antitubercular agent. It is a benzoate ester, a bridged compound, a cyclic ether, a dihydroagarofuran sesquiterpenoid and an organic heterotricyclic compound. It derives from an orbiculin G.\n",
      " The molecule is a dihydroagarofuran sesquiterpenoid that consists of dihydro-beta-agarofuran substituted by an acetoxy group at position 1 and benzoyloxy groups at positions 2, 6 and 9. Isolated from Tripterygium wilfordii, it exhibits inhibition of both NF-kappaB activation and nitric oxide production. It has a role as an antineoplastic agent, a NF-kappaB inhibitor and a plant metabolite. It is a benzoate ester, a bridged compound, a cyclic ether, a dihydroagarofuran sesquiterpenoid and an organic heterotricyclic compound. \n",
      " The molecule is a dihydroagarofuran sesquiterpenoid that is Tripterygium wilfordii. It has a role as a plant metabolite. It is a benzoate ester, a dihydroagarofuran sesquiterpenoid, a pyridine alkaloid and a sesquiterpene alkaloid. It derives from a nicotinic acid.\n",
      "\n",
      "510 0.8507086172847941 0.7571556199152901 0.977580007065394 \n",
      " C[C@H]1CC/C=C(/C[C@@H](C(=O)N[C@H](C(=O)N([C@@H](C(=O)N[C@H](CC(=O)O1)C2=CC=C(C=C2)O)CC3=C(NC4=CC=CC=C43)Br)C)C)C)\\\\C\n",
      "The molecule is a cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it has been shown to exhibit cytotoxic and microfilament disruption activity. It has a role as an antineoplastic agent, an actin polymerisation inhibitor, an animal metabolite and a marine metabolite. It is a cyclodepsipeptide, a macrocycle and an organobromine compound.\n",
      "The molecule is a cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it has been shown to exhibit cytotoxic and microfilament disruption activity. It has a role as a metabolite, an actin polymerisation inhibitor and an antineoplastic agent. It is a cyclodepsipeptide, a macrocycle and an organobromine compound.\n",
      " The molecule is a cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity. It has a role as an antineoplastic agent, an animal metabolite and a marine metabolite. It is a cyclodepsipeptide, a macrocycle and an organobromine compound. \n",
      " The molecule is a cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it has been shown to exhibit cytotoxic and microfilament disruption activity. It has a role as an actin polymerisation inhibitor, an antineoplastic agent, an animal metabolite and a marine metabolite. It is a cyclodepsipeptide, a macrocycle and an organobromine compound.\n",
      "\n",
      "523 0.6263961081576068 0.8050005088470488 0.9721050064919134 \n",
      " CC[C@H](C)[C@@H](C(=O)[O-])NO\n",
      "The molecule is a monocarboxylic acid anion, obtained by removal of a proton from the carboxylic acid group of N-hydroxy-L-isoleucine. It is a monocarboxylic acid anion, a member of hydroxylamines and a N-hydroxy-alpha-amino-acid anion. It is a conjugate base of a N-hydroxy-L-isoleucine.\n",
      "The molecule is an N-hydroxyamino acid anion that is the conjugate base of N-hydroxy-L-isoleucine, obtained by deprotonation of the carboxy group. It is a N-hydroxy-alpha-amino-acid anion and a monocarboxylic acid anion. It is a conjugate base of a N-hydroxy-L-isoleucine.\n",
      " The molecule is a monocarboxylic acid anion, obtained by deprotonation of the carboxy group of N-hydroxy-L-isoleucine. It is a N-hydroxy-alpha-amino-acid anion, a member of acetates and a monocarboxylic acid anion. It is a conjugate base of a N-hydroxy-L-isoleucine. \n",
      " The molecule is a monocarboxylic acid anion, obtained by removal of a proton from the carboxylic acid group of N-hydroxy-L-isoleucine. It is a N-hydroxy-alpha-amino-acid anion, a member of hydroxylamines and a monocarboxylic acid anion. It is a conjugate base of a N-hydroxy-L-isoleucine.\n",
      "\n",
      "536 0.7205119964472879 0.49189405387550905 0.8657748745713122 \n",
      " CCCCCCCC/C=C\\\\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC1[C@@H]([C@H](C([C@H]([C@H]1O)O)O)O)O)OC(=O)CCC/C=C\\\\C/C=C\\\\C/C=C\\\\C/C=C\\\\CCCCC\n",
      "The molecule is 1-acyl-2-arachidonoyl-sn-glycero-3-phospho-D-myo-inositol in which the 1-acyl group is specified as oleoyl. It has a role as a human metabolite. It derives from an oleic acid and an arachidonic acid. It is a conjugate acid of a 1-oleoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol(1-).\n",
      "The molecule is a 1-acyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol in which the 1-acyl group is specified as (10Z)-octadecenoyl. It has a role as a mouse metabolite. It derives from an arachidonic acid. It is a conjugate acid of a 1-(10Z)-octadecenoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol(1-).\n",
      " The molecule is a 1-acyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol in which the 1-acyl group is specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl. It has a role as a mouse metabolite. It is a conjugate acid of a 1-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-2-arachidonoyl-sn- \n",
      " The molecule is a 1-acyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol in which the 1-acyl group is specified as oleoyl. It derives from an oleic acid and an arachidonic acid. It is a conjugate acid of a 1-oleoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol(1-).\n",
      "\n",
      "538 0.26121235157521 0.4630902478011465 0.8184142081165389 \n",
      " C1=CC(=CC=C1CN=C(N)SCCCC2=CN=CN2)Cl.Br.Br\n",
      "The molecule is a hydrobromide salt obtained by reaction of clobenpropit with two equivalents of hydrobromic acid. An extremely potent histamine H3 antagonist/inverse agonist (pA2 = 9.93). Also displays partial agonist activity at H4 receptors; induces eosinophil shape change with an EC50 of 3 nM. It has a role as a H4-receptor agonist and a H3-receptor antagonist. It contains a clobenpropit(2+).\n",
      "The molecule is the dibromide salt of clobenpropit. It has a role as a H3-receptor antagonist and an anti-allergic agent. It is a member of imidazoles and an organochlorine compound. It contains a clobenpropit(2+).\n",
      " The molecule is an imidothiocarbamic ester that consists of isothiourea bearing two 5-chloro-1H-imidazol-2-yl substituents at position 2 as well as two bromomethyl substituents at position 4. An extremely potent histamine H3 antagonist/inverse agonist (pA2 = 9.93). Also displays partial agonist activity at H4 receptors; induces eosinophil shape change with an EC50 of 3 nM. It has a role as a H3-receptor antagonist and a H4-receptor agonist. It is a member of imidazoles, an imidothiocarbamic ester and an organobrom \n",
      " The molecule is a hydrobromide salt that is the dibromide salt of clobenpropit(2+). An extremely potent histamine H3 antagonist/inverse agonist (pA2 = 9.93). Also displays partial agonist activity at H4 receptors; induces eosinophil shape change with an EC50 of 3 nM. It has a role as a H3-receptor antagonist and a H4-receptor agonist. It contains a clobenpropit(2+).\n",
      "\n",
      "542 0.1172462425787206 0.1614779529153535 0.3611991438443344 \n",
      " C1=CN(C(=NCCCCN=C(N)N)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O\n",
      "The molecule is cytidine in which the 2-keto group on the cytosine ring is substituted by the amino group of agmatine. It derives from an agmatine.\n",
      "The molecule is a nucleoside analogue in which adenosine has been modified by a guanidino group and one of the hydrogens of the exocyclic amino group is substituted by a 4-aminobutyl group. It is a nucleoside analogue and a member of guanidines. It derives from an adenosine.\n",
      " The molecule is a cytidine having a guanidino group in place of the amino group at position 2 on the cytosine ring and an azido group on the guanidine ring. It is a nucleoside analogue, a member of guanidines and a cytidine analogue. It derives from a cytosine. \n",
      " The molecule is a guanidine derivative consisting of a 3,6-diaminopropyl group attached to the N-1 position of agmatine. It derives from an agmatine.\n",
      "\n",
      "559 0.2002753507690659 0.5283432634926197 0.6315160189578788 \n",
      " CCCCCCCCCCC[C@H](CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)(O)O)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@@]3(C[C@H]([C@H]([C@H](O3)[C@@H](CO)O)O)O[C@@]4(C[C@H]([C@H]([C@H](O4)[C@@H](CO)OP(=O)(O)OCCN)O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)C[C@@H](CCCCCCCCCCC)O)NC(=O)C[C@@H](CCCCCCCCCCC)O)O)OC(=O)C[C@@H](CCCCCCCCCCC)O)O\n",
      "The molecule is a lipid A derivative, comprising lipid IVA glycosylated with two 3-deoxy-D-manno-octulosonic acid (KDO) residues with the terminal KDO carrying a (2-aminoethyl)phosphoryl group at position 7. It derives from a lipid IVA. It is a conjugate acid of a 7-O-[(2-aminoethyl)phosphoryl]-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA(6-).\n",
      "The molecule is lipid IVA glycosylated with four 3-deoxy-D-manno-octulosonic acid (KDO) residues. It is a conjugate acid of a (KDO)3-lipid IVA(7-).\n",
      " The molecule is a lipid IVA consisting of 7-O-[(2-aminoethyl)phosphoryl]-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA in which the phospho group has been oxidised to the corresponding phosphate. It is a lipid IVA and a member of phosphatidic acids. It is a conjugate acid of a 7-O-[(2-aminoethyl)phosphoryl]-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid \n",
      " The molecule is lipid IVA glycosylated with two 3-deoxy-D-manno-octulosonic acid (KDO) residues. It is a conjugate acid of a 7-O-[(2-aminoethyl)phosphoryl]-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA(7-).\n",
      "\n",
      "564 0.6891153717245884 0.6891153717245884 0.8738315181650206 \n",
      " C/C(=C\\\\C=O)/CC/C=C(\\\\C)/CO\n",
      "The molecule is a monoterpenoid that is geranial bearing a hydroxy substituent at position 8. It is a monoterpenoid, an enal and a member of prenols.\n",
      "The molecule is a monoterpenoid that is geraniol bearing an oxo substituent at position 8. It is a monoterpenoid, a member of prenols and an enal.\n",
      " The molecule is a monoterpenoid that is geraniol bearing an oxo substituent at position 8. It is a monoterpenoid, a member of prenols and an enal. \n",
      " The molecule is a monoterpenoid that is geranial bearing a hydroxy substituent at position 8. It is a monoterpenoid, a member of prenols and an enal.\n",
      "\n",
      "575 1.7620058714416993e-78 0.10281254447883102 0.21081284712197476 \n",
      " C(CN[C@@H](CCO)C(=O)O)[C@@H](C(=O)O)NCC[C@@H](C(=O)O)O\n",
      "The molecule is an avenic acid A. It has a role as a phytosiderophore. It is an enantiomer of a (R,R,R)-avenic acid A.\n",
      "The molecule is the N(5)-[(3S)-3-hydroxybutanoyl] derivative of L-ornithine. It is a L-ornithine derivative and a non-proteinogenic alpha-amino acid. It is a conjugate acid of a N(5)-[(3S)-3-hydroxybutanoyl]-L-ornithine(3-).\n",
      " The molecule is an optically active form of mugineic acid having L-configuration. It is a 2-hydroxydicarboxylic acid and a non-proteinogenic L-alpha-amino acid. It derives from a L-glutamic acid. It is a conjugate acid of a (2S,3S)-2-hydroxy-3-{[(2S)-2-carboxylato-2-hydrazinoethyl]amino}butanoate. It is an enantiomer of a (2R,3R)-mugineic acid. \n",
      " The molecule is a tricarboxylic acid. It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a conjugate acid of a mugineate(2-).\n",
      "\n",
      "580 0.5221618310698869 0.35659593473171664 0.7567010270382103 \n",
      " CSCCC(=O)[O-]\n",
      "The molecule is a thia fatty acid anion that is the conjugate base of 3-(methylthio)propionic acid. It has a role as a human metabolite. It derives from a propionate. It is a conjugate base of a 3-(methylthio)propionic acid.\n",
      "The molecule is a 3-(methylsulfanyl)propionate resulting from the deprotonation of the carboxy group of 3-(methylthio)propionic acid. The major species at pH 7.3. It is a conjugate base of a 3-(methylthio)propionic acid.\n",
      " The molecule is a monocarboxylic acid anion resulting from deprotonation of the carboxy group of 3-carboxypropionic acid; the major species at pH7.3. It has a role as a plant metabolite. It is a conjugate base of a 3-carboxypropionic acid. \n",
      " The molecule is a monocarboxylic acid anion that is the conjugate base of 3-(methylthio)propionic acid. It derives from a propionate. It is a conjugate base of a 3-(methylthio)propionic acid.\n",
      "\n",
      "597 0.13358951252533516 0.08437698860281763 0.31627719591534115 \n",
      " CC(C(C)O)O\n",
      "The molecule is a butanediol in which hydroxylation is at C-2 and C-3. It is a butanediol, a glycol and a secondary alcohol.\n",
      "The molecule is a glycol that is butane carrying three hydroxy substituents at positions 2 and 3. It derives from a hydride of a butane.\n",
      " The molecule is a glycol having two hydroxy groups in the 1- and 2-positions. It has a role as a non-polar solvent, a refrigerant and a human xenobiotic metabolite. It derives from a hydride of a butane. \n",
      " The molecule is a butanediol compound having two hydroxy groups in the 1- and 3-positions. It is a butanediol and a glycol. It derives from a hydride of a butane.\n",
      "\n",
      "599 0.10583501156027397 0.31450985808787335 0.5686133437511796 \n",
      " C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O.C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O.C(=C/C(=O)O)\\\\C(=O)O\n",
      "The molecule is a fumarate salt prepared from cobimetinib by reaction of one molecule of fumaric acid for every two molecules of cobimetinib. An inhibitor of mitogen-activated protein kinase that is used in combination with vemurafenib for the treatment of patients with unresectable or metastatic melanoma. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor and an antineoplastic agent. It is a fumarate salt and an organoammonium salt. It contains a cobimetinib(1+).\n",
      "The molecule is a fumarate salt prepared from equimolar amounts of cis-3-[(3S)-piperidin-2-yl]propanoic acid and 3-[(2S)-piperidin-2-yl]propanoic acid. It contains a cis-3-[(2S)-piperidin-2-yl]propanoic acid and a 3-[(2S)-piperidin-2-yl]propanoate.\n",
      " The molecule is a malate salt obtained by combining cobimetinib with one molar equivalent of malic acid. Used for treatment of unresectable or metastatic melanoma. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It contains a cobimetinib(1+). \n",
      " The molecule is a fumarate salt prepared from equimolar amounts of cobimetinib and fumaric acid. It is used in combination with vemurafenib for the treatment of patients with unresectable or metastatic melanoma. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor and an antineoplastic agent. It contains a cobimetinib.\n",
      "\n",
      "606 0.13506865967460394 0.17902540018030985 0.28628047234213755 \n",
      " CN1C2=C(C3=CC=CC=C3S1(=O)=O)OC(=O)N(C2=O)C4=CC=CC=N4\n",
      "The molecule is an organic heterotricyclic compound that is 2H,5H-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione 6,6-dioxide substituted at positions 3 and 5 by pyridin-2-yl and methyl groups respectively. A prodrug of piroxicam, it is used for the relief of pain and inflammation in musculoskeletal disorders such as rheumatoid arthritis and osteoarthritis. It has a role as a prodrug, a non-steroidal anti-inflammatory drug, a cyclooxygenase 1 inhibitor, a non-narcotic analgesic, a platelet aggregation inhibitor and a hepatotoxic agent. It is a member of pyridines and an organic heterotricyclic compound. It derives from a piroxicam.\n",
      "The molecule is a benzothiazine that is 1,3-benzothiazol-2(3H)-one 2,2-dioxide substituted by a methyl group at position 3, a pyridin-2-yl group at position 1 and a pyridin-2-yl group at position 3. It has a role as an environmental contaminant, a xenobiotic and a herbicide. It is a benzothiazine, a sulfone and a member of pyridines.\n",
      " The molecule is a member of the class of 2-benzofurans that is 1H-2-benzofuran-1-one substituted at position 3 by a carboxamidocarbonyl group and at position 4 by a pyrimidin-2-yl group. A non-steroidal anti-inflammatory drug of the oxicam class. It has a role as a non-steroidal anti-inflammatory drug, an analgesic and an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor. It is a member of 2-benzofurans, a N-pyrrolecarboxamide, a sulfone and a member of pyrimidines. \n",
      " The molecule is a member of the class of thiazolidinones that is 1,3-benzothiazol-2(3H)-one 2,2-dioxide substituted at position 4 by a methyl group and at position 3 by a 2-pyridyl group. A non-steroidal anti-inflammatory drug of the oxicam class, it is used to relieve pain and works by preventing the production of endogenous prostaglandins involved in the mediation of pain, stiffness, tenderness and swelling. It has a role as an analgesic, a cyclooxygenase 1 inhibitor, a non-steroidal anti-inflammatory drug, an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor and an antirheumatic drug. It is a benzothiazolidine, a member of pyridines and a sulfonamide.\n",
      "\n",
      "608 0.2643910905931183 0.3366424348557351 0.5691860817828049 \n",
      " CCCCCC(/C=C/C=C\\\\C/C=C\\\\C/C=C\\\\CCCC(=O)O)O\n",
      "The molecule is a HETE that is (5Z,8Z,11Z,13E)-15-hydroxyicosa-5,8,11,13-tetraenoic acid bearing a hydroxy substituent at position 15. It has a role as a mouse metabolite. It derives from an icosa-5,8,11,13-tetraenoic acid. It is a conjugate acid of a (5Z,8Z,11Z,13E)-15-HETE(1-).\n",
      "The molecule is an icosanoid that is (5Z,8Z,11Z,13E)-icosatetraenoic acid substituted at position 15 by a hydroxy group. It has a role as a mouse metabolite. It is an icosanoid, a long-chain fatty acid and a hydroxy polyunsaturated fatty acid.\n",
      " The molecule is a HETE that consists of (5Z,8Z,11Z,13E)-icosatetraenoic acid having the hydroxy group located at position 15. It has a role as a metabolite. It is a conjugate acid of a 15-HETE(1-). \n",
      " The molecule is an icosanoid that is (5Z,8Z,11Z,13E)-icosatetraenoic acid substituted at position 15 by a hydroxy group. It has a role as a human xenobiotic metabolite. It is a HETE and a secondary allylic alcohol. It derives from an icosa-5,8,11,13-tetraenoic acid. It is a conjugate acid of a 15-HETE(1-).\n",
      "\n",
      "612 0.24746906037245253 0.2688553727834729 0.4010850390893221 \n",
      " CCC/C=C\\\\1/C2=CC=CC=C2C(=O)O1\n",
      "The molecule is a gamma-lactone that is phthalide substituted by a butylidene group at position 3. Isolated from Ligusticum porteri, it exhibits hypoglycemic activity. It has a role as a metabolite, a hypoglycemic agent and an EC 3.2.1.20 (alpha-glucosidase) inhibitor. It is a member of 2-benzofurans and a gamma-lactone. It derives from a 2-benzofuran-1(3H)-one.\n",
      "The molecule is a member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one substituted by a butylidene group at position 3. It has a role as a metabolite.\n",
      " The molecule is a member of the class of 2,3-dihydro-1H-inden-1-ones that is 2,3-dihydro-1H-inden-1-one in which the hydrogen at position 3 is replaced by a formyl group. It has a role as a fungicide. It is a member of 2,3-dihydro-1H-inden-1-ones and a gamma-lactone. It derives from an isatin. \n",
      " The molecule is a member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one substituted by a propylidene group at position 3. It has been isolated from the mycelia of Cordyceps sinensis. It has a role as a fungal metabolite. It is a gamma-lactone and a member of 2-benzofurans.\n",
      "\n",
      "618 0.6871914863696575 0.4377121098094503 0.8342380825648356 \n",
      " CCCCCCCCCCCCCCCCCCCCCCCCCC\n",
      "The molecule is a straight-chain alkane comprising of 26 carbon atoms. It has a role as a volatile oil component and a plant metabolite.\n",
      "The molecule is a straight-chain alkane containing 24 carbon atoms. It has a role as a plant metabolite and a volatile oil component.\n",
      " The molecule is an alkane consisting of an unbranched chain of 15 carbon atoms. It has a role as a semiochemical and a plant metabolite. \n",
      " The molecule is a straight-chain alkane with 27 carbon atoms. It has a role as a volatile oil component and a plant metabolite.\n",
      "\n",
      "632 0.27335332645175137 0.2945078066927885 0.9253742688467129 \n",
      " C[C@@]12CC[C@@]3(C(=C[C@H]([C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)O)[C@@H]1CC(CC2)(C)C)C\n",
      "The molecule is the pentacyclic triterpenoid that is the 11alpha-hydroxy derivative of beta-amyrin. It is a pentacyclic triterpenoid and a secondary alcohol. It derives from a beta-amyrin.\n",
      "The molecule is a pentacyclic triterpenoid that is olean-12-ene in which the hydrogens at the 3beta and 16beta positions have been replaced by hydroxy groups. Found in the seeds of the downy thorn-apple, Datura innoxia. It has a role as a plant metabolite. It is a pentacyclic triterpenoid and a diol. It derives from a hydride of an oleanane.\n",
      " The molecule is a pentacyclic triterpenoid with formula C30H50O2, originally isolated from the roots of Tripterygium hypoglaucum. It has a role as a plant metabolite. It is a pentacyclic triterpenoid, a secondary alcohol and a diol. It derives from a hydride of an oleanane. \n",
      " The molecule is the pentacyclic triterpenoid that is the 11alpha-hydroxy derivative of beta-amyrin. It is a pentacyclic triterpenoid and a diol. It derives from a beta-amyrin.\n",
      "\n",
      "637 0.4187221119312167 0.345066065939696 0.5191496599754014 \n",
      " CNCCC1=CNC2=C1C(=CC=C2)OP(=O)(O)O\n",
      "The molecule is a tryptamine alkaloid that is N-methyltryptamine carrying an additional phosphoryloxy substituent at position 4. It has a role as a hallucinogen and a fungal metabolite. It is an organic phosphate, a tryptamine alkaloid and a secondary amino compound. It derives from a tryptamine. It is a conjugate acid of a baeocystin(1-).\n",
      "The molecule is a tryptamine alkaloid that is N,N-dimethyltryptamine carrying an additional phosphoryloxy substituent at position 4. The major hallucinogenic alkaloid isolated from Psilocybe mushrooms (also known as Teonanacatl or \"magic mushrooms\"). It has a role as a hallucinogen, a fungal metabolite, a prodrug and a serotonergic agonist. It is a tryptamine alkaloid, a member of tryptamines and an organic phosphate. It derives from a psilocin. It is a conjugate acid of a psilocybin(1-).\n",
      " The molecule is a tryptamine alkaloid that is baeocystin carrying an additional phospho substituent at position 4. The major hallucinogenic alkaloid isolated from Psilocybe mushrooms (also known as Teonanacatl or \"magic mushrooms\"). It has a role as a hallucinogen, a fungal metabolite, a serotonergic agonist and an EC 3.4.21.26 (prolyl oligopeptidase) inhibitor. It is a tryptamine alkaloid, an organic heteropentacyclic compound and an organophosphate oxoacid. It derives from a baeocystin. It is a conjugate acid of a baeocystin(1-). \n",
      " The molecule is a tryptamine alkaloid that is N-methyltryptamine carrying an additional phosphoryloxy substituent at position 4. The major hallucinogenic alkaloid isolated from Psilocybe mushrooms (also known as Teonanacatl or \"magic mushrooms\"). It has a role as a hallucinogen, a fungal metabolite, a prodrug and a serotonergic agonist. It is a tryptamine alkaloid, a member of tryptamines and an organic phosphate. It derives from a tryptamine. It is a conjugate acid of a baeocystin(1-).\n",
      "\n",
      "640 0.716921733051622 0.8214345043897252 0.9221963890094689 \n",
      " CCCCC/C=C\\\\C[C@@H](/C=C/C=C\\\\C/C=C\\\\CCCC(=O)NCC(=O)[O-])OO\n",
      "The molecule is a monocarboxylic acid anion that is the conjugate base of N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycine, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a conjugate base of a N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycine.\n",
      "The molecule is conjugate base of N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycine. It has a role as a human metabolite. It is a conjugate base of a N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycine.\n",
      " The molecule is an N-acylglycinate resulting from the deprotonation of the carboxy group of N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycine. The major species at pH 7.3. It is a conjugate base of a N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycine. \n",
      " The molecule is an N-acylglycinate that is the conjugate base of N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycine, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a conjugate base of a N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycine.\n",
      "\n",
      "657 0.1933468608720848 0.3235037883328726 0.7363341441897148 \n",
      " CCCCOC(=O)C(C)OC1=CC=C(C=C1)OC2=NC=C(C=C2)C(F)(F)F\n",
      "The molecule is a carboxylic ester resulting from the formal condensation of the carboxy group 2-(4-{[5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid with the hydroxy group of butan-1-ol. It is a carboxylic ester, an organofluorine compound, a member of pyridines and an aromatic ether. It derives from a 2-(4-{[5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid and a butan-1-ol.\n",
      "The molecule is a butyl 2-(4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy)propanoate that has S configuration. It is the inactive enantiomer of the herbicide fluazifop-P-butyl. It is an enantiomer of a fluazifop-P-butyl.\n",
      " The molecule is a benzoate ester that is the methyl ester of 2-(4-{[5-(trifluoromethyl)pyridin-2-yl]oxy}pyridin-2-yl)propanoic acid. It is the active enantiomer of the herbicide fluazifop-P-butyl. It has a role as an agrochemical, a herbicide and an EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor. It is an enantiomer of a (S)-fluazifop-P-butyl. \n",
      " The molecule is a butyl ester resulting from the formal condensation of the carboxy group of 2-(4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy)propanoic acid with the hydroxy group of butanol. It is an aromatic ether, a member of pyridines, an organofluorine compound and a carboxylic ester. It derives from a 2-(4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy)propanoic acid and a butan-1-ol.\n",
      "\n",
      "671 0.2836921086161996 0.37264478591362166 0.47946182957904626 \n",
      " C1[C@H]([C@@H]([C@H]([C@H]1O)CCC(=O)O)CCC(=O)CCCCC(=O)O)O\n",
      "The molecule is a prostanoid that is prostaglandin E2-UM in which the oxo group at position 9 has been reduced to the corresponding alcohol (alpha-configuration). It has a role as a metabolite. It is a prostanoid, an oxo dicarboxylic acid, a secondary alcohol and a ketone.\n",
      "The molecule is a prostaglandin Falpha that is prostaglandin F2alpha bearing an additional oxo substituent at position 7. It has a role as a metabolite. It is a prostaglandins Falpha and a ketone. It derives from a prostaglandin F2alpha.\n",
      " The molecule is a member of the class of prostaglandins Falpha that is prostaglandin F2alpha in which the methyl group has been oxidised to the corresponding carboxylic acid and in which the double bond at positions 13-14 has been reduced to a single bond. It has a role as a metabolite. It is a prostaglandins Falpha, an oxo dicarboxylic acid and a ketone. \n",
      " The molecule is a prostanoid that is prostaglandin F2alpha which is lacking two methylenes in the carboxyalkyl chain and in which the hydroxy group at position 15 has been oxidised to the corresponding ketone. It has a role as a metabolite. It is a prostanoid, a cyclic ketone, a secondary alcohol and a diol.\n",
      "\n",
      "730 0.29984008545567775 0.3164258710371833 0.4787080305853178 \n",
      " C([C@@H](C(=O)[O-])[NH3+])SS(=O)(=O)[O-]\n",
      "The molecule is an alpha-amino-acid anion that is the conjugate base of S-sulfo-L-cysteine; major species ar pH 7.3. It is a conjugate base of a S-sulfo-L-cysteine.\n",
      "The molecule is an S-substituted L-cysteine where the S-substituent is specified as a sulfo group. It has a role as a plant metabolite and a human metabolite. It is an organic thiosulfate and a S-substituted L-cysteine(1-). It is a conjugate base of a S-sulfo-L-cysteine.\n",
      " The molecule is an S-substituted L-cysteinate(1-) obtained by deprotonation of the carboxy and sulfo groups as well as protonation of the amino group of S-sulfo-L-cysteine; major species at pH 7.3. It has a role as a plant metabolite. It is an organosulfonate oxoanion and a S-substituted L-cysteinate(1-). It is a conjugate base of a S-sulfo-L-cysteine. \n",
      " The molecule is conjugate base of S-sulfo-L-cysteine having anionic carboxy and sulfo groups and a protonated amino group; major species at pH 7.3. It is a L-alpha-amino acid anion and an alkanesulfate oxoanion. It is a conjugate base of a S-sulfo-L-cysteine.\n",
      "\n",
      "732 0.5004986066042498 0.3673306672643805 0.6540292989632326 \n",
      " C/C=C(/C)\\\\C(=O)OC(C)(C)[C@@H]1CC2=C(O1)C=CC3=C2OC(=O)C=C3\n",
      "The molecule is an alpha,beta-unsaturated carboxylic ester obtained by formal condensation of the carboxy group of angelic acid with the hydroxy group of 2-[(8S)-2-oxo-8,9-dihydro-2H-furo[2,3-h][1]benzopyran-8-yl]propan-2-ol. It has a role as an anti-inflammatory agent, an apoptosis inducer, a hepatoprotective agent, an antineoplastic agent, a rat metabolite and a plant metabolite. It is a furanocoumarin and an alpha,beta-unsaturated carboxylic ester. It derives from an angelic acid.\n",
      "The molecule is an enoate ester obtained by formal acetylation of the tertiary hydroxy group of 2-[(8S)-2-oxo-8,9-dihydro-2H-furo[2,3-h][1]benzopyran-8-yl]propan-2-ol. It has a role as a plant metabolite. It is a furanocoumarin and an enoate ester.\n",
      " The molecule is an acetate ester obtained by formal condensation of the carboxy group of (2Z)-2,2-dimethylprop-2-en-1-oic acid with the tertiary hydroxy group of 7,8-dihydro-2H-furo[2,3-g][1]benzopyran-5,10-dione. It has a role as a plant metabolite. It is a furanocoumarin, an acetate ester and a tertiary alcohol. \n",
      " The molecule is an enoate ester obtained by formal condensation of the carboxy group of angelic acid with the hydroxy group of 2-[(8S)-2-oxo-8,9-dihydro-2H-furo[2,3-h][1]benzopyran-8-yl]propan-2-ol. It has a role as a plant metabolite. It is a furanocoumarin and an enoate ester. It derives from a angelic acid.\n",
      "\n",
      "791 0.3461810263936401 0.13944309174479658 0.4668625563648487 \n",
      " C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O\n",
      "The molecule is an N-arylpiperazine that is (3aR,4S,7R,7aS)-2-{[(1R,2R)-2-(piperazin-1-ylmethyl)cyclohexyl]methyl}hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione in which position N4 of the piperazine ring is substituted by a 1,2-benzothiazol-3-yl group. Lurasidone is used (generally as the hydrochloride salt) as an atypical antipsychotic for the treatment of schizophrenia. It has a role as an adrenergic antagonist, a dopaminergic antagonist, a serotonergic antagonist and a second generation antipsychotic. It is a 1,2-benzisothiazole, a N-arylpiperazine, a bridged compound and a dicarboximide. It derives from a maleimide. It is a conjugate base of a lurasidone(1+).\n",
      "The molecule is a dicarboximide that is lurasidone in which the methyl hydrogen attached to the nitrogen is replaced by a (1R,2R,4S,7R,8aS)-octahydro-1H-4,7-methanoisoindol-1-yl group. It is a potent and selective 5-HT1A receptor antagonist (pKi values are 9.0, 6.6, 7.5, 6.6 and  6.0 for 5-HT1A, 5-HT1C, 5-HT2 and 5-HT3 receptors respectively). Displays > 100-fold selectivity over 5-HT1A, 5-HT2A, 5-HT2C receptors and other receptor types. Centrally active following systemic administration. It has a role as a serotonergic antagonist, a dopaminergic antagonist and an antipsychotic agent. It is a dicarboximide, a member of 1,3-thiazoles, a N-arylpiperazine and a bridged compound. It is a conjugate base of a lurasidone(1+).\n",
      " The molecule is a secondary carboxamide resulting from the formal condensation of the carboxy group of (1R,2R,4S,7R,8R)-4-(1H-1,2,3-triazol-1-yl)-7-[(4S)-2,2-dimethylcyclopropyl]-1-oxo-1,2,3,4,6,7,8-octahydronaphthalen-2-carboxylic acid with the primary amino group of (7S,8R)-7-amino-N-methyl-1,5,6,7-tetrahydropyrrolo[1,2-a][1,4]benzodiazepine-2,3,8(3H,7H \n",
      " The molecule is a dicarboximide that is (3aR,4S,7R,7aS)-hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione which is substituted by a 2-[4-(benzothiazol-1-yl)piperidin-1-yl]cyclohexyl group at position 2. It is a potent and selective 5-HT1A receptor partial agonist (Ki = 27 nM). It has a role as a serotonergic antagonist and an antipsychotic agent. It is a N-alkylpiperazine, a N-arylpiperazine, an organosulfur heterocyclic compound, a member of isoindoles and a bridged compound. It is a conjugate base of a lurasidone(1+).\n",
      "\n",
      "794 0.07993137878319521 0.07617019454013037 0.3828562959331128 \n",
      " CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CC1)CCOC(=O)CC2=C(N(C3=C2C=C(C=C3)OC)C(=O)C4=CC=C(C=C4)Cl)C)NC(=O)C5=CC=CC=C5\n",
      "The molecule is a carboxylic ester obtained by formal condensation of the carboxy group of indometacin with the hydroxy group of 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl N(2)-benzoyl-N,N-dipropyl-alpha-glutaminate. Used (as its dimaleate salt) to control pain and inflammation associated with musculoskeletal and joint disorders. Following oral administration, it is metabolised to indometacin and proglumide, a drug with antisecretory effects that helps prevent injury to the stomach lining. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a lipoxygenase inhibitor, an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor, an antipyretic and a prodrug. It is a N-acylindole, an aromatic ether, a carboxylic ester, a N-alkylpiperazine, a member of benzamides and a member of monochlorobenzenes. It derives from an indometacin and a proglumide.\n",
      "The molecule is a member of the class of quinolines that is a metabolite of LY-310762. It has a role as a marine xenobiotic metabolite. It is a member of quinolines, a N-acylpiperazine, a N-alkylpiperazine, an aromatic ether, a member of monochlorobenzenes, a tertiary amino compound and a carboxylic ester.\n",
      " The molecule is a carboxylic ester resulting from the formal condensation of the carboxy group of 2-{3-[(1-carboxy-1-oxopropan-2-yl)amino]-2-oxo-1,3-dihydropropan-1-yl}-5-chloro-1-methyl-1H-indole-3-carboxylic acid with the hydroxy group of 2-{3-[(1-carboxy-1-oxopropan-2-yl)amino]-2-oxo-1,3-dihydropropan-1-yl}-1,3-dihydro-2-benzofuran-5-carboxylic \n",
      " The molecule is a carboxylic ester resulting from the formal condensation of the carboxy group of N-benzoyl-7-methoxy-2-methyl-1-(3-oxopropyl)-1,4-dihydroisoquinoline-3-carboxylic acid with the hydroxy group of 2-[4-(4-chlorobenzoyl)piperazin-1-yl]ethyl-3-methoxy-1-oxo-3,4-dihydroisoquinoline-6-carboxylic acid. Used (as its hydrochloride salt) for treatment of musculoskeletal and joint disorders. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, an antipyretic, an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor and a lipoxygenase inhibitor. It is a N-acylpiperazine, a N-alkylpiperazine, an aromatic ether, a member of monochlorobenzenes, a tertiary amino compound, a carboxylic ester and an aromatic amide. It derives from a N-benzoyl-7-methoxy-2-methyl-1-(3-oxopropyl)-1,4-dihydroisoquinoline-3-carboxylic acid and a 2-[4-(4-chlorobenzoyl)piperazin-1-yl]ethyl-3-methoxy-1-oxo-3,4-dihydroisoquinoline-6-carboxylic acid.\n",
      "\n",
      "807 0.556186405390965 0.6941223307227627 0.8420331358660859 \n",
      " C(CCNCC(=O)N)CC(C(=O)O)N\n",
      "The molecule is a lysine derivative in which the N(epsilon) of the amino acid carries a carbamoylmethyl group. It is a lysine derivative and a non-proteinogenic alpha-amino acid.\n",
      "The molecule is a lysine derivative that is lysine in which one of the hydrogens attached to N(6) is substituted by a carbamoyl group. It is a lysine derivative and a non-proteinogenic alpha-amino acid.\n",
      " The molecule is an L-lysine derivative in which the N(epsilon) of the amino acid carries a carboxymethyl substituent. It is a L-lysine derivative and a non-proteinogenic alpha-amino acid. \n",
      " The molecule is a lysine derivative in which the N(epsilon) of the amino acid carries an acetyl group. It is a lysine derivative and a non-proteinogenic alpha-amino acid.\n",
      "\n",
      "831 0.2060877744734819 0.17028949796347545 0.3073245066903749 \n",
      " CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC\n",
      "The molecule is a triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by palmitic (hexadecanoic) acid. It derives from a hexadecanoic acid.\n",
      "The molecule is a triglyceride that is glycerol in which all three hydroxy groups have been formally esterified with palmitic acid. It has a role as a plant metabolite and a Caenorhabditis elegans metabolite. It derives from a glycerol.\n",
      " The molecule is a triglyceride that is glycerol in which all three hydroxy groups have been formally esterified with acetic acid. It has a role as a plant metabolite and a Caenorhabditis elegans metabolite. It derives from an acetic acid. \n",
      " The molecule is a triglyceride that is glycerol in which all three hydroxy groups have been formally esterified with palmitic acid. It has a role as a plant metabolite and a Caenorhabditis elegans metabolite. It derives from a hexadecanoic acid.\n",
      "\n",
      "835 0.44386639620723506 0.4697317221780363 0.650640131264456 \n",
      " CCC(C)[C@@H](C(=O)N[C@@H](C(C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)CN\n",
      "The molecule is an oligopeptide composed of glycine, L-tyrosine, L-serine, L-isoleucine, L-threonine, L-serine, L-histidine and L-tyrosine joined in sequence by peptide linkages.\n",
      "The molecule is an oligopeptide composed of L-tyrosine, L-serine, L-serine, L-isoleucine, L-isoleucine, L-threonine and L-tyrosine joined in sequence by peptide linkages. It has a role as a metabolite. It derives from a L-tyrosine, a L-serine, a L-isoleucine, a L-isoleucine and a L-tyrosine.\n",
      " The molecule is an oligopeptide composed of L-glutamine, L-tyrosine, L-serine, L-alanine, L-tyrosine, L-serine, L-proline, L-isoleucine, glycine, L-tyrosine, L-serine, L-proline, L-isoleucine, glycine, L-aspartic acid and L-tyrosine joined in sequence by peptide linkages. \n",
      " The molecule is an oligopeptide composed of glycine, L-tyrosine, L-serine, L-serine, L-serine, L-phenylalanine, L-isoleucine, L-tyrosine, L-trytophan, L-phenylalanine and L-tyrosine joined in sequence by peptide linkages.\n",
      "\n",
      "842 0.26922847802452793 0.38144059014720033 0.5478307532435246 \n",
      " C([C@@H](C(=O)O)OP(=O)(O)O)S(=O)(=O)O\n",
      "The molecule is a carboxyalkyl phosphate and a carboxyalkanesulfonic acid. It derives from a rac-lactic acid. It is a conjugate acid of a (2R)-2-O-phosphonato-3-sulfonatolactate(4-).\n",
      "The molecule is a carboxyalkyl phosphate that is D-erythro-3-sulfolactic acid in which the hydroxy group at position 2 has been converted into the corresponding phosphate. It is a carboxyalkyl phosphate, a carboxyalkyl phosphate and an organosulfonic acid. It derives from a D-erythro-3-sulfolactic acid. It is a conjugate acid of a D-erythro-3-sulfolactate(3-).\n",
      " The molecule is the (R)-enantiomer of 2-O-sulfo-3-phosphoglyceric acid. It derives from a D-glyceric acid. It is a conjugate acid of a (R)-2-O-sulfo-3-phosphonatoglycerate(3-). \n",
      " The molecule is a carboxyalkyl phosphate that is D-erythronic acid in which the hydroxy group at position 2 has been oxidised to the corresponding phosphate. It derives from a D-erythronic acid. It is a conjugate acid of a (2R)-2-O-phosphonato-3-sulfonatolactate(3-).\n",
      "\n",
      "845 0.33099649006352 0.38668367233736545 0.5048346075512471 \n",
      " C([C@@H]([C@H]([C@@H](C(=O)C(=O)[O-])O)O)O)O\n",
      "The molecule is a 2-oxo monocarboxylic acid anion. It derives from a L-idonate and a L-gulonate. It is a conjugate base of a 2-dehydro-L-idonic acid.\n",
      "The molecule is a ketogluconate that is the conjugate base of 2-dehydro-L-gluconic acid, obtained by deprotonation of the carboxy group. It has a role as a human metabolite. It is a ketogluconate and a monocarboxylic acid anion. It is a conjugate base of a 2-dehydro-L-gluconic acid.\n",
      " The molecule is a carbohydrate acid anion that is the conjugate base of 2-dehydro-L-gulonic acid, obtained by deprotonation of the carboxy group. It is a conjugate base of a 2-dehydro-L-gulonic acid. \n",
      " The molecule is a ketoaldonate and a member of xylonates. It derives from a L-xylonate. It is a conjugate base of a 2-dehydro-L-xylonic acid.\n",
      "\n",
      "868 0.2767787445814542 0.1502657398051342 0.44512568515144557 \n",
      " C1=CC=C(C=C1)C2=NOC(=N2)C3=CC=CS3\n",
      "The molecule is a 1,2,4-oxadizole in which the hydrogens at positions 3 and 5 have been replaced by phenyl and thiophen-2-yl groups, respectively. It is used as a broad spectrum nematicidal seed treatment. It has a role as a nematicide and an agrochemical. It is a member of thiophenes and a 1,2,4-oxadiazole.\n",
      "The molecule is a 1,2-oxazole compound having a 4-phenyl-1,2-oxazol-3-yl group at the 2-position. It has a role as an environmental contaminant, a xenobiotic and a herbicide. It is a member of 1,2-thiazoles and a member of thiophenes.\n",
      " The molecule is a member of the class of 1,2-benzoxazoles that is 1,2-benzoxazole substituted by a 2,1-benzothiazol-3-yl group at position 4. It is a member of 1,2-benzoxazoles and a member of 1,3-benzothiazoles. \n",
      " The molecule is a 1,2,4-oxadiazole that is 1,2,4-oxadiazole substituted at positions 3 and 5 by 2-thienyl and phenyl groups respectively. It has a role as a metabolite. It is a member of 1,2,4-oxadiazoles and a member of thiophenes.\n",
      "\n",
      "870 0.2090303607333249 0.3731861984238621 0.5918046561779643 \n",
      " C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)O)O\n",
      "The molecule is a glucotriose consisting of D-glucopyranose, alpha-D-glucopyranose and beta-D-glucopyranose residues joined in sequence by two (1->4) glycosidic bonds. The configuration of the anomeric centre at the non-reducing terminus is not specified. It is a partially-defined glycan and a glucotriose.\n",
      "The molecule is a trisaccharide that is lactose in which the hydroxy group at the 3' position has been converted to the corresponding D-glucopyranosyl derivative. It is a trisaccharide and a partially-defined glycan. It derives from a lactose and a D-glucopyranose.\n",
      " The molecule is a trisaccharide consisting of beta-D-galactopyranose, alpha-D-glucopyranose and D-glucopyranose residues joined in sequence by (1->4) and (1->3) glycosidic linkages. It derives from a beta-D-Galp-(1->4)-alpha-D-Glcp and an alpha-cellobiose. \n",
      " The molecule is a glucotriose consisting of D-glucopyranose, alpha-D-glucopyranose and D-glucopyranose residuce joined in sequence by (1->4) and (1->4) glycosidic bonds. It is a glucotriose and a partially-defined glycan. It derives from a maltose and an alpha-cellobiose.\n",
      "\n",
      "871 0.20318446418719072 0.5218568546206059 0.7623473532858729 \n",
      " COC1=C(C=C(C=C1)[C@H](C=C)C2=CC(=C(C=C2O)OC)O)O\n",
      "The molecule is a member of the class of hydroquinones that is benzene-1,4-diol substituted by a methoxy group at position 5 and a prop-en-1-yl group at position 2 which in turn is substituted by a 3-hydroxy-4-methoxyphenyl group at position 1. It has been isolated from Pterocarpus santalinus. It has a role as a metabolite and a plant metabolite. It is an aromatic ether and a member of hydroquinones.\n",
      "The molecule is a member of the class of resorcinols that is eugenol in which the phenyl group that is allylated by hydroxy groups at positions 2 and 3, and methoxy groups at positions 4 and 5'. It has a role as a metabolite. It is a member of catechols and a dimethoxybenzene. It derives from an eugenol.\n",
      " The molecule is a member of the class of benzofurans that is 2,3-dihydro-1-benzofuran substituted by a hydroxy group at position 5, a methoxy group at position 4, a 2-methylprop-2-en-1-yl group at position 2 and a 3-hydroxyphenyl group at position 3. It has been isolated from Pterocarpus santalinus. It has a role as a metabolite and a plant metabolite. It is a member of benzofurans, a member of phenols and an aromatic ether. \n",
      " The molecule is a member of the class of hydroquinones that is benzene-1,3-diol substituted by a prop-2-en-1-yl group at position 4 which in turn is substituted by a 3-hydroxy-4-methoxyphenyl substituent at position 1. It has been isolated from Pterocarpus santalinus. It has a role as a metabolite and a plant metabolite. It is a member of hydroquinones, a member of methoxybenzenes and a polyphenol.\n",
      "\n",
      "880 0.41032302768839235 0.39382502567578503 0.5902565925489303 \n",
      " CCCC/C=C\\\\CCCCCCCC(=O)N\n",
      "The molecule is a primary fatty amide resulting from the formal condensation of the carboxy group of myristoleic acid with ammonia. It derives from a myristoleic acid.\n",
      "The molecule is a fatty amide resulting from the formal condensation of the carboxy group of tetradec-9-enoic acid with ammonia. It has a role as a human metabolite. It derives from a tetradec-9-enoic acid.\n",
      " The molecule is a primary fatty amide resulting from the formal condensation of the carboxy group of (Z)-hexadec-9-enoic acid with ammonia. It has a role as a human metabolite. It derives from a (Z)-hexadec-9-enoic acid. \n",
      " The molecule is a fatty amide resulting from the formal condensation of the carboxy group of (9Z)-hexadecenoic acid with ammonia. It derives from a palmitoleic acid.\n",
      "\n",
      "890 0.32835879305731147 0.3518659428966598 0.5024673679639357 \n",
      " C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)N)O)O)OP(=O)(O)O\n",
      "The molecule is a 2-amino-2-deoxy-D-glucopyranose 6-phosphate that has an alpha-configuration at the anomeric position. It has a role as a human metabolite and a Saccharomyces cerevisiae metabolite. It derives from an alpha-D-glucosamine. It is a conjugate acid of an alpha-D-glucosamine 6-phosphate(1-).\n",
      "The molecule is a galactosamine phosphate that is alpha-D-galactosamine substituted at position 1 by a monophosphate group. It derives from an alpha-D-galactosamine. It is a conjugate acid of a 6-O-phosphonato-alpha-D-galactosamine(1-).\n",
      " The molecule is a 2-ammonio-2-deoxy-D-glucopyranose in which the anomeric centre has alpha-configuration. It is a conjugate acid of an alpha-D-glucosamine 6-phosphate. \n",
      " The molecule is a glucosamine phosphate that is alpha-D-glucosamine having a monophosphate group at the 6-position. It derives from an alpha-D-glucosamine. It is a conjugate acid of an alpha-D-glucosamine 6-phosphate(1-).\n",
      "\n",
      "893 0.26337949320553106 0.36198567192555253 0.4994817583403018 \n",
      " O[As](=O)(O)[O-].[Na+]\n",
      "The molecule is an inorganic sodium salt that is the monosodium salt of arsenic acid. It has a role as a carcinogenic agent. It contains an arsenate(1-).\n",
      "The molecule is an inoganic sodium salt with formula with formula NaAsO2. It has a role as an insecticide, an antibacterial agent, an EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor, an apoptosis inducer and an antineoplastic agent. It contains an arsenate(1-).\n",
      " The molecule is an inorganic sodium salt composed from sodium cations and arsenate dianions in a 1:1 ratio. It has a role as a poison, a nephrotoxin and a hepatic steatosis inducing agent. It contains an arsenate(2-). \n",
      " The molecule is an inorganic sodium salt composed from sodium cations and arsenate dianions in a 2:1 ratio. It has a role as a poison. It contains an arsenate(1-).\n",
      "\n",
      "913 0.39767245395817813 0.49229350704801816 0.6009215690683195 \n",
      " C([C@H]([C@@H](C(=O)CO)O)O)O\n",
      "The molecule is the D-enantiomer of xylulose. It has a role as a human metabolite, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite and a mouse metabolite. It is an enantiomer of a L-xylulose.\n",
      "The molecule is the straight-chain keto form of D-tagatose. It has a role as a bacterial xenobiotic metabolite. It is an enantiomer of a L-tagatose.\n",
      " The molecule is the D-enantiomer of ketohexonic acid. It has a role as a bacterial xenobiotic metabolite. It is an enantiomer of a L-ketohexonic acid. \n",
      " The molecule is the D-enantiomer of xylulose. It has a role as a plant metabolite. It is an enantiomer of a L-xylulose.\n",
      "\n",
      "931 0.38008085818269216 0.3213866291886162 0.4869202378743401 \n",
      " C1C[C@H](N(C1)C(=O)CNC(=O)CN)C(=O)O\n",
      "The molecule is a tripeptide composed of glycine, glycine and L-proline amino acids joined in sequence by peptide linkages. It is a tautomer of a Gly-Gly-Pro zwitterion.\n",
      "The molecule is a tripeptide composed of glycine, glycine and L-proline residues joined in sequence. It has a role as a metabolite.\n",
      " The molecule is a tripeptide composed of glycine, L-proline, and L-proline residues joined in sequence. It has a role as a metabolite. It derives from a glycine, a L-proline and a L-proline zwitterion. \n",
      " The molecule is a tripeptide composed of glycine, glycine and L-proline joined in sequence by peptide linkages. It has a role as a metabolite. It derives from a glycine, a glycine and a L-proline.\n",
      "\n",
      "939 0.18200343432388327 0.3140236316800944 0.43881897981318446 \n",
      " C/C(=C\\\\CCC(C)(C=C)O)/C=O\n",
      "The molecule is a monoterpenoid that is linalool bearing an oxo substituent at position 8. It is a monoterpenoid, a tertiary alcohol and an enal.\n",
      "The molecule is a monoterpenoid that is octa-2,7-dienal substituted by a hydroxy group at position 8 and methyl groups at positions 2 and 6 respectively. It has been isolated from the leaves of Cleistocalyx operculatus and has been shown to exhibit inhibitory effects on the viral neuraminidases from two influenza viral strains, H1N1 and H9N2. It has a role as a plant metabolite and an EC 3.2.1.18 (exo-alpha-sialidase) inhibitor. It is a monoterpenoid, a tertiary alcohol and an aldehyde.\n",
      " The molecule is a monoterpenoid that is octa-2,7-dienal substituted by a hydroxy group at position 8 and methyl groups at positions 2 and 6 (the 2E-stereoisomer). It has a role as a volatile oil component and a plant metabolite. It is a monoterpenoid, a tertiary alcohol and an aldehyde. \n",
      " The molecule is a monoterpenoid that is geraniol bearing an additional hydroxy substituent at position 5 (the 2E-stereoisomer). It has a role as a metabolite. It is a monoterpenoid, a tertiary alcohol and an olefinic compound.\n",
      "\n",
      "974 0.6298502533900868 0.8415000910184904 0.9471548395860722 \n",
      " CCCCC/C=C\\\\C/C=C\\\\CCCCCCCC(=O)OC[C@H](CO)O\n",
      "The molecule is a 1-acyl-sn-glycerol that is the S-enantiomer of 1-monolinolein. It is a 1-monolinolein and a 1-acyl-sn-glycerol. It is an enantiomer of a 3-linoleoyl-sn-glycerol.\n",
      "The molecule is a 1-acyl-sn-glycerol that has octadecadienoyl (linoleoyl) as the 1-acyl group. It is a 1-acyl-sn-glycerol and a 1-monoleoylglycerol. It is an enantiomer of a 3-linoleoyl-sn-glycerol.\n",
      " The molecule is a 1-acyl-sn-glycerol that is the S-enantiomer of 1-monolinoleoyl glycerol. It is a 1-acyl-sn-glycerol and a 1-monolinoleoylglycerol. It is an enantiomer of a 3-linoleoyl-sn-glycerol. \n",
      " The molecule is a 1-acyl-sn-glycerol that is the S-enantiomer of 1-monolinolein. It is a 1-acyl-sn-glycerol and a 1-monolinolein. It is an enantiomer of a 3-linoleoyl-sn-glycerol.\n",
      "\n",
      "991 0.2241146515901863 0.2967053493444554 0.43455382667095854 \n",
      " CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3\n",
      "The molecule is a member of the class of indazoles carrying benzyl and 3-(dimethylamino)propyl groups at positions 1 and 3 respectively. A locally-acting nonsteroidal anti-inflammatory drug that also exhibits local anaesthetic and analgesic properties. It has a role as a central nervous system stimulant, a non-steroidal anti-inflammatory drug, a hallucinogen, a local anaesthetic and an analgesic. It is a member of indazoles, an aromatic ether and a tertiary amino compound. It is a conjugate base of a benzydamine(1+).\n",
      "The molecule is a member of the class of indazoles that is 1H-indazole which is substituted at positions 1 and 3 by benzyl and 3-(dimethylamino)propoxy groups, respectively. It is a member of indazoles, a tertiary amino compound and an aromatic ether.\n",
      " The molecule is a member of the class of benzodioxoles that is 1,3,4,5-tetrahydro-2H-1,4-benzodiazocine which is substituted at positions 1 and 3 by dimethylcarbamoyl and methylidene groups, respectively. It is the active metabolite of benzydamine, which is used as a local analgesic for the short-term management of mild to moderate pain. It has a role as an analgesic, a non-narcotic analgesic, a cyclooxygenase 2 inhibitor and a non-steroidal anti-inflammatory drug. It is a benzodioxole and an organonitrogen heterocyclic compound. It is a conjugate base of a benzyd \n",
      " The molecule is a member of the class of indazoles that is 1H-indazole which is substituted at positions 1 and 3 by benzyl and 3-(dimethylamino)propoxy groups, respectively. It is a H1-receptor antagonist which was developed for the treatment of inflammatory and pruritic (itching) skin disorders. It has a role as an antihypertensive agent, a cyclooxygenase 2 inhibitor, a cyclooxygenase 1 inhibitor, a non-steroidal anti-inflammatory drug and a vasodilator agent. It is a member of indazoles, a tertiary amino compound and an aromatic ether.\n",
      "\n",
      "995 0.4043228288391878 0.2992102258049629 0.5441799557959847 \n",
      " CCOC1=CC=CC=C1OCCN[C@@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N.Cl\n",
      "The molecule is a hydrochloride resulting from the reaction of equimolar amounts of ent-tamulosin and hydrogen chloride. It contains an ent-tamsulosin(1+). It is an enantiomer of a tamsulosin hydrochloride.\n",
      "The molecule is a hydrochloride salt resulting from the reaction of equimolar amounts of tamsulosin and hydrogen chloride. A specific alpha1 adrenoceptor antagonist used for the treatment of prostatic hyperplasia. It has a role as an alpha-adrenergic antagonist and an antineoplastic agent. It contains a tamsulosin(1+).\n",
      " The molecule is the hydrochloride salt of tamsulosin. The racemate containing equimolar amounts of (S)-tamsulosin hydrochloride and (R)-tamsulosin hydrochloride is used for the treatment of prostatic hyperplasia. It has a role as an alpha-adrenergic antagonist and an antineoplastic agent. It contains a tamsulosin(1+). It is an enantiomer of a (R)-tamsulosin hydrochloride. \n",
      " The molecule is a hydrochloride salt resulting from the reaction of equimolar amounts of tamsulosin and hydrogen chloride. It has a role as an alpha-adrenergic antagonist and an antineoplastic agent. It contains a tamsulosin(1+).\n",
      "\n",
      "1005 0.31541014255823424 0.26281255946919396 0.4522665073986119 \n",
      " CCCCCCCC/C=C\\\\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[NH3+])OC(=O)CCC/C=C\\\\C/C=C\\\\C/C=C\\\\C/C=C\\\\CCCCC\n",
      "The molecule is a phosphatidylethanolamine 38:5 obtained by transfer of a proton from the amino to the phosphate group of 1-oleoyl-2-arachidonoyl-sn-glycerol-3-phosphoethanolamine. It is a tautomer of a 1-oleoyl-2-arachidonoyl-sn-glycerol-3-phosphoethanolamine.\n",
      "The molecule is a phosphatidylethanolamine 37:5 zwitterion in which the acyl groups at positions 1 and 2 are specified as 10Z-octadecenoyl and arachidonoyl respectively. It is a phosphatidylethanolamine 37:5 zwitterion and a 1-acyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine zwitterion.\n",
      " The molecule is a phosphatidylethanolamine 35:5 zwitterion in which the acyl groups at positions 1 and 2 are specified as 1-O-(5Z,8Z,11Z,14Z-icosatetraenoyl) and arachidonoyl respectively. It is a phosphatidylethanolamine 35:5 zwitterion and a 1-acyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine zwitterion. \n",
      " The molecule is a phosphatidylethanolamine 37:5 zwitterion in which the acyl groups at positions 1 and 2 are specified as oleoyl and arachidonoyl respectively. It is a phosphatidylethanolamine 37:5 zwitterion and a 1-acyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine zwitterion. It is a tautomer of a 1-oleoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine.\n",
      "\n",
      "1007 0.15867865090944902 0.19729997180004152 0.6905274360473287 \n",
      " C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O[C@@]6(C[C@@H]([C@H]([C@@H](O6)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)O)NC(=O)C)O)CO)O[C@H]7[C@H]([C@H](O[C@H]([C@@H]7O)O[C@@H]8[C@H](OC([C@@H]([C@H]8O)NC(=O)C)O)CO)CO)O)NC(=O)C)O)O)O\n",
      "The molecule is a glucosamine oligosaccharide comprising N-acetyl-alpha-neuraminosyl, beta-D-galactosyl, 2-acetamido-2-deoxy-beta-D-glucosyl, beta-D-galactosyl, 2-acetamido-2-deoxy-3-O-(alpha-L-fucosyl)-beta-D-glucosyl, beta-D-galactosyl, and 2-acetamido-2-deoxy-D-glucose joined together in sequence by (2->3), (1->4), (1->3), (1->4), (1->3) and (1->4) glycosidic linkages, respectively. It is a carbohydrate acid derivative, a galactosamine oligosaccharide and a glucosamine oligosaccharide. It is a conjugate acid of an alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc(1-).\n",
      "The molecule is a branched amino octasaccharide consisting of the tetrasaccharide beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosamine having an alpha-N-acetylneuraminyl residue attached at the 3-position of the galactosyl residue at the non-reducing end and an alpha-L-fucosyl residue attached at the 3-position of the N-acetyl-D-glucosaminyl residue at the reducing end. It has a role as an epitope. It is an amino octasaccharide and a glucosamine oligosaccharide.\n",
      " The molecule is a carbohydrate acid derivative anion resulting from the deprotonation of the carboxy group of alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc. The major species at pH 7. \n",
      " The molecule is a glucosamine oligosaccharide comprising N-acetyl-alpha-neuraminosyl, beta-D-galactosyl, 2-acetamido-2-deoxy-3-O-(alpha-L-fucosyl)-beta-D-glucosyl, beta-D-galactosyl, 2-acetamido-2-deoxy-3-O-(alpha-L-fucosyl)-beta-D-glucosyl, beta-D-galactosyl, and 2-acetamido-2-deoxy-D-glucose joined together in sequence by (2->3), (1->4), (1->3), (1->4), (1->3) and (1->4) glycosidic linkages, respectively. It is a glucosamine oligosaccharide, a galactosamine oligosaccharide and a carbohydrate acid derivative. It derives from an alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc. It is a conjugate acid of an alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-\n",
      "\n",
      "1009 0.11466242285587572 0.10159234632792838 0.31839115775894655 \n",
      " CC(C)CCCCCCCCCCCCCCCC=C\n",
      "The molecule is a branched C20 alkene consisting of a 19-carbon chain with a double bond between C-1 and C-2 and a methyl group at C-18.\n",
      "The molecule is an alkene that is docosane substituted by a methyl group at position 18. Metabolite observed in cancer metabolism. It has a role as a human metabolite.\n",
      " The molecule is an alkene that is hept-1-ene substituted by a methyl group at position 3. It has a role as a plant metabolite. It derives from a hydride of a hept-1-ene. \n",
      " The molecule is an unbranched nineteen-carbon alkene with one double bond between C-1 and C-2. It has a role as a plant metabolite and a bacterial metabolite.\n",
      "\n",
      "1011 0.3162729575529707 0.4009303368612343 0.581473569276706 \n",
      " CCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@@H](CCCCCCCCCCCCCCC)O\n",
      "The molecule is a dihydroceramide in which the ceramide N-acyl group is specified as eicosanoyl It has a role as a mouse metabolite. It derives from an icosanoic acid.\n",
      "The molecule is an N-acylhexadecasphinganine in which the acyl group is specified as icosanoyl. It is a N-acylhexadecasphinganine and a Cer(d38:0). It derives from an icosanoic acid.\n",
      " The molecule is a dihydroceramide in which the ceramide N-acyl group is specified as octadecanoyl (stearoyl). It is a N-acylsphinganine and a N-stearoyl-sphingoid base. It derives from an octadecanoic acid. \n",
      " The molecule is a dihydroceramide in which the ceramide N-acyl group is specified as eicosanoyl (arachidoyl). It has a role as a mouse metabolite. It is a N-acylsphinganine and a N-stearoyl-sphingoid base. It derives from an icosanoic acid.\n",
      "\n",
      "1014 0.2653856085536222 0.32395479726318 0.4285870237282496 \n",
      " CC(=C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O\n",
      "The molecule is a dicarboxylic acid, a pyrrolidinecarboxylic acid, a L-proline derivative and a non-proteinogenic L-alpha-amino acid. It has a role as an antinematodal drug and an excitatory amino acid agonist.\n",
      "The molecule is an L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a prop-1-en-2-yl group at position 5. It is a L-proline derivative, a non-proteinogenic L-alpha-amino acid and an isopropenyl carboxylic acid.\n",
      " The molecule is an L-proline derivative in which the hydrogen attached to the nitrogen of the pyrrolidine ring is replaced by a carboxymethyl group. It is a L-proline derivative, a N-acyl-L-alpha-amino acid and a non-proteinogenic L-alpha-amino acid. \n",
      " The molecule is an L-proline derivative in which the pyrrolidine ring is substituted by a carboxymethyl group at position 3 and a 2-isopropenyl group at position 5. It is a pyrrolidinecarboxylic acid, a L-proline derivative and a non-proteinogenic L-alpha-amino acid.\n",
      "\n",
      "1018 0.6481927306028747 0.7395824404049812 0.9666288111286023 \n",
      " CC(=CCC/C(=C/CC/C(=C/CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\COP(=O)([O-])OP(=O)([O-])O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)NC(=O)C)/C)/C)/C)/C)/C)/C)/C)/C)/C)/C)C\n",
      "The molecule is an organophosphate oxoanion obtained by deprotonation of both free diphosphate OH groups of alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-1-diphospho-ditrans,polycis-undecaprenol; major species at pH 7.3. It is a conjugate base of an alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-1-diphospho-ditrans,polycis-undecaprenol.\n",
      "The molecule is an organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol. It is a conjugate base of an alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol.\n",
      " The molecule is an organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-1-diphospho-ditrans,polycis-undecaprenol. Major species at pH 7.3. It is a conjugate base of an alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-alpha-D-mannosyl \n",
      " The molecule is an organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-1-diphospho-ditrans,polycis-undecaprenol. Major species at pH 7.3. It is a conjugate base of an alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-1-diphospho-ditrans,polycis-undecaprenol.\n",
      "\n",
      "1033 0.7227194198897027 0.3901136249380182 1.0 \n",
      " C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C\n",
      "The molecule is a bile acid taurine conjugate of deoxycholic acid. It has a role as a human metabolite. It derives from a deoxycholic acid. It is a conjugate acid of a taurodeoxycholate.\n",
      "The molecule is the bile acid taurine conjugate of deoxycholic acid. It has a role as a human metabolite. It is a bile acid taurine conjugate and a monocarboxylic acid amide. It derives from a deoxycholic acid. It is a conjugate acid of a taurodeoxycholate.\n",
      " The molecule is a bile acid taurine conjugate of dihydroxy-5beta-cholanic acid. It has a role as a human metabolite. It is a bile acid taurine conjugate and a monocarboxylic acid amide. It derives from a dihydroxy-5beta-cholanic acid. It is a conjugate acid of a tauro-dihydroxy-5beta-cholanate. \n",
      " The molecule is a bile acid taurine conjugate of deoxycholic acid. It has a role as a human metabolite. It derives from a deoxycholic acid. It is a conjugate acid of a taurodeoxycholate.\n",
      "\n",
      "1046 0.6279342507972085 0.6118540898894637 0.8323978179356308 \n",
      " CCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](COP(=O)([O-])[O-])[C@@H](/C=C/CCCCCCCCCCCCC)O\n",
      "The molecule is a ceramide 1-phosphate(2-) in which the N-acyl group is specified as eicosanoyl. It is a conjugate base of a N-icosanoylsphingosine 1-phosphate.\n",
      "The molecule is a N-acylsphingosine 1-phosphate(2-) in which the N-acyl group is specified as eicosanoyl; major species at pH 7.3. It is a conjugate base of a N-eicosanoylsphingosine 1-phosphate.\n",
      " The molecule is a N-acylsphingosine 1-phosphate(2-) in which the N-acyl group is specified as hexadecanoyl (palmitoyl). It is a conjugate base of a N-hexadecanoylsphingosine 1-phosphate. \n",
      " The molecule is a ceramide 1-phosphate(2-) in which the ceramide N-acyl group is specified as eicosanoyl. It is a conjugate base of a N-eicosanoylsphingosine 1-phosphate.\n",
      "\n",
      "1066 0.6847577959328691 0.35031701289215755 0.8308988231572436 \n",
      " C/C/1=C/2\\\\[C@@]([C@@H](/C(=C/C3=[NH+]/C(=C(\\\\C4=[NH+][C@H]([C@@H]([C@@]4(C)CCC(=O)[O-])CC(=O)[O-])[C@]5([C@@]([C@@H](C1=[NH+]5)CCC(=O)[O-])(C)CC(=O)N)C)/C)/[C@H](C3(C)C)CCC(=O)[O-])/N2)CCC(=O)[O-])(C)CC(=O)N\n",
      "The molecule is a precorrin carboxylic acid anion that is the dianionic form of hydrogenobyrinic acid a,c-diamide. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). It is a conjugate base of a hydrogenobyrinic acid a,c-diamide. It is a conjugate acid of a hydrogenobyrinic acid a,c-diamide(4-).\n",
      "The molecule is a precorrin carboxylic acid anion that is the tetraanionic form of hydrogenobyrinic acid. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). It is a conjugate base of a hydrogenobyrinic acid. It is a conjugate acid of a hydrogenobyrinate(6-).\n",
      " The molecule is tetraanion of hydrogenobyrinic acid a,c-diamide It is a conjugate base of a hydrogenobyrinic acid a,c-diamide and a hydrogenobyrinic acid a,c-diamide(2-). \n",
      " The molecule is a precorrin carboxylic acid anion that is the tetraanionic form of hydrogenobyrinic acid a,c-diamide It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). It is a conjugate base of a hydrogenobyrinic acid a,c-diamide and a hydrogenobyrinic acid a,c-diamide(2-).\n",
      "\n",
      "1071 0.39042914348191704 0.2884002470437969 0.8429891763978068 \n",
      " COC1=C(C=CC(=C1)O)[C@@H]2COC3=C([C@H]2O)C=CC(=C3)O\n",
      "The molecule is a member of the class of isoflavans that is isoflavan with hydroxy substituents at positions 4, 7 and 4' and a methoxy group at position 2 (the 3R,4S stereoisomer). It is isolated from Caragana conferta and exhibits significant anti-inflammatory activity in the respiratory burst assay. It has a role as a metabolite and an anti-inflammatory agent. It is a secondary alcohol, a monomethoxybenzene and a member of hydroxyisoflavans.\n",
      "The molecule is a member of the class of hydroxyisoflavans that is (3R,4S)-3,4-dihydroisoflavan substituted by hydroxy groups at positions 7 and 2' and a methoxy group at position 4'. It has a role as an anti-inflammatory agent and a plant metabolite. It is a member of hydroxyisoflavans and a methoxyisoflavan. It derives from a (3R,4S)-3,4-dihydroisoflavan.\n",
      " The molecule is a hydroxyisoflavan that is (R)-isoflavan substituted by hydroxy groups at positions 7 and 2' and a methoxy group at position 4'. It has a role as a plant metabolite. It is a member of hydroxyisoflavans, a methoxyisoflavan and a secondary alcohol. It derives from a (R)-isoflavan. \n",
      " The molecule is a member of the class of isoflavans that is isoflavan with hydroxy groups at positions 3, 7 and 4' and a methoxy group at position 2' (the 3R,4S stereoisomer). It is isolated from Caragana conferta and exhibits significant anti-inflammatory activity in the respiratory burst assay. It has a role as a metabolite and an anti-inflammatory agent. It is a secondary alcohol, a monomethoxybenzene, a member of hydroxyisoflavans and a methoxyisoflavan.\n",
      "\n",
      "1079 0.660611121723954 0.8149837141259721 1.0 \n",
      " COC1=C(C=C(C=C1)C[C@@H]2C3=CC(=C(C=C3CC[NH2+]2)OC)OC)OC\n",
      "The molecule is an organic cation that is the conjugate acid of (R)-tetrahydropapaverine, obtained by protonation of the secondary amino group; major species at pH 7.3. It is an ammonium ion derivative and an organic cation. It is a conjugate acid of a (R)-tetrahydropapaverine.\n",
      "The molecule is an organic cation that is the conjugate acid of (R)-laudanosine, obtained by protonation of the secondary amino group. It is an ammonium ion derivative and an organic cation. It is a conjugate acid of a (R)-laudanosine.\n",
      " The molecule is an organic cation that is the conjugate acid of (R)-norlaudanosoline, obtained by protonation of the secondary amino group; major species at pH 7.3. It is an ammonium ion derivative and an organic cation. It is a conjugate acid of a (R)-norlaudanosoline. \n",
      " The molecule is an organic cation that is the conjugate acid of (R)-tetrahydropapaverine, obtained by protonation of the secondary amino group; major species at pH 7.3. It is an ammonium ion derivative and an organic cation. It is a conjugate acid of a (R)-tetrahydropapaverine.\n",
      "\n",
      "1141 0.09842973096083582 0.22705121615058635 0.35979939934371236 \n",
      " C1=CC=C2C=CC=CC2=C1\n",
      "The molecule is an aromatic hydrocarbon comprising two fused benzene rings. It occurs in the essential oils of numerous plant species e.g. magnolia. It has a role as a volatile oil component, a plant metabolite, an environmental contaminant, a carcinogenic agent, a mouse metabolite and an apoptosis inhibitor. It is an ortho-fused bicyclic arene and a member of naphthalenes.\n",
      "The molecule is a mancude carbobicyclic parent consisting of a cycloheptatriene and cyclopentadiene rings. It has a role as a plant metabolite and a mouse metabolite.\n",
      " The molecule is a polycyclic aromatic hydrocarbon composed of three fused benzene rings which takes its name from the two terms 'phenyl' and 'anthracene.' It has a role as an environmental contaminant and a mouse metabolite. It is an ortho-fused polycyclic arene, a member of phenanthrenes and a polycyclic aromatic hydrocarbon. \n",
      " The molecule is a mancude carbobicyclic parent consisting of a cycloheptatriene and cyclopentadiene rings. It has a role as a plant metabolite and a volatile oil component. It is an ortho-fused bicyclic arene, a member of naphthalenes and a mancude carbobicyclic parent.\n",
      "\n",
      "1171 0.8058957786493766 0.3761343279692976 0.9887760724645923 \n",
      " CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)NC(=O)C)O[C@H]4[C@H]([C@H](O[C@H]([C@@H]4O)O[C@@H]5[C@H](O[C@H]([C@@H]([C@H]5O)NC(=O)C)O[C@H]6[C@H]([C@H](O[C@H]([C@@H]6O)O[C@@H]7[C@H](O[C@H]([C@@H]([C@H]7O)NC(=O)C)O[C@H]8[C@H]([C@@H]([C@H](O[C@@H]8OC[C@@H]9[C@H]([C@@H]([C@@H]([C@@H](O9)O[C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)NC(=O)C)O[C@@H]1[C@H](OC([C@@H]([C@H]1O)NC(=O)C)O)CO)CO)O)O[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O[C@@]1(C[C@@H]([C@H]([C@@H](O1)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)O)NC(=O)C)O)O)NC(=O)C)O)O)NC(=O)C)O)CO)O)O)CO)CO)O)CO)CO)O)CO)CO)O)O\n",
      "The molecule is a branched amino oligosaccharide that is an nonadecasaccharide derivative consisting of a linear trisaccharide of beta-D-mannose and two N-acetyl-beta-D-glucosamine residues all linked in sequence (1->4), to the mannosyl residue of which are linked linked (1->3) and (1->6) two N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl linear octasaccharide units. It is an amino oligosaccharide and a glucosamine oligosaccharide.\n",
      "The molecule is a branched amino oligosaccharide that is a pentadecasaccharide derivative consisting of a linear trisaccharide of beta-D-mannose and two N-acetyl-beta-D-glucosamine residues all linked in sequence (1->4), to the mannosyl residue of which are linked linked (1->3) and (1->6) two N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl linear hexasaccharide units. It is an amino oligosaccharide and a glucosamine oligosaccharide.\n",
      " The molecule is a branched amino oligosaccharide that is a pentadecasaccharide derivative consisting of a linear trisaccharide of beta-D-mannose and two N-acetyl-beta-D-glucosamine residues (one of which is at the reducing end) all linked in sequence (1->4), to the mannosyl residue of which are linked (1->3) and (1->6) two N-glycoloyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl- \n",
      " The molecule is a branched amino oligosaccharide that is a nonadecasaccharide derivative consisting of a linear trisaccharide of beta-D-mannose and two N-acetyl-beta-D-glucosamine residues all linked in sequence (1->4), to the mannosyl residue of which are linked linked (1->3) and (1->6) two N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl linear octasaccharide units. It is an amino oligosaccharide and a glucosamine oligosaccharide.\n",
      "\n",
      "1176 0.4148298828628241 0.28962707957406775 0.6356579408934371 \n",
      " C1=CC=C2C(=C1)C(=CN2)CC=NO\n",
      "The molecule is an aldoxime resulting from the formal condensation of the aldehyde moiety of indol-3-ylacetaldehyde with hydroxylamine. It is a member of indoles and an aldoxime.\n",
      "The molecule is an aldoxime obtained by the formal condensation of the aldehyde group of indole-3-acetaldehyde with hydroxylamine. It is an oxoaldehyde and a member of indoles. It derives from an indole-3-acetaldehyde.\n",
      " The molecule is an indolylacetaldehyde that is 3-(indol-3-yl)acetaldehyde having a double bond at position 2. It has a role as a bacterial metabolite. It is a member of indoles and an indolylacetaldehyde. \n",
      " The molecule is an aldoxime resulting from the formal condensation of the aldehyde moiety of indol-3-acetaldehyde with hydroxylamine. It is an aldoxime and a member of indoles. It derives from an indole-3-acetaldehyde.\n",
      "\n",
      "1178 0.7742939453939356 0.4275818823945556 0.8755278894087016 \n",
      " CCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC/C=C\\\\CCCCCCCC\n",
      "The molecule is a 1,2-diacyl-sn-glycerol that has lauroyl and oleoyl as 1- and 2-acyl groups respectively. It is a 1,2-diacyl-sn-glycerol, a 1-lauroyl-2-oleoylglycerol and a dodecanoate ester. It is an enantiomer of a 3-lauroyl-2-oleoyl-sn-glycerol.\n",
      "The molecule is a 2,3-diacyl-sn-glycerol that has oleoyl and lauroyl as the 2- and 3-acyl groups respectively. It is a 2,3-diacyl-sn-glycerol, a 1-lauroyl-2-oleoylglycerol and a dodecanoate ester. It is an enantiomer of a 1-lauroyl-2-oleoyl-sn-glycerol.\n",
      " The molecule is a 1,2-diacyl-sn-glycerol with myristoyl and palmitoleoyl as 1- and 2-acyl groups respectively. It has a role as a mouse metabolite. It is a 1,2-diacyl-sn-glycerol and a tetradecanoate ester. It derives from a palmitoleic acid. \n",
      " The molecule is a 1,2-diacyl-sn-glycerol that has oleoyl and lauroyl as the 1- and 2-acyl groups respectively. It is a 1,2-diacyl-sn-glycerol, a 1-lauroyl-2-oleoylglycerol and a dodecanoate ester. It is an enantiomer of a 2-oleoyl-3-lauroyl-sn-glycerol.\n",
      "\n",
      "1218 0.3552513686819699 0.37621665428491147 0.5277099807063024 \n",
      " C(CCN)C[C@@H](C(=O)[O-])[NH3+]\n",
      "The molecule is an L-alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of L-lysine; major species at pH 7.3. It has a role as a human metabolite. It is a conjugate base of a L-lysinium(1+). It is a tautomer of a L-lysine.\n",
      "The molecule is an optically active form of lysinium having L-configuration. It has a role as an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite and a plant metabolite. It is a lysinium(1+) and a polar amino acid zwitterion. It is a conjugate base of a L-lysinium(2+). It is a conjugate acid of a L-lysine and a L-lysine zwitterion. It is an enantiomer of a D-lysinium(1+).\n",
      " The molecule is an optically active form of lysinium having L-configuration. It has a role as an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite and a plant metabolite. It is a lysinium(1+) and a L-alpha-amino acid zwitterion. It is a conjugate base of a L-lysinium(2+). It is a conjugate acid of a L-lysine and a L-lysine zwitterion. It is an enantiomer of a D-lysinium(1+). \n",
      " The molecule is an L-alpha-amino acid zwitterion obtained from L-lysine by transfer of a proton from the carboxy to the amino group; major species at pH 7.3. It is a tautomer of a L-lysine.\n",
      "\n",
      "1224 0.24615591878745427 0.24615591878745427 0.42766628109442595 \n",
      " C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)O)O)OC)C\n",
      "The molecule is a quaternary ammonium ion obtained by methylation of the tertiary amino function of reticuline. It derives from a reticuline.\n",
      "The molecule is a tembetarine obtained by methylation of the tertiary amino function of (R)-reticuline. It has a role as a plant metabolite. It is a benzylisoquinoline alkaloid and a tembetarine. It derives from a (S)-reticuline. It is an enantiomer of a (R)-tembetarine.\n",
      " The molecule is a tembetarine obtained by methylation of the tertiary amino function of (R)-reticuline. It has a role as a plant metabolite. It is a benzylisoquinoline alkaloid and a tembetarine. It derives from a (S)-reticuline. It is an enantiomer of a (R)-tembetarine. \n",
      " The molecule is a tembetarine obtained by methylation of the tertiary amino function of reticuline. It has a role as a plant metabolite. It is a benzylisoquinoline alkaloid and a tembetarine. It derives from a reticuline.\n",
      "\n",
      "1243 0.10974172960774563 2.893794516527669e-78 0.2285184744536011 \n",
      " CC1C(NC2=CC=CC=C2C1=O)C=O\n",
      "The molecule is an amino aldehyde that is 1,2,3,4-tetrahydroquinoline which is substituted at positions 2, 3, and 4 by formyl, methyl, and oxo groups, respectively. It is an aromatic ketone, a cyclic ketone, a member of quinolines and an amino aldehyde.\n",
      "The molecule is a member of the class of oxindoles that is 1,3-dihydro-2H-indol-2-one which is substituted at position 4 by a formyl group and at position 3 by a methyl group. It is a metabolite of metolachlor. It has a role as a bacterial xenobiotic metabolite. It is a member of oxindoles and a member of methylindoles.\n",
      " The molecule is a member of the class of pyrrolidin-2-ones that is 2,3-dihydro-1H-pyrrol-1-one substituted by a formyl group at position 3 and methyl groups at positions 2 and 4. It has a role as a plant metabolite. It is a member of pyrrolidin-2-ones, an aldehyde and a methyl ketone. It derives from a 3-formyl-2,3-dihydro-1H-pyrrol-1-one. \n",
      " The molecule is a member of the class of quinolones that is 1,4-dihydroquinoline-3-carbaldehyde in which the hydrogen at position 4 has been replaced by a formyl group. It is a quinolone, a cyclic ketone, an aromatic ketone and a delta-lactam.\n",
      "\n",
      "1254 0.7349672056201979 0.7585045874691145 0.9770064524882032 \n",
      " CCCCC[C@@H]1[C@@H](O1)C[C@@H](/C=C/C=C\\\\C/C=C\\\\CCCC(=O)O)OO\n",
      "The molecule is a hydroperoxy fatty acid that is (14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoic acid in which the hydroperoxy group is located at position 12S. It has a role as a human xenobiotic metabolite and a mouse metabolite. It is a conjugate acid of a (12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoate.\n",
      "The molecule is a hydroperoxy fatty acid that is (14S,15R)-EET in which the pro-S hydrogen at position 14 has been replaced by a hydroperoxy group. It has a role as a human xenobiotic metabolite and a mouse metabolite. It is a conjugate acid of a (12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoate.\n",
      " The molecule is a hydroperoxy fatty acid that is (14R,15S)-epoxy-(5Z,8Z,12E)-icosatrienoic acid in which the hydroperoxy group is located at position 11R. It has a role as a human xenobiotic metabolite. It is a conjugate acid of an (11R)-hydroperoxy-(14R,15S)-epoxy-(5Z,8Z,12E)-icosatrienoate. \n",
      " The molecule is a hydroperoxy fatty acid that is (14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoic acid in which the hydroperoxy group is located at position 14S. It has a role as a human xenobiotic metabolite and a mouse metabolite. It is a conjugate acid of a (12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoate.\n",
      "\n",
      "1256 0.18713917671332136 0.27959501137572096 0.7688027497008504 \n",
      " CC(C)(C(=O)[O-])O\n",
      "The molecule is a hydroxy fatty acid anion that is the conjugate base of 2-hydroxyisobutyric acid, arising from deprotonation of the carboxy group; major species at pH 7.3. It has a role as a human xenobiotic metabolite. It derives from an isobutyrate. It is a conjugate base of a 2-hydroxyisobutyric acid.\n",
      "The molecule is a hydroxy monocarboxylic acid anion. It derives from a propionate. It is a conjugate base of a 2-hydroxyisobutyric acid.\n",
      " The molecule is a hydroxy monocarboxylic acid anion that is the conjugate base of 2-hydroxy-2-methylpropanoic acid. It is a conjugate base of a 2-hydroxy-2-methylpropanoic acid. \n",
      " The molecule is a hydroxy monocarboxylic acid anion that is the conjugate base of 2-hydroxyisobutyric acid, arising from deprotonation of the carboxy group. It has a role as a human metabolite. It derives from an isobutyrate. It is a conjugate base of a 2-hydroxyisobutyric acid.\n",
      "\n",
      "1260 0.5688606667852565 0.5152910735419387 0.673928096644812 \n",
      " CC/C=C\\\\C/C=C\\\\C/C=C\\\\C/C=C\\\\CCCCC(=O)[O-]\n",
      "The molecule is a polyunsaturated fatty acid anion that is the conjugate base of (6Z,9Z,12Z,15Z)-octadecatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. It has a role as a plant metabolite. It is a conjugate base of an all-cis-octadeca-6,9,12,15-tetraenoic acid.\n",
      "The molecule is an unsaturated fatty acid anion that is the conjugate base of (6Z,9Z,12Z,15Z)-octadecatetraenoic acid, obtained by deprotonation of the carboxy group. It is a long-chain fatty acid anion, a polyunsaturated fatty acid anion and an octadecatetraenoate. It is a conjugate base of a (6Z,9Z,12Z,15Z)-octadecatetraenoic acid.\n",
      " The molecule is an octadecatetraenoate that is the conjugate base of (4Z,7Z,10Z,13Z)-octadecatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a conjugate base of a (4Z,7Z,10Z,13Z)-octadecatetraenoic acid. \n",
      " The molecule is an unsaturated fatty acid anion that is the conjugate base of (6Z,9Z,12Z,15Z)-octadecatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a conjugate base of a (6Z,9Z,12Z,15Z)-octadecatetraenoic acid.\n",
      "\n",
      "1263 0.43180107294380665 0.42748811236486217 0.8762496202396681 \n",
      " CC(=CCC/C(=C/CC/C(=C/CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\COP(=O)(O)OP(=O)(O)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O)/C)/C)/C)/C)/C)/C)/C)/C)/C)/C)C\n",
      "The molecule is a polyprenyl phospho oligosaccharide that is a trisaccharide consisting of one mannose and two glucose residues linked via a diphospho group to undecaprenol. It is a conjugate acid of an alpha-D-Man-(1->3)-beta-D-Glc-(1->4)-alpha-D-Glc-1-diphospho-ditrans,polycis-undecaprenol(2-).\n",
      "The molecule is a polyprenyl glycosyl phosphate consisting of alpha-D-mannosyl-(1->3)-beta-D-mannosyl-(1->4)-alpha-D-glucose attached at the 1-position to decaprenyl phosphate. It is a conjugate acid of an alpha-D-mannosyl-(1->3)-beta-D-mannosyl-(1->4)-alpha-D-glucosyl-1-diphosphodecaprenol(2-).\n",
      " The molecule is an organophosphate oxoanion that is the dianion of alpha-D-Man-(1->3)-beta-D-Glc-(1->4)-alpha-D-Glc-1-diphospho-ditrans,polycis-undecaprenol arising from deprotonation of both free diphosphate OH groups; major species at pH 7.3. It is a conjugate base of an alpha-D-Man-(1->3)-beta-D-Glc-(1->4)-alpha-D-Glc-1-diphospho-ditrans,polycis-undecaprenol. \n",
      " The molecule is a polyprenyl phospho oligosaccharide that is a tetrasaccharide consisting of one glucosyl residue, two mannose and two glucose residues linked via a diphospho group to undecaprenol. It is a conjugate acid of an alpha-D-Man-(1->3)-beta-D-Glc-(1->4)-alpha-D-Glc-1-diphospho-ditrans,polycis-undecaprenol(2-).\n",
      "\n",
      "1274 0.35785295135514417 0.2742361512190857 0.473795023091535 \n",
      " C[C@@H]([C@@H](C(=O)O)N)C(=O)O\n",
      "The molecule is an aspartic acid derivative having a 3-methyl substituent. It is a non-proteinogenic L-alpha-amino acid and an amino dicarboxylic acid. It is a conjugate acid of a threo-3-methyl-L-aspartate(1-).\n",
      "The molecule is the D-enantiomer of threo-3-methyl-L-aspartic acid. It has a role as a Saccharomyces cerevisiae metabolite. It is a conjugate acid of a D-threo-3-methyl-L-aspartate(1-). It is an enantiomer of a L-threo-3-methyl-D-aspartic acid.\n",
      " The molecule is a threonic acid. It is a conjugate acid of a threonate(1-) and a L-threonate(1-). It is an enantiomer of a D-threonic acid. \n",
      " The molecule is a sulfur-containing amino acid that is L-aspartic acid substituted at position 3 by a methyl group (the 3S-enantiomer). It is a sulfur-containing amino acid, a L-aspartic acid derivative and a non-proteinogenic L-alpha-amino acid. It is a conjugate acid of a threo-3-methyl-L-aspartate(1-).\n",
      "\n",
      "1277 0.3136527588708991 0.4071331007948428 0.7088483910604877 \n",
      " CC(=O)O[C@@H]1C[C@@H]2[C@]3(CCCC([C@@H]3CC[C@]2([C@H]4[C@]1([C@H]5[C@@H](OC(=O)C5=CC4)OC)C)C)(C)C)C\n",
      "The molecule is a scalarane sesterterpenoid that is 12-epi-scalarin in which the hydorxy group at position 19 is replaced by a methoxy group. It has been isolated from the sponge, Hyattella species. It has a role as an animal metabolite. It is a scalarane sesterterpenoid, an acetate ester, an organic heteropentacyclic compound and a gamma-lactone. It derives from a 12-epi-scalarin.\n",
      "The molecule is a scalarane sesterterpenoid isolated from the sponge, Hyattella species. It has a role as an animal metabolite. It is an acetate ester, a gamma-lactone and an organic heteropentacyclic compound.\n",
      " The molecule is a scalarane sesterterpenoid with formula C29H40O5, originally isolated from the sponge, Hyattella species. It has a role as a metabolite. It is a scalarane sesterterpenoid, a gamma-lactone and an organic heteropentacyclic compound. \n",
      " The molecule is a scalarane sesterterpenoid that is 12-epi-deoxoscalarin in which the acetoxy group at position 12 is replaced by a hydroxy group while the hydroxy group at position 19 is replaced by an acetoxy group. It has been isolated from the sponge, Hyattella species. It has a role as an animal metabolite. It is a scalarane sesterterpenoid and an acetate ester. It derives from a 12-epi-scalarin.\n",
      "\n",
      "1285 0.7145623962970346 0.331673375408117 0.9182031414464616 \n",
      " CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O[C@H]2[C@H]([C@H](O[C@@H]([C@@H]2O)O)CO)O)CO)O)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O\n",
      "The molecule is an amino trisaccharide consisting of beta-D-galactopyranose, 2-acetamido-2-deoxy-beta-D-galactopyranose and alpha-D-galactopyranose residues joined in sequence by (1->3) glycosidic linkages. It is an amino trisaccharide and a member of acetamides. It derives from a beta-D-Galp-(1->3)-beta-D-GalpNAc.\n",
      "The molecule is an amino trisaccharide consisting of beta-D-galactopyranose, 2-acetamido-2-deoxy-beta-D-galactopyranose and alpha-D-glucopyranose residues joined in sequence by (1->3) and (1->3) glycosidic bonds. It is an amino trisaccharide and a member of acetamides. It derives from a beta-D-Galp-(1->3)-beta-D-GalpNAc and an alpha-D-GalpNAc-(1->3)-beta-D-Galp.\n",
      " The molecule is an amino trisaccharide consisting of beta-D-galactose at the reducing end having a N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl group attached at the 4-position. It is an amino trisaccharide and a galactosamine oligosaccharide. \n",
      " The molecule is an amino trisaccharide consisting of beta-D-galactopyranose, 2-acetamido-2-deoxy-beta-D-galactopyranose and alpha-D-galactopyranose residues joined in sequence by (1->3) glycosidic bonds. It is an amino trisaccharide and a member of acetamides. It derives from a beta-D-Gal-(1->3)-beta-D-GalNAc.\n",
      "\n",
      "1290 0.1631388009786321 0.1145873951097111 0.28289132011877904 \n",
      " C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2NCCCCCCN4C(=O)C=CC4=O)CCC5=C3C=CC(=C5)OC\n",
      "The molecule is an aza-steroid that is 3-O-methyl-17beta-estradiol in which the 17beta-hydroxy group is replaced by a 6-(maleimid-1-yl)hexylamino group. An inibitor of phospholipase C. It has a role as an EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor. It is an aza-steroid, a member of maleimides and an aromatic ether. It derives from a 17beta-estradiol.\n",
      "The molecule is a member of the class of maleimides that is 2-(2-oxo-1,3-dihydro-2H-inden-4-yl)ethane-1,4-dione in which one of the hydrogens of the methyl group is replaced by a 4-(2-oxo-1,3-dihydro-2H-pyrrol-2-yl)butyl group. It is a synthetic analogue of gonadotropin-releasing hormone, and is used as a subcutaneous hydrogel implant (particularly as the hydrochloride salt) for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty. It has a role as an antineoplastic agent, a hormone antagonist, an EC 1.14.14.14 (aromatase) inhibitor and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is a member of maleimides, a member of isoquinolines and an aromatic ether. It derives from a maleimide.\n",
      " The molecule is a 3-oxo-Delta(4) steroid that is 5alpha-androst-16-ene-3-one in which the 17beta hydrogen has been replaced by a [(4R,4aR,8aR)-4,7-dimethyl-2,4,4a,5,6,7,8,8a,12,12a-decahydropyrrolo[1,2-a][1,4]benzodiazepin-8-yl]nitrilo group. A 17beta-hydroxy steroid receptor \n",
      " The molecule is a 17beta-hydroxy steroid, being 17beta-estradiol methoxylated at C-2. It has a role as an antineoplastic agent, a neuroprotective agent and an EC 1.14.13.39 (nitric oxide synthase) inhibitor. It is a 17beta-hydroxy steroid, a 3-oxo-Delta(4) steroid, an aromatic ether and a member of maleimides. It derives from a hydride of an estrane.\n",
      "\n",
      "1300 0.13479494507318684 0.052577209622556534 0.2453627834691055 \n",
      " C[C@H](C[N+]1=CNC2=C(N=CN=C21)N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3=CC=CC=C3\n",
      "The molecule is an organic cation obtained by protonation of the exocyclic amino group of tenofovir alafenamide. It is an ammonium ion derivative and an organic cation. It is a conjugate acid of a tenofovir alafenamide.\n",
      "The molecule is an organic cation that is the isopropyl ester of tenofovir. A prodrug for tenofovir, it is used (as the fumarate salt) in combination therapy for the treatment of HIV-1 infection. It has a role as an antiviral drug, a HIV-1 reverse transcriptase inhibitor and a prodrug. It derives from a tenofovir (anhydrous).\n",
      " The molecule is an L-alanine derivative that is isopropyl L-alaninate in which one of the amino hydrogens is replaced by an (S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(oxo)phosphoryl group. A prodrug for tenofovir, it is used (as the fumarate salt) in combination therapy for the treatment of HIV-1 infection. It has a role as an antiviral drug, a HIV-1 reverse transcriptase inhibitor and a prodrug. It is a L-alanine derivative, an organic phosphoramidate, a \n",
      " The molecule is an organic cation that is the isopropyl ester of tenofovir alafenamide, a prodrug for tenofovir, used in combination therapy for the treatment of HIV-1 infection. It has a role as an antiviral drug, a HIV-1 reverse transcriptase inhibitor and a prodrug. It derives from a tenofovir alafenamide.\n",
      "\n",
      "1345 0.5769504747423929 0.5582120491728166 0.8554949578991715 \n",
      " C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2O)CO)OC[C@@H]3[C@@H]([C@@H]([C@H](C(O3)O)NC(=O)C)O)O)NC(=O)C)O)O)O\n",
      "The molecule is an amino trisaccharide consisting of alpha-L-fucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose and 2-acetamido-2-deoxy-D-galactopyranose residues joined in sequence by (1->3) and (1->6) glycosidic bonds. It is an amino trisaccharide, a member of acetamides and a glucosamine oligosaccharide. It derives from a beta-D-GlcpNAc-(1->6)-D-GalpNAc and an alpha-L-Fucp-(1->3)-beta-D-GlcpNAc.\n",
      "The molecule is an amino trisaccharide consisting of alpha-L-fucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose and 2-acetamido-2-deoxy-D-glucopyranose residues joined in sequence by (1->3) and (1->6) glycosidic bonds. It is an amino trisaccharide, a member of acetamides and a glucosamine oligosaccharide.\n",
      " The molecule is an amino trisaccharide consisting of alpha-L-fucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose and 2-acetamido-2-deoxy-D-galactopyranose residues joined in sequence by (1->3) and (1->6) glycosidic bonds. It is a member of acetamides, an amino trisaccharide and a glucosamine oligosaccharide. \n",
      " The molecule is an amino trisaccharide consisting of alpha-L-fucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose and 2-acetamido-2-deoxy-D-galactopyranose residues joined in sequence by (1->3) and (1->6) glycosidic bonds. It is an amino trisaccharide and a member of acetamides. It derives from an alpha-L-Fucp-(1->3)-beta-D-GlcpNAc and an alpha-L-Fucp-(1->6)-beta-D-GlcpNAc.\n",
      "\n",
      "1385 0.12601311098685247 0.14532405608844742 0.3327438175837422 \n",
      " C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H]([C@H](CO)O)[C@@H]([C@@H](CO)O)O)O)O)O)O\n",
      "The molecule is a glycosyl alditol consisting of D-glucitol in which the hydroxy group at position 3 has been converted into the corresponding beta-D-glucopyranosyl derivative.\n",
      "The molecule is an alpha-D-glucoside consisting of D-glucitol having an alpha-D-glucosyl residue attached at the 4-position. Used as a sugar substitute. It has a role as a metabolite, a laxative and a sweetening agent. It derives from an alpha-D-glucose and a D-glucitol.\n",
      " The molecule is an alpha-D-glucoside consisting of D-mannitol having an alpha-D-glucosyl residue attached at the 3-position. It derives from an alpha-D-mannose and a D-mannitol. \n",
      " The molecule is a disaccharide that is D-mannitol in which the hydroxy group at position 3 has been converted into the corresponding alpha-D-glucopyranoside. It is a member of carbohydrates and carbohydrate derivatives and a glycosylmannose. It derives from a D-mannitol and an alpha-D-glucose.\n",
      "\n",
      "1393 0.3003454820531837 0.27951421560498946 0.46309213696949 \n",
      " CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC=C2)N3CCOCC3)C4=CC5=C(C=C4)C(=NO5)C6CCNCC6\n",
      "The molecule is a biaryl resulting from the formal oxidative coupling of the 6 position of 3-(piperidin-4-yl)-1,2-benzoxazole with the 3 position of p-toluic acid and subsequent condensation of the carboxy group with the primary amino group of 3-(morpholin-4-yl)aniline to give the corresponding carboxamide. An inhibitor of p38-alpha MAP kinase. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a biaryl, a member of morpholines, a member of benzamides, a member of 1,2-benzoxazoles, a member of piperidines and a secondary amino compound.\n",
      "The molecule is a benzamide obtained by formal condensation of the carboxy group of 2-methyl-4-(morpholin-4-yl)benzoic acid with the amino group of 3-(morpholin-4-yl)aniline. Potent and selective 5-HT1B/1D receptor antagonist (pKi values are 8.5 for both guinea pig 5-HT1D and rat 5-HT1B receptors). Displays > 100-fold selectivity over 5HT1A, 5-HT2A, 5-HT2C receptors and other receptor types. Centrally active following oral administration. It has a role as a serotonergic antagonist. It is a member of isoxazoles, a member of morpholines, a member of isoxazoles and a member of benzamides. It is a conjugate base of a GR 127935(1+).\n",
      " The molecule is a member of the class of benzamides obtained by formal condensation of the carboxy group of 2'-methyl-4'-(1,3,2-dioxaphosphinan-2-yl)biphenyl-4-carboxylic acid with the amino group of 2-amino-1,3,4-oxadiazin-5(6H)-one. It has a role as an EC 2.7.10.2 (mitogen-activated protein kinase) inhibitor, an apoptosis inducer and an antineoplastic agent. It is a member of benzamides, a \n",
      " The molecule is a member of the class of isoxazoles that is the amide obtained by formal condensation of the carboxy group of 2-methyl-4-(morpholin-4-yl)benzoic acid with the amino group of 3-(morpholin-4-yl)aniline. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of isoxazoles, a member of morpholines, a member of benzamides, an aminopyridine and a member of morpholines.\n",
      "\n",
      "1395 0.5516730078944196 0.4269671874527825 0.65340235545473 \n",
      " CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CCC[N+](C)(C)C)O\n",
      "The molecule is an acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 4-trimethylammoniobutanoic acid. It is an acyl-CoA and a quaternary ammonium ion. It derives from a coenzyme A and a 4-(trimethylammonio)butanoic acid. It is a conjugate acid of a gamma-butyrobetainyl-CoA(3-).\n",
      "The molecule is an acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of gamma-butyrobetainic acid. It derives from a gamma-butyrobetainic acid. It is a conjugate acid of a gamma-butyrobetainyl-CoA(3-).\n",
      " The molecule is a triacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of gamma-butyrobetainic acid. It is a conjugate acid of a gamma-butyrobetainyl-CoA(3-). \n",
      " The molecule is a triply charged acyl-CoA resulting from the formal condensation of the thiol group of coenzyme A with the carboxy group of gamma-butyrobetainic acid. It has a role as a bacterial metabolite. It is an acyl-CoA and a quaternary ammonium ion. It derives from a gamma-butyrobetainic acid. It is a conjugate acid of a gamma-butyrobetainyl-CoA(3-).\n",
      "\n",
      "1431 0.6766353496836681 0.5940815933780238 0.7869039916105822 \n",
      " CC(=C)CCOP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)O)O\n",
      "The molecule is an organic triphosphate formed by condensation between the gamma-phospho group of uridine 5'-triphosphate and isopentenyl alcohol. It derives from an UTP and an isopentenyl alcohol.\n",
      "The molecule is an organic triphosphate formed by condensation between the gamma-phospho group of uridine 5'-triphosphate and prenol (gamma,gamma-dimethylallyl alcohol). It derives from an UTP and a prenol.\n",
      " The molecule is an organic triphosphate formed by condensation between the gamma-phospho group of uridine 5'-triphosphate and cycloprop-2-en-1-one. It derives from an UTP and a cycloprop-2-en-1-one. \n",
      " The molecule is an organic triphosphate formed by condensation between the gamma-phospho group of uridine 5'-triphosphate and crotyl alcohol. It derives from an UTP and a crotyl alcohol.\n",
      "\n",
      "1433 0.18253974671423717 0.2040307194200197 0.3590880448819813 \n",
      " C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F\n",
      "The molecule is a member of the class of benzamides obtained by formal condensation of the carboxy group of 4'-(trifluoromethyl)biphenyl-2-carboxylic acid with the primary amino group of 9-[4-(4-aminopiperidin-1-yl)butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide. Used (as its mesylate salt) as a complement to a low-fat diet and other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. It has a role as an anticholesteremic drug and a MTP inhibitor. It is a member of piperidines, a member of fluorenes, a member of benzamides and a member of (trifluoromethyl)benzenes. It is a conjugate base of a lomitapide(1+).\n",
      "The molecule is a tertiary carboxamide obtained by formal condensation of the carboxy group of 4-[4-(trifluoromethyl)phenyl]cyclohexane-1,7-dione with the amino group of 2-(trifluoromethyl)ethylamine. It has a role as a metabolite. It is a member of benzamides, a member of fluorobenzenes, a N-acylpiperazine and a dicarboxylic acid diamide.\n",
      " The molecule is a tertiary carboxamide resulting from the formal condensation of the carboxy group of (2R)-2-[1-(4-trifluoromethylbenzoyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-3-(trifluoromethyl)propanoic acid with the amino group of 3-[1-(4-trifluoromethylbenzoyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]nitriloacetic acid. It is an N-acylpyrrolidine, a member of (trifluoromethyl)benzenes, a tertiary carboxamide and a \n",
      " The molecule is a carbohydrazide that is a carboxamide resulting from the formal condensation of the carboxy group of lomitapide with the amino group of octafluoromethylamine. Used as a complement to a low-fat diet and other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. It has a role as an anticholesteremic drug and a MTP inhibitor. It is a member of benzamides, a carbohydrazide, a member of (trifluoromethyl)benzenes, an organofluorine compound and a tertiary carboxamide.\n",
      "\n",
      "1443 0.2926394666583954 0.3055284387537101 0.41032302768839235 \n",
      " CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=[NH+]C=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C\n",
      "The molecule is a pyridinium ion obtained by protonation of the pyridine nitrogen in vorapaxar. It is a conjugate acid of a vorapaxar.\n",
      "The molecule is an organic cation resulting from the protonation of the tertiary amino group of tiazamacrocycle. It is a conjugate acid of a tiazamacrocycle.\n",
      " The molecule is an organic cation obtained by protonation of the carbamate group of vilanterol. It is an ammonium ion derivative and an organic cation. It is a conjugate acid of a vilanterol. \n",
      " The molecule is an organic cation that is the conjugate acid of vorapaxar, obtained by protonation of the tertiary amino group. Major microspecies at pH 7.3. It is a conjugate acid of a vorapaxar.\n",
      "\n",
      "1445 0.42340377271042484 0.34947157576927906 0.638289010247634 \n",
      " C1=CC=C(C=C1)C(C(=O)O)O\n",
      "The molecule is a 2-hydroxy monocarboxylic acid that is acetic acid in which two of the methyl hydrogens are substituted by phenyl and hydroxyl groups. It has a role as an antibacterial agent and a human xenobiotic metabolite. It is a 2-hydroxy monocarboxylic acid and a member of benzenes. It derives from an acetic acid. It is a conjugate acid of a mandelate.\n",
      "The molecule is a 2-hydroxy monocarboxylic acid that is mandelic acid bearing a phenyl group at position 2. It has a role as a human xenobiotic metabolite. It derives from a mandelic acid. It is a conjugate acid of a mandelate.\n",
      " The molecule is a hydroxy monocarboxylic acid that is mandelic acid bearing a hydroxy substituent at position 2. It has a role as a human metabolite. It derives from an acetic acid. It is a conjugate acid of a mandelate. \n",
      " The molecule is a 2-hydroxy monocarboxylic acid that is mandelic acid in which the hydroxy hydrogen has been replaced by a phenyl group. It has a role as a human xenobiotic metabolite. It is a 2-hydroxy monocarboxylic acid and a member of benzyl alcohols. It derives from a mandelic acid. It is a conjugate acid of a mandelate.\n",
      "\n",
      "1448 0.3338258574387579 0.21593715370801164 0.5645234201733418 \n",
      " CC1=[NH+]C(=CC=C1)C#CC2=CC=CC=C2\n",
      "The molecule is a pyridinium ion that is the conjugate acid of 2-methyl-6-(phenylethynyl)pyridine, arising from protonation of the pyridine nitrogen. It is a conjugate acid of a 2-methyl-6-(phenylethynyl)pyridine.\n",
      "The molecule is an organic cation obtained by protonation of the imino group of 6-methyl-2-(phenylethynyl)pyridinium. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). It is a conjugate acid of a 6-methyl-2-(phenylethynyl)pyridinium.\n",
      " The molecule is an organic cation obtained by protonation of the two methyl groups of 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-ium. It is an ammonium ion derivative and an organic cation. It is a conjugate acid of a 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-ium. \n",
      " The molecule is an organic cation obtained by protonation of the ring nitrogen of 2-methyl-6-(phenylethynyl)pyridinium. It is an organic cation and an ammonium ion derivative. It is a conjugate acid of a 2-methyl-6-(phenylethynyl)pyridinium.\n",
      "\n",
      "1449 0.27774345355411334 0.2847831310947988 0.5025301697132335 \n",
      " C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](C(O[C@H]3[C@@H](CO)O)O)O)CO)O)O)O)O\n",
      "The molecule is a galactotriose consisting of two alpha-D-galactopyranosyl groups and a D-galactofuranose group linked in sequence by (1->4) and (1->3) glycosidic bonds.\n",
      "The molecule is a glycosylarabinose consisting of alpha-D-galactopyranose, alpha-D-galactopyranose and D-arabinofuranose residues joined in sequence by (1->4) glycosidic bonds. It derives from an alpha-D-Galp-(1->4)-alpha-D-Galp and an alpha-D-galactose.\n",
      " The molecule is a trisaccharide consisting of beta-D-galactopyranose, alpha-L-fucopyranose and D-glucopyranose residues joined in sequence by (1->4) and (1->3) glycosidic bonds. It derives from an alpha-L-Fucp-(1->3)-D-Glcp and a beta-D-Galp-(1->4)-alpha-L-Fucp. \n",
      " The molecule is a glycosylgalactose consisting of two alpha-D-galactosyl residues and a D-galactofuranose residue joined in sequence by (1->4) and (1->3) glycosidic bonds. It derives from an alpha-D-Galp-(1->4)-D-Galp.\n",
      "\n",
      "1473 0.1163723518870134 0.16759528034797933 0.4821021307504214 \n",
      " C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)O\n",
      "The molecule is a trihydroxyflavone with the hydroxy groups at positions C-5, -7 and -8. It has a role as an antioxidant and a metabolite.\n",
      "The molecule is a trihydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 6 and 8. A dihydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 7 and 8. A naturally occurring flavonoid produced by several plants, including the weed Tridax procumbens (coalbuttons or tridax daisy) and the tree Godmania aesculifolia, In animal models, it has shown efficacy against several diseases of the nervous system, including Alzheimer's, Parkinson's, and Huntington's. It has a role as a plant metabolite, a tropomyosin-related kinase B receptor agonist, an antidepressant, an antioxidant and an antineoplastic agent.\n",
      " The molecule is a trihydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 7 and 8. A dihydroxyflavone that consists of flavone substituted by hydroxy groups at positions 5 and 3'. A natural product found in several plant species, including Butea mollis and Chrysanthemum indicum. It has a role as an antioxidant, a neuroprotective agent, an EC 1.13.11.31 (arachidonate 5-lipoxygenase) inhibitor, an EC 3.4.21.26 (pro \n",
      " The molecule is a trihydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 6 and 8. It has a role as a plant metabolite.\n",
      "\n",
      "1489 0.5159135250811717 0.5028112754403544 0.6807723264416277 \n",
      " C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=CC3=CC4=C(C(=C3C(=C2C(=O)OC)C)O)C(=O)[C@@]5(C(=O)C=C([C@H]([C@@]5(C4=O)O)O)OC)OC)OC)OC)OC\n",
      "The molecule is a member of the class of tetracenomycins that is 8-demethyltetracenomycin C in which the hydroxyl hydrogens at position 8 and 10 a are replaced by a 2,3,4-tri-O-methyl-alpha-L-rhamnosyl and methyl groups respectively. It has a role as a bacterial metabolite and an antimicrobial agent. It is an alpha-L-rhamnoside, a carboxylic ester, an enol ether, an enone, a monosaccharide derivative, a member of phenols, a tetracenomycin, a methyl ester and a tertiary alpha-hydroxy ketone. It derives from a tetracenomycin C.\n",
      "The molecule is a member of the class of tetracenomycins that is 8-demethyltetracenomycin C in which the hydroxyl hydrogen at position 8 is replaced by an oxo group. It has a role as a bacterial metabolite. It is a tetracenomycin, a member of phenols, an enone, an organic heterotetracyclic compound, a methyl ester, a cyclic ketone and a tertiary alpha-hydroxy ketone. It derives from a tetracenomycin C.\n",
      " The molecule is a member of the class of tetracenomycins that is 8-demethyltetracenomycin C in which the hydroxyl hydrogen at position 8 is replaced by an alpha-L-rhamnosyl residue. It has a role as a bacterial metabolite. It is a tetracenomycin, a polyphenol, an enone, an alpha-L-rhamnoside, an ether, a cyclic ketone, a methyl ketone, a tricarboxylic acid and a tertiary alpha-hydroxy ketone. \n",
      " The molecule is a member of the class of tetracenomycins that is 8-demethyltetracenomycin C in which the hydroxyl hydrogen at position 8 is replaced by an alpha-L-rhamnosyl residue. It has a role as a bacterial metabolite. It is a tetracenomycin, a member of phenols, an enone, an alpha-L-rhamnoside, an enol ether, a monosaccharide derivative, a methyl ester, a cyclic ketone and a tertiary alpha-hydroxy ketone. It derives from a tetracenomycin C.\n",
      "\n",
      "1503 0.3372339928160607 0.3571007019395884 0.5451346760002929 \n",
      " CCCCCCCC/C=C\\\\CCCCCCCC#N\n",
      "The molecule is a fatty nitrile obtained by formal condensation of oleic acid with ammonia. It has a role as a plant metabolite. It is a fatty nitrile and an olefinic compound. It derives from an oleic acid.\n",
      "The molecule is a fatty nitrile that is octadecanenitrile containing a double bond located at position 9 (the Z-geoisomer). It has a role as a nonionic surfactant. It is a fatty nitrile and a fatty nitrile.\n",
      " The molecule is a fatty nitrile that is (Z)-non-2-ene in which one of the terminal methyl hydrogens has been replaced by a nitrilo group. It has a role as a plant metabolite. It is a fatty nitrile and an alicyclic compound. It derives from a (Z)-non-2-ene. \n",
      " The molecule is a fatty nitrile obtained by formal condensation of oleic acid and stearol. It has a role as an EC 3.1.1.1 (carboxylesterase) inhibitor. It derives from an oleic acid.\n",
      "\n",
      "1518 0.5538178115791323 0.4907608164258587 0.7143526666926269 \n",
      " C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C\n",
      "The molecule is the glycine conjugate of lithocholic acid. It is a bile acid glycine conjugate and a N-acylglycine. It derives from a lithocholic acid. It is a conjugate acid of a glycolithocholate.\n",
      "The molecule is a bile acid glycine conjugate of glycolithocholic acid. It has a role as a human metabolite. It derives from a glycolithocholic acid. It is a conjugate acid of a glycolithocholic acid.\n",
      " The molecule is a bile acid glycine conjugate derived from deoxycholic acid. It has a role as a human metabolite. It derives from a deoxycholic acid. It is a conjugate acid of a glycolithocholate. \n",
      " The molecule is the N-acyl derivative of glycolithocholic acid. It is a bile acid glycine conjugate and a N-acylglycine. It derives from a glycolithocholic acid. It is a conjugate acid of a glycolithocholic acid.\n",
      "\n",
      "1519 0.7160950032103272 0.5759122747892644 0.8656812074303079 \n",
      " CC(=O)N[C@@H](CC1=CC(=C(C=C1)O)N=NC2=CC=C(C=C2)C(=O)O)C(=O)NCC(=O)NCC(=O)O\n",
      "The molecule is a tripeptide consisting of AcTyrGlyGly with a (p-carboxyphenyl)diazenyl substituent at the 3-position on the tyrosine phenyl ring. It is a tripeptide and a monoazo compound.\n",
      "The molecule is a tripeptide consisting of AcTyrGlyGly with a (4-carboxyphenyl)diazenyl group at the 3-position on the tyrosine phenyl ring. It is a monoazo compound, a tripeptide and a member of benzoic acids.\n",
      " The molecule is a tripeptide consisting of AcTyrGlyGly with a (2,4-dioxo-1,2,3,4-tetrahydroquinolin-7-yl)diazenyl group at the 3-position on the tyrosine phenyl ring. It is a tripeptide and a monoazo compound. \n",
      " The molecule is a tripeptide consisting of AcTyrGlyGly with a (4-carboxyphenyl)diazenyl group at the 3-position on the tyrosine phenyl ring. It is a tripeptide and a monoazo compound.\n",
      "\n",
      "1563 0.45762901704415687 0.45762901704415687 0.8372022246794097 \n",
      " CCC1=C(NC(=C1C)CC2C(=C(C(=O)N2)C)C=C)CC3=C(C4=C(N3)/C(=C\\\\5/[C@H]([C@@H]([C@H](N5)C(=O)[O-])C)CCC(=O)[O-])/CC4=O)C\n",
      "The molecule is a dicarboxylic acid dianion that results from the removal of a proton from each of the carboxylic acid groups of dinoflagellate luciferin. It is a conjugate base of a dinoflagellate luciferin(1-).\n",
      "The molecule is the linear tetrapyrrole anion that is dinoflagellate luciferin protonated to pH 7.3. It is a conjugate base of a dinoflagellate luciferin. It is a conjugate acid of a dinoflagellate luciferin(2-).\n",
      " The molecule is the linear tetrapyrrole anion that is dinoflagellate luciferin protonated to pH 7.3. It is a conjugate base of a dinoflagellate luciferin. It is a conjugate acid of a dinoflagellate luciferin(2-). \n",
      " The molecule is a dicarboxylic acid dianion that results from the removal of a proton from each of the carboxylic acid groups of oxidized dinoflagellate luciferin. It is a conjugate base of an oxidized dinoflagellate luciferin.\n",
      "\n",
      "1571 0.1515505100097667 0.22580749403385655 0.4321740397334421 \n",
      " CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3\n",
      "The molecule is an N-alkylpiperazine in which one nitrogen of the piperazine ring is substituted by a methyl group, while the other is substituted by a diphenylmethyl group. It has a role as an antiemetic, a cholinergic antagonist, a central nervous system depressant, a local anaesthetic and a H1-receptor antagonist.\n",
      "The molecule is a N-alkylpiperazine that is piperazine in which the nitrogens atoms are substituted by phenyl groups. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride salt) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering. It has a role as a central nervous system stimulant. It is a N-alkylpiperazine and a tertiary amine.\n",
      " The molecule is a tertiary amine. It has a role as an antiemetic, a histamine antagonist, a calcium channel blocker, a cholinergic antagonist and a H1-receptor antagonist. \n",
      " The molecule is a N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by two phenyl groups. It has a role as a H1-receptor antagonist, a central nervous system depressant, a cholinergic antagonist and an antiemetic. It is a N-alkylpiperazine and a N-methylpiperazine.\n",
      "\n",
      "1579 0.4911168827685851 0.43954185231518683 0.620907930245014 \n",
      " CC(C)C1=CC(=CC(=C1O)C(C)C)/C=C(\\\\C#N)/C(=O)NCCCC2=CC=CC=C2\n",
      "The molecule is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2E)-2-cyano-3-[4-hydroxy-3,5-di(propan-2-yl)phenyl]prop-2-enoic acid with the amino group of 3-phenylpropylamine. It has a role as a vascular endothelial growth factor receptor antagonist. It is an enamide, a member of phenols, a nitrile, a monocarboxylic acid amide and a secondary carboxamide.\n",
      "The molecule is a monocarboxylic acid amide resulting from the formal condensation of the carboxy group of (2E)-2-cyano-3-(3,3-dimethylallyl)acrylic acid with the amino group of 3-phenylpropanenitrile. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor. It is a member of phenols, a monocarboxylic acid amide, a nitrile and a primary carboxamide. It derives from a 3-phenylpropanenitrile.\n",
      " The molecule is a monocarboxylic acid amide resulting from the formal condensation of the carboxy group of (2E)-2-cyano-3-(3,5-diisopropyl-4-hydroxy-1,2-dioxocyclopent-2-en-1-yl)prop-2-enoic acid with the amino group of (hydrazinocarbonyl)acetic acid. It is a potent and selective estrogen receptor alpha (ERalpha) agonist. It has a role as an estrogen receptor agonist, an antineoplastic agent and an apoptosis inducer. It is a monocarboxylic acid amide, a nitrile, a member of pyrans, an enol \n",
      " The molecule is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2E)-2-cyano-3-(3-hydroxy-4-isopropyl-5-methylphenyl)prop-2-enoic acid with the amino group of 3-phenylpropan-1-amine. It has a role as a fungicide. It is a member of phenols, a monocarboxylic acid amide, a nitrile and an enamide.\n",
      "\n",
      "1597 0.47899288458159167 0.4839507929658321 0.6142314918382626 \n",
      " COC1=CC(=C2C(=C1)OC(=C(C2=O)O)C3=CC=C(C=C3)O)O\n",
      "The molecule is a monomethoxyflavone that is the 7-methyl ether derivative of kaempferol. It has a role as a plant metabolite. It is a trihydroxyflavone, a member of flavonols and a monomethoxyflavone. It derives from a kaempferol.\n",
      "The molecule is a monomethoxyflavone that is apigenin in which the hydroxy group at position 7 is methylated. It has a role as a metabolite. It is a dihydroxyflavone and a monomethoxyflavone. It derives from an apigenin.\n",
      " The molecule is a monomethoxyflavone that is kaempferol in which the hydroxy group at position 7 is replaced by a methoxy group. It has a role as an antioxidant, a hypoglycemic agent, an anti-inflammatory agent and a metabolite. It is a dihydroxyflavone, a monomethoxyflavone and a member of flavonols. It derives from a kaempferol. \n",
      " The molecule is a monomethoxyflavone that is kaempferol in which the hydroxy group at position 7 is methylated. It has a role as a metabolite. It is a dihydroxyflavone and a monomethoxyflavone. It derives from a kaempferol.\n",
      "\n",
      "1602 0.6558262293154606 0.19269427103799838 0.9327222899884782 \n",
      " C(C[C@@H](CC(=O)NCCC[C@@H](CC(=O)NCCC[C@@H](CC(=O)N[C@@H]1[C@@H]([C@H]([C@H](O[C@H]1NC2=[NH+][C@@H]([C@H](N2)[C@@H](C[NH3+])O)C(=O)[O-])CO)OC(=O)N)O)[NH3+])[NH3+])[NH3+])C[NH3+]\n",
      "The molecule is a primary aliphatic ammonium ion which is obtained from streptothricin D by protonation of the guanidino and amino groups and deprotonation of the carboxylic acid group. It is a primary aliphatic ammonium ion, a monocarboxylic acid anion and a guanidinium ion. It is a conjugate acid of a streptothricin D acid.\n",
      "The molecule is a primary aliphatic ammonium ion which is obtained from streptothricin D by protonation of the guanidino and amino groups. It is a guanidinium ion and a primary aliphatic ammonium ion. It is a conjugate acid of a streptothricin D.\n",
      " The molecule is the primary acidic form of streptothricin D acid. It is a conjugate acid of a streptothricin D acid (pH 7.3). \n",
      " The molecule is a primary aliphatic ammonium ion which is obtained from streptothricin F by protonation of the guanidino and amino groups and deprotonation of the carboxylic acid group. It is a primary aliphatic ammonium ion, a monocarboxylic acid anion and a guanidinium ion. It is a conjugate acid of a streptothricin F acid.\n",
      "\n",
      "1604 0.2872614948629222 0.3570754142866086 0.4855108570582971 \n",
      " COC1=CC=C(C=C1)SCCC2=CC=NC=C2\n",
      "The molecule is a member of the class of pyridines that is 2-(pyridin-4-yl)ethane-1-thiol in which the thiol hydrogen is replaced by a 4-methoxyphenyl group. It has a role as a VEGF activator. It is a member of pyridines, a monomethoxybenzene and an aryl sulfide. It is a conjugate base of a GS4012 free base(1+).\n",
      "The molecule is an aryl sulfide that is pyridine substituted by a 4-methoxybenzyl group at position 2 and a (pyridin-4-yl)methyl group at position 3. It is a highly selective inhibitor of p38alpha mitogen-activated protein kinase that also exhibits anti-cancer properties. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor, an antineoplastic agent and an apoptosis inducer. It is a member of pyridines, an aryl sulfide and a monomethoxybenzene.\n",
      " The molecule is a member of the class of pyridines that is pyridine which is substituted at positions 2 and 3 by a 2-(thieno[3,2-c]pyridin-5-yl)sulfanyl group. It is a platelet aggregation inhibitor that is used for treatment of hypertension. It has a role as a platelet aggregation inhibitor. It is a thienopyridine and a member of pyridines. \n",
      " The molecule is a member of the class of pyridines that is pyridine which is substituted by a p-methoxyphenyl group at position 4 and a (pyridin-4-yl)methyl group at position 3. It is a metabolite of the drug 'Hyathazine. It has a role as a marine xenobiotic metabolite. It is a member of pyridines, an aryl sulfide and a monomethoxybenzene.\n",
      "\n",
      "1605 0.34753375075380677 0.37053446019377395 0.49054439563875046 \n",
      " C(=O)[O-].[Na+]\n",
      "The molecule is an organic sodium salt which is the monosodium salt of formic acid. It has a role as a buffer and an astringent. It contains a formate.\n",
      "The molecule is an organic sodium salt resulting from the replacement of the proton from one of the carboxy groups of formic acid by a sodium ion. It has a role as a food acidity regulator. It contains a formic acid.\n",
      " The molecule is the sodium salt of formic acid. It has a role as a buffer. It derives from a formic acid. \n",
      " The molecule is an organic sodium salt that is the monosodium salt of formic acid. It has a role as a Saccharomyces cerevisiae metabolite, a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It contains a formic acid.\n",
      "\n",
      "1627 0.36770818111230835 0.47241774521032415 0.6105569309725055 \n",
      " COC1=C(C2=C(C=C1O)O[C@@H]([C@H](C2=O)O)C3=CC=CC=C3)OC\n",
      "The molecule is a dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3 and 7 and methoxy groups at positions 5 and 6. It has been isolated from Pisonia aculeata. It has a role as a metabolite and a plant metabolite. It is a member of dihydroflavonols, a dihydroxyflavanone, a dimethoxyflavanone and a secondary alpha-hydroxy ketone. It derives from a (2S)-flavanone.\n",
      "The molecule is a trihydroxyflavanone that is flavanone substituted by methoxy groups at positions 5 and 7 and hydroxy groups at positions 6 and 8 (the 2S,3R-stereoisomer). It has been isolated from the buds of Cleistocalyx operculatus and has been shown to exhibit inhibitory effects on the viral neuraminidases from two influenza viral strains, H1N1 and H9N2. It has a role as a plant metabolite and an EC 3.2.1.18 (exo-alpha-sialidase) inhibitor. It is a trimethoxyflavanone, a dihydroxyflavanone and a secondary alpha-hydroxy ketone.\n",
      " The molecule is a monohydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3, 5 and 7 and a methoxy group at position 6. Isolated from Dioscorea bulbifera, it exhibits anti-inflammatory activity. It has a role as an anti-inflammatory agent and a plant metabolite. It is a monohydroxyflavanone, a monomethoxyflavanone, a member of 3'-hydroxyflavanones and a secondary alpha-hydroxy ketone. \n",
      " The molecule is a trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5 and 7 and methoxy groups at positions 6 and 8 respectively. It has a role as a plant metabolite. It is a trihydroxyflavanone, a monomethoxyflavanone and a secondary alpha-hydroxy ketone. It derives from a (2S)-flavanone.\n",
      "\n",
      "1631 0.7349958759709075 0.7036763215057287 0.9686835217076638 \n",
      " CCCCC/C=C\\\\C/C=C\\\\CCCC/C=C\\\\CCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O\n",
      "The molecule is an unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (5Z,11Z,14Z)-icosatrienoic acid. It is an unsaturated fatty acyl-CoA and a long-chain fatty acyl-CoA. It is a conjugate acid of a (5Z,11Z,14Z)-icosatrienoyl-CoA(4-).\n",
      "The molecule is an octadecatrienoyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (5Z,11Z,14Z)-icosatrienoic acid. It is a conjugate acid of a (5Z,11Z,14Z)-icosatrienoyl-CoA(4-).\n",
      " The molecule is an unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (5Z,11Z,14Z)-icosatrienoic acid. It is a long-chain fatty acyl-CoA, an 11,12-saturated fatty acyl-CoA and a monounsaturated fatty acyl-CoA. It derives from a (5Z,11Z,14Z)-icosatrienoic acid. It is a conjugate acid of a (5Z,11Z,14Z)-icosatrienoyl- \n",
      " The molecule is an unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (5Z,11Z,14Z)-icosatrienoic acid. It is a long-chain fatty acyl-CoA and an unsaturated fatty acyl-CoA. It is a conjugate acid of a (5Z,11Z,14Z)-icosatrienoyl-CoA(4-).\n",
      "\n",
      "1638 0.7903576404177411 0.8718324700257342 0.9819795610338048 \n",
      " CC(=CCC/C(=C/CC/C(=C/CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\CC/C(=C\\\\COP(=O)(O)OP(=O)(O)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)OP(=O)(O)OC[C@@H](CO)O)O)NC(=O)C)O)NC(=O)C)/C)/C)/C)/C)/C)/C)/C)/C)/C)/C)C\n",
      "The molecule is a polyprenyl glycosyl diphosphate having eleven prenyl units and with 4-O-[(2R)-1-glycerylphosphono]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosamine as the glycosyl fragment. It is a conjugate acid of a 4-O-[(2R)-1-glycerylphosphonato]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl undecaprenyl diphosphate(3-).\n",
      "The molecule is a polyprenyl glycosyl diphosphate having eleven prenyl units and with 4-O-[1-D-ribitylphosphono-(2R)-1-glycerylphosphono]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosamine as the glycosyl fragment. It is a conjugate acid of a 4-O-[1-D-ribitylphosphonato-(2R)-1-glycerylphosphonato]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl ditrans,octacis-undecaprenyl diphosphate(4-).\n",
      " The molecule is a polyprenyl glycosyl diphosphate having eleven prenyl units and with 4-O-[di(2R)-1-glycerylphosphono]--N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosamine as the glycosyl fragment. It is a conjugate acid of a 4-O-[di(2R)-1-glycerylphosphonato]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-gluc \n",
      " The molecule is a polyprenyl glycosyl diphosphate having eleven prenyl units and with 4-O-[(2R)-1-glycerylphosphono]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosamine as the glycosyl fragment. It is a conjugate acid of a 4-O-[(2R)-1-glycerylphosphonato]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl undecaprenyl diphosphate(4-).\n",
      "\n",
      "1659 0.24380350481198051 0.2910667207586006 0.49552745175803187 \n",
      " CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2\n",
      "The molecule is a ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4. It has a role as an opioid analgesic, a mu-opioid receptor agonist, a xenobiotic and an environmental contaminant. It is a tertiary amine, a ketone and a member of benzenes. It derives from a heptan-3-one.\n",
      "The molecule is a ketone that is pentan-3-one substituted by a dimethylamino group at position 4 and a dimethylamino group at position 5. It is a ketone and a tertiary amino compound.\n",
      " The molecule is a tertiary amine that is propan-2-one substituted at position 1 by a 1,1'-bi(phenyl)-2-yl group and at position 3 by methyl and dimethylamino groups. It is an antidote to opioid poisoning. It has a role as an opioid analgesic, a kappa-opioid receptor agonist and an antidote to opioid poisoning. It is a tertiary amine and a cyclic ketone. \n",
      " The molecule is a ketone that is pentan-3-one substituted by two phenyl groups at position 1 and a dimethylamino group at position 4. It is a metabolite of the opioid analgesic tramadol. It has a role as a mu-opioid receptor agonist, an antispasmodic drug and an opioid analgesic. It is a tertiary amine and a ketone.\n",
      "\n",
      "1665 0.24951929595541728 0.22320653777585786 0.4029968779170684 \n",
      " C(CCC(=O)NCCCCCC(=O)O)CCN\n",
      "The molecule is the N-(6-aminohexanoyl) derivative of 6-aminohexanoic acid It derives from a hexanoic acid. It is a conjugate acid of a N-(6-aminohexanoyl)-6-aminohexanoate. It is a tautomer of a N-(6-aminohexanoyl)-6-aminohexanoic acid zwitterion.\n",
      "The molecule is an N-acyl-amino acid that is hexanoic acid arising from amide formation between the amino group of 6-aminohexanoic acid. It is a lysine derivative and a N-acyl-amino acid. It derives from a hexanoic acid.\n",
      " The molecule is a dicarboxylic acid monoamide that is the amide of 6-aminohexanoic acid. It is a beta-amino acid, a dicarboxylic acid monoamide and an omega-amino fatty acid. It derives from a hexanoic acid. \n",
      " The molecule is an N-acyl-gamma-aminobutyric acid resulting from the formal condensation of the amino group of hexanoic acid with the carboxy group of 6-aminohexanoic acid. It is a monocarboxylic acid, a primary amino compound and a N-acyl-gamma-aminobutyric acid. It derives from a hexanoic acid. It is a conjugate acid of a 6-aminohexanoate.\n",
      "\n",
      "1667 0.5602459350611141 0.3318441439407864 0.713468202450026 \n",
      " [O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[K+].[K+]\n",
      "The molecule is a potassium salt that is the dipotassium salt of dichromic acid. It has a role as an oxidising agent, an allergen and a sensitiser. It contains a dichromate(2-).\n",
      "The molecule is a potassium salt that is the dipotassium salt of dichromate(2-). It has a role as a fertilizer. It is a dipotassium salt and a potassium salt. It contains a dichromate(2-).\n",
      " The molecule is a potassium salt having chromic acid as the counterion. It has a role as a dye. It is a chromate salt and a potassium salt. It contains a chromate(2-). \n",
      " The molecule is a potassium salt that is the dipotassium salt of dichromic acid. It has a role as a catalyst. It is a potassium salt and an inorganic sulfate salt. It contains a dichromate(2-).\n",
      "\n",
      "1670 0.3113401545932084 0.285996325323059 0.444216661563303 \n",
      " CCCC[N+]1=C(C2=C(C=C1)C3=CC=CC=C3N2CC4=CC=CC=C4)C5=CC=CC=C5Cl.[Br-]\n",
      "The molecule is an organic bromide salt having 9-benzyl-2-butyl-1-(2-chlorophenyl)-9H-beta-carbolin-2-ium as the counterion It has a role as an antineoplastic agent and an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It contains a DH334(1+).\n",
      "The molecule is an organic bromide salt and a quaternary ammonium salt. It has a role as an antineoplastic agent and an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor.\n",
      " The molecule is an organic bromide salt having DY-416(1+) as the counterion. It has a role as an antineoplastic agent and a tyrosine kinase inhibitor. It contains a DY-416(1+). \n",
      " The molecule is an organic bromide salt having benzyldiaminium as the counterion. It has a role as an antineoplastic agent and an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It contains a benzyldiaminium.\n",
      "\n",
      "1672 0.6665688825877877 0.6665688825877877 0.8359304975281392 \n",
      " C(CC(=O)O)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N\n",
      "The molecule is a tripeptide composed of two L-glutamic acid and one L-glutamine units joined by peptide linkages. It derives from a L-glutamic acid and a L-glutamine.\n",
      "The molecule is a tripeptide composed of two L-glutamic acid units and L-glutamine joined in sequence by peptide linkages. It has a role as a metabolite. It derives from a L-glutamic acid and a L-glutamine.\n",
      " The molecule is a tripeptide composed of two L-glutamic acid units and L-glutamine joined in sequence by peptide linkages. It has a role as a metabolite. It derives from a L-glutamic acid and a L-glutamine. \n",
      " The molecule is a tripeptide composed of two L-glutamic acid and one L-glutamine residues joined in sequence. It derives from a L-glutamic acid and a L-glutamine.\n",
      "\n",
      "1675 0.3126142688114491 0.3126142688114491 0.7234881079828167 \n",
      " C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=C(C=C34)OC)O\n",
      "The molecule is a 17-oxo steroid that is estrone in which the hydrogen at position 2 has been replaced by a methoxy group. It has a role as a human metabolite and a mouse metabolite. It is a 3-hydroxy steroid, a 17-oxo steroid, an alicyclic ketone, a member of phenols and an aromatic ether. It derives from an estrone.\n",
      "The molecule is a 2-hydroxy steroid that is 2-hydroxyestrone in which the hydroxy group at position 3 has been converted to the corresponding methyl ether. It is a 2-hydroxy steroid, a 17-oxo steroid and an aromatic ether. It derives from a 2-hydroxyestrone.\n",
      " The molecule is a 2-hydroxy steroid that is 2-hydroxyestrone in which the hydroxy group at position 3 has been converted to the corresponding methyl ether. It is a 2-hydroxy steroid, a 17-oxo steroid and an aromatic ether. It derives from a 2-hydroxyestrone. \n",
      " The molecule is a 17-oxo steroid that is estrone in which the hydrogen at position 4 has been replaced by a methoxy group. It has a role as an estrogen, a human metabolite, a genotoxin and a biomarker. It is a 17-oxo steroid, a 3-hydroxy steroid, an aromatic ether and a member of phenols. It derives from an estrone.\n",
      "\n",
      "1713 0.47743845392120204 0.39520417528468854 0.6514755361539756 \n",
      " CC(C)CCCC(C)CCCC(C)CCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O\n",
      "The molecule is a multi-methyl-branched fatty acyl-CoA(4-) arising from deprotonation of phosphate and diphosphate functions of 4,8,12-trimethyltridecanoyl-CoA. It has a role as a human metabolite. It is a conjugate base of a 4,8,12-trimethyltridecanoyl-CoA.\n",
      "The molecule is a multi-methyl-branched fatty acyl-CoA(4-) oxanion arising from deprotonation of the phosphate and diphosphate OH groups of 4,8,12-trimethyltridecanoyl-CoA; major species at pH 7.3. It is a multi-methyl-branched fatty acyl-CoA(4-), a long-chain fatty acyl-CoA(4-) and a multi-methyl-branched fatty acyl-CoA(4-). It is a conjugate base of a 4,8,12-trimethyltridecanoyl-CoA.\n",
      " The molecule is a multi-methyl-branched fatty acyl-CoA(4-) oxanion arising from deprotonation of phosphate and diphosphate OH groups of 4,8-dimethylnonanoyl-CoA; major species at pH 7.3. It is a multi-methyl-branched fatty acyl-CoA(4-), a 3-methyl fatty acyl-CoA(4-) and an 11,12-saturated fatty acyl-CoA(4-). It is a conjugate base of a 4,8-dimethylnonanoyl-CoA. \n",
      " The molecule is an acyl-CoA(4-) arising from deprotonation of phosphate and diphosphate functions of 4,8,12-trimethyltridecanoyl-CoA; major species at pH 7.3. It is a multi-methyl-branched fatty acyl-CoA(4-) and a long-chain fatty acyl-CoA(4-). It is a conjugate base of a 4,8,12-trimethyltridecanoyl-CoA.\n",
      "\n",
      "1724 0.4631534946456125 0.4243189737804242 0.6614961750465734 \n",
      " CCN\\\\1C2=CC=CC=C2O/C1=C\\\\C=C\\\\C=C\\\\C3=[N+](C4=CC=CC=C4O3)CC.[I-]\n",
      "The molecule is a cyanine dye, an organic iodide salt and a member of 1,3-benzoxazoles. It has a role as a fluorochrome. It contains a C5-oxacyanine cation.\n",
      "The molecule is a C3 cyanine dye having 3-ethyl-1,3-benzoxazol-2(3H)-yl units at each end. It has a role as a fluorochrome. It is an organic iodide salt, a cyanine dye and a member of 1,3-benzoxazoles. It contains a C3-oxacyanine cation.\n",
      " The molecule is a C3 cyanine dye having 3-(2-cyanoethenyl)-1,3-benzoxazol-2(3H)-yl units at each end. It has a role as a fluorochrome. It is an organic iodide salt, a cyanine dye and a member of 1,3-benzoxazoles. It contains a C3-oxacyanine cation. \n",
      " The molecule is an organic iodide salt and a member of 1,3-benzoxazoles. It has a role as a fluorochrome. It contains a dithiazanine.\n",
      "\n",
      "1725 0.774943444141268 0.7963944585760957 1.0 \n",
      " C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)N\n",
      "The molecule is a tetrapeptide composed of L-glutamic acid, L-leucine, L-phenylalanine and L-alanine joined in sequence by peptide linkages. It has a role as a metabolite. It derives from a L-glutamic acid, a L-leucine, a L-phenylalanine and a L-alanine.\n",
      "The molecule is a tetrapeptide composed of L-glutamic acid, L-leucine and L-alanine joined in sequence by peptide linkages. It has a role as a metabolite. It derives from a L-glutamic acid, a L-leucine and a L-alanine.\n",
      " The molecule is a tetrapeptide composed of L-leucine, L-phenylalanine and two L-glutamic acid units joined in sequence by peptide linkages. It has a role as a metabolite. It derives from a L-leucine, a L-phenylalanine and a L-glutamic acid. \n",
      " The molecule is a tetrapeptide composed of L-glutamic acid, L-leucine, L-phenylalanine and L-alanine joined in sequence by peptide linkages. It has a role as a metabolite. It derives from a L-glutamic acid, a L-leucine, a L-phenylalanine and a L-alanine.\n",
      "\n",
      "1739 0.24142649641845312 0.16318891998127327 0.43763255854260275 \n",
      " CC[C@H](C)[C@H]1C(=O)N[C@@H](CSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CCCCN)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)N)C(=O)N[C@@H]3[C@@H](SC[C@H](NC(=O)CNC(=O)[C@@H]4CCCN4C3=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N/C(=C\\\\C)/C(=O)NCC(=O)N[C@@H]5CSC[C@H]6C(=O)N/C=C\\\\SC[C@H](C(=O)N[C@H](C(=O)N6)CC7=CC=C(C=C7)O)NC(=O)[C@@H](NC(=O)[C@@H](NC5=O)CC8=CC=CC=C8)CC(=O)N)C\n",
      "The molecule is a type A lantibiotic that is a tetracyclic 21-amino-acid peptide which contains meso-lanthionine, 3-methyllanthionine, and S-(2-aminovinyl)-D-cysteine. It is obtained from Staphylococcus epidermidis Tue 3298 and exhibits antibiotic activity against many Gram-positive bacteria. It has a role as a metabolite and an antibacterial agent. It is a type A lantibiotic and a macrocycle.\n",
      "The molecule is a type-A lantibiotic containing 34 amino acid residues (including lanthionine (Lan), methyllanthionine (MeLan), didehydroalanine (Dha) and didehydroaminobutyric acid (Dhb)) and five thioether bridges. It is obtained by fermentation of the bacterium Lactococcus lactis and shows particular activity against Clostridium botulinum. It is used in the production of various processed foods to suppress Gram-positive spoilage and pathogenic bacteria and so extend shelf life. It has a role as an antimicrobial food preservative, a metabolite and an antibacterial agent. It is a macrocycle and a type A lantibiotic.\n",
      " The molecule is a 19-membered heterodetic cyclic peptide containing 3-methylthioalanine and cysteinyl residues that is isolated from the culture broth of Streptoverticillium cinnamoneus and exhibits antifungal and antiproliferative properties. It has a role as an antimicrobial agent, a metabolite and an antineoplastic agent. It is a heterodetic cyclic peptide and a peptide antibiotic. \n",
      " The molecule is a type-A lantibiotic containing 3-methyllanthionine and S-(2-aminovinyl)-3-methylcysteine residues and four intra-chain thioether bridges. It is obtained from Bacillus sp. HIL Y-85,54728 and is active in vivo against methicillin-resistant Staphylococcus aureus (MRSA). It has a role as a metabolite and an antibacterial agent. It is a type A lantibiotic and a macrocycle. It is a tautomer of a lantibiotic amine zwitterion.\n",
      "\n",
      "1743 0.4063501306587675 0.4221975046346309 0.7591355397277384 \n",
      " CCCCC/C=C\\\\C[C@@H](/C=C/C=C\\\\C/C=C\\\\C/C=C\\\\CCC(=O)O)O\n",
      "The molecule is a hydroxydocosapentaenoic acid that is (4Z,7Z,10Z,12E,16Z)-docosapentaenoic acid in which the hydroxy group is located at the 14S-position. An intermediate of specialised proresolving mediators It has a role as a human xenobiotic metabolite. It is a hydroxydocosapentaenoic acid and a secondary allylic alcohol. It derives from a (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid. It is a conjugate acid of a (4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoate.\n",
      "The molecule is a hydroxydocosapentaenoic acid that is (4Z,7Z,10Z,12E,16Z)-docosapentaenoic acid in which the hydroxy group is located at the 17S-position. The 17S-oxygenated product of omega-6-DPA which possesses anti-inflammatory activity. It has a role as a human xenobiotic metabolite. It is a hydroxydocosapentaenoic acid and a secondary allylic alcohol.\n",
      " The molecule is a hydroxydocosapentaenoic acid that is (4Z,7Z,10Z,12E,16Z)-docosapentaenoic acid in which the hydroxy group is located at the 14S-position. The 14S-oxygenated product of omega-6-DPA which possesses anti-inflammatory activity. It has a role as a human xenobiotic metabolite. It is a hydroxydocosapentaenoic acid and a secondary allylic alcohol. \n",
      " The molecule is a hydroxydocosapentaenoic acid that is (4Z,7Z,10Z,12E,16Z)-docosapentaenoic acid in which the hydroxy group is located at the 14S-position. The 17S-oxygenated product of omega-6-DPA which possesses anti-inflammatory activity. It has a role as a human xenobiotic metabolite. It is a hydroxydocosapentaenoic acid and a secondary allylic alcohol. It is a conjugate acid of a (4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoate. It is an enantiomer of a (4Z,7Z,10Z,12E,14R,16Z)-14-hydroxydocosapentaenoic acid.\n",
      "\n",
      "1757 0.3875869084456226 0.45732403925184817 0.5776448813565073 \n",
      " C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl\n",
      "The molecule is a hydrochloride salt resulting from the reaction of equimolar amounts of raloxifene and hydrogen chloride. It has a role as a bone density conservation agent, an estrogen antagonist and an estrogen receptor modulator. It contains a raloxifene(1+).\n",
      "The molecule is a hydrochloride obtained by combining raloxifene with one molar equivalent of hydrochloric acid. It has a role as a muscarinic antagonist. It contains a raloxifene(1+).\n",
      " The molecule is a hydrochloride salt resulting from the reaction of equimolar amounts of raloxifene and hydrogen chloride. An estrogen receptor modulator, it is used for the treatment of osteoporosis. It has a role as an estrogen receptor modulator, an EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor and a bone density conservation agent. It contains a raloxifene(1+). \n",
      " The molecule is the hydrochloride salt of raloxifene. It has a role as a bone density conservation agent, an estrogen receptor modulator and an estrogen antagonist. It contains a raloxifene(1+).\n",
      "\n",
      "1785 0.36336851046305346 0.4640728651391701 0.5994646121657496 \n",
      " COC1=C(C=CC(=C1)C[C@@H](C(=O)[O-])[NH3+])O\n",
      "The molecule is an aromatic L-alpha-amino acid zwitterion resulting from transfer of a proton from the carboxy to the amino group of 3-O-methyldopa. Major species at pH 7.3 It has a role as a human metabolite. It is a tautomer of a 3-O-methyldopa.\n",
      "The molecule is zwitterionic form of L-tyrosine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3. It is a tautomer of a L-tyrosine.\n",
      " The molecule is an L-alpha-amino acid zwitterion obtained from L-m-tyrosine by transfer of a proton from the carboxy group to the amino group; major species at pH 7.3. It is a tautomer of a L-m-tyrosine. \n",
      " The molecule is an amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 3-O-methyl-L-tyrosine; major species at pH 7.3. It is a tautomer of a 3-O-methyl-L-tyrosine.\n",
      "\n",
      "1789 0.31088871374339033 0.40970201395714806 0.5578909880542187 \n",
      " C[C@@H](CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C\n",
      "The molecule is a member of the class of phenothiazines that is 10H-phenothiazine substituted by a (2R)-3-(dimethylamino)-2-methylpropyl group and a methoxy group at positions 10 and 2 respectively. It has a role as a phenothiazine antipsychotic drug, a dopaminergic antagonist, a serotonergic antagonist, a cholinergic antagonist, a non-narcotic analgesic, an EC 3.4.21.26 (prolyl oligopeptidase) inhibitor and an anticoronaviral agent. It is a member of phenothiazines and a tertiary amine. It derives from a hydride of a 10H-phenothiazine.\n",
      "The molecule is a phenothiazine derivative having an allyl group at the 2-position and a 2-(dimethylamino)-1-propyl group at the 10-position. It has a role as an anxiolytic drug, a sedative, a histamine antagonist, a muscarinic antagonist, a serotonergic antagonist, a dopaminergic antagonist and an antiemetic. It is a member of phenothiazines and a tertiary amine. It is a conjugate base of a perazine(2+).\n",
      " The molecule is a member of the class of phenothiazines that is 10H-phenothiazine having a dimethylamino substitutent at position 2 and an O-methyl group at position 7. It has a role as a phenothiazine antipsychotic drug, a dopaminergic antagonist, an antiemetic and an EC 3.4.21.26 (prolyl oligopeptidase) inhibitor. It is a tertiary amine and a member of phenothiazines. \n",
      " The molecule is a member of the class of phenothiazines that is 10H-phenothiazine substituted by a methoxy group at position 7 and a 2-(dimethylamino)propyl group at position 10. It has a role as a phenothiazine antipsychotic drug, a dopaminergic antagonist, a serotonergic antagonist, a muscarinic antagonist, a histamine antagonist and a sedative. It is a member of phenothiazines, an aromatic ether and a tertiary amino compound. It derives from a hydride of a 10H-phenothiazine.\n",
      "\n",
      "1824 0.28212132890770353 0.1506891059504648 0.3842919479996029 \n",
      " C1=NC(=C2C(=N1)NC(=O)N2)N\n",
      "The molecule is a oxopurine that is adenine bearing a single oxo substituent at position 8. It has a role as a human metabolite. It is a member of 6-aminopurines, an oxopurine and a nucleobase analogue. It derives from an adenine. It is a tautomer of an 8-hydroxyadenine.\n",
      "The molecule is the parent compound of the 6-aminopurines, composed of a purine having an amino group at C-6. It has a role as a human metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a purine nucleobase and a member of 6-aminopurines. It derives from a hydride of a 9H-purine.\n",
      " The molecule is an oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6 and 8. It is a tautomer of a 2,6-dihydroxy-7,9-dihydro-8H-purin-8-one, a 9H-purine-2,6,8-triol and a 7H-purine-2,6,8-triol. \n",
      " The molecule is a purine nucleobase that consists of purine bearing an amino substituent at position 6. It has a role as a fundamental metabolite. It is an oxopurine, a purine nucleobase and a nucleobase analogue. It derives from an adenine.\n",
      "\n",
      "1828 0.6131969758151087 0.5336574766564385 0.9072423724374428 \n",
      " CCCCCCCCCCCCCCCCCCCCCC[C@@H](C(=O)N[C@@H](COP(=O)([O-])OC1[C@@H]([C@H](C([C@H]([C@H]1O)O)O)O)O)[C@@H]([C@H](CCCCCCCCCCCCCC)O)O)O\n",
      "The molecule is an inositol phosphophytoceramide(1-) having a tetracosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and hydroxylation at C-2 of the very-long-chain fatty acid. It is a conjugate base of an Ins-1-P-Cer(t18:0/2-OH-24:0).\n",
      "The molecule is an inositol phosphophytoceramide(1-) having a tetracosanoyl group attached to the ceramide nitrogen. Major species at pH 7.3. It is a conjugate base of an Ins-1-P-Cer(t18:0/2-OH-24:0).\n",
      " The molecule is an inositol phosphophytoceramide(1-) having a 2-hydroxyhexacosanoyl group attached to the ceramide nitrogen. Major species at pH 7.3. It is a conjugate base of an Ins-1-P-Cer(t18:0/2-OH-26:0). \n",
      " The molecule is an inositol phosphophytoceramide(1-) having a tetracosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and hydroxylation at C-2 of the very-long-chain fatty acid. Major species at pH 7.3. It is a conjugate base of an Ins-1-P-Cer(t18:0/2-OH-24:0).\n",
      "\n",
      "1830 0.6921089598195365 0.438325004749406 0.927006477908737 \n",
      " CC(=CC(=O)NCC(=O)O)C\n",
      "The molecule is an N-acylglycine in which the acyl group is specified as 3-methylbut-2-enoyl. It has a role as a metabolite. It derives from a 3-methylbut-2-enoic acid and a glycine.\n",
      "The molecule is an N-acylglycine in which the acyl group is specified as 3-methylbut-2-enoyl. It has a role as a metabolite. It is a conjugate acid of a N-isovalerylglycinate.\n",
      " The molecule is an N-acylglycine in which the acyl group is specified as 3,4-didehydrobutanoyl. It has a role as a metabolite. It is a conjugate acid of a N-[3,4-didehydrobutanoyl]glycinate. \n",
      " The molecule is an N-acylglycine in which the acyl group is specified as 3-methylbut-2-enoyl. It has a role as a metabolite. It derives from a 3-methylbut-2-enoic acid.\n",
      "\n",
      "1846 0.13302118260421175 0.13868437519705445 0.4977156292920502 \n",
      " C(CCl)Cl\n",
      "The molecule is a member of the class of chloroethanes substituted by two chloro groups at positions 1 and 2. It has a role as a non-polar solvent and a mutagen.\n",
      "The molecule is the simplest member of the class of chloroethanes, that is ethane in which a single hydrogen is substituted by chlorine. A colourless gas at room temperature and pressure (boiling point 12Â°C), it is used as a mild topical anaesthetic to numb the skin prior to ear piercing, skin biopsies, etc., and is also used in the treatment of sports injuries. It was formerly used in the production of tetraethyllead. It has a role as a local anaesthetic, an antipruritic drug and an inhalation anaesthetic.\n",
      " The molecule is a member of the class of chloromethanes that is methane in which two of the hydrogens have been replaced by chlorine. A dense, non-flammible colourless liquid at room temperature (b.p. 40°C, d = 1.33) which is immiscible with water, it is widely used as a solvent, a paint stripper, and for the removal of caffeine from coffee and tea. It has a role as a polar aprotic solvent, a carcinogenic agent and an environmental contaminant. It is a member of chloromethanes and a \n",
      " The molecule is a member of the class of chloroethanes that is ethane substituted by chloro groups at positions 1 and 2.\n",
      "\n",
      "1863 0.43046119398467625 0.30862071091161636 0.7581944988171497 \n",
      " C1=CC2=C(C=C1NC(=O)CCCC(=O)[O-])NC(=[NH+]2)N\n",
      "The molecule is a zwitterion obtained by transfer of a proton from the carboxy group to position 3 of the benzimidazole ring of 5-[(2-aminobenzimidazol-6-yl)amino]-5-oxopentanoic acid. It is a zwitterion and a dicarboxylic acid monoamide. It is a tautomer of a 5-[(2-aminobenzimidazol-6-yl)amino]-5-oxopentanoic acid.\n",
      "The molecule is a dicarboxylic acid monoamide that is the conjugate base of 5-[(3-amino-2-oxo-1,3-dihydropyridin-5-yl)amino]-4-oxopentanoic acid. It is a monocarboxylic acid anion and a dicarboxylic acid monoamide. It is a conjugate base of a 5-[(3-amino-2-oxo-1,3-dihydropyridin-5-yl)amino]-4-oxopentanoic acid.\n",
      " The molecule is a monocarboxylic acid anion obtained by deprotonation of the carboxy group of 5-[(2-aminobenzoyl)amino]-6-oxo-1,2,3,6-tetrahydrobenzo[de]isoquinoline-3-carboxylic acid. It is a conjugate base of a 5-[(2-aminobenzoyl)amino]-6-oxo-1,2,3,6-tetrahydrobenzo[de]isoquinoline-3-carboxylic acid. \n",
      " The molecule is a dicarboxylic acid monoamide resulting from the transfer of a proton from the carboxy group to the benzimidazole moiety of 5-[(2-aminobenzimidazol-6-yl)amino]-5-oxopentanoic acid. It is a monocarboxylic acid anion and a dicarboxylic acid monoamide. It is a conjugate base of a 5-[(2-aminobenzimidazol-6-yl)amino]-5-oxopentanoic acid.\n",
      "\n",
      "1865 0.1598667024288609 0.15772035390173755 0.35823424853044045 \n",
      " CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3\n",
      "The molecule is a 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5. It has a role as a xenobiotic, an environmental contaminant, an anxiolytic drug, an anticonvulsant and a sedative. It is a 1,4-benzodiazepinone and an organochlorine compound.\n",
      "The molecule is a 1,4-benzodiazepinone, an organochlorine compound and an organofluorine compound. It has a role as an anxiolytic drug. It derives from a monofluorobenzene and a diazepam.\n",
      " The molecule is a 1,4-benzodiazepinone, an organochlorine compound and an organic heterotricyclic compound. It has a role as an anxiolytic drug. It derives from a monofluorobenzene and a diazepam. \n",
      " The molecule is a nitrazepam which is substituted at positions 1 by a methyl group. It is used as an anticonvulsant and as a hypnotic for the short-term management of insomnia. It has a role as a sedative, an antispasmodic drug, an anticonvulsant and a GABA modulator. It is a 1,4-benzodiazepinone and an organochlorine compound.\n",
      "\n",
      "1868 0.09671387307177672 0.24162769632106262 0.3458993655617658 \n",
      " C1=C(NC=N1)/C=C\\\\C(=O)O\n",
      "The molecule is a urocanic acid in which the double bond of the carboxyethene moiety has Z configuration. It is a conjugate acid of a cis-urocanate.\n",
      "The molecule is a monocarboxylic acid that is acrylic acid in which one of the methyl hydrogens at position 4 is replaced by an imidazol-4-yl group. It has a role as a metabolite. It is a member of imidazoles and a monocarboxylic acid. It derives from an acrylic acid.\n",
      " The molecule is a 1H-imidazole that is 1H-imidazole which is substituted by a carboxymethylidene group at position 2. It has a role as an animal metabolite. It is a conjugate acid of a urocanic acid(1-). \n",
      " The molecule is the cis-isomer of uronic acid. It has a role as a plant metabolite. It is a conjugate acid of a cis-uronate.\n",
      "\n",
      "1886 0.23932322547561033 0.34256782361810656 0.5051418376265435 \n",
      " COC1=C(C=C(C=C1)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O\n",
      "The molecule is a flavanone 7-O-beta-D-glucoside having hesperetin as the flavanone component. It has a role as a metabolite. It is a flavanone 7-O-beta-D-glucoside, a monomethoxyflavanone, a member of 3'-hydroxyflavanones, a dihydroxyflavanone, a monosaccharide derivative and a member of 4'-methoxyflavanones. It derives from a hesperetin.\n",
      "The molecule is a viscumneoside that is homoeriodictyol in which the hydroxy group at position 7 has been converted to the corresponding beta-D-glucopyranoside, the 2-hydroxy group of which has been converted to its beta-D-glucoside. Found in Viscum coloratum, an evergreen hemiparasitic plant whose stems and leaves are used in traditional Chinese medicine for the treatment of rheumatism. It has a role as a plant metabolite. It is a flavanone glycoside, a beta-D-glucoside and a monosaccharide derivative. It derives from a homoeriodictyol and a beta-D-glucose.\n",
      " The molecule is a flavanone glycoside that is homoeriodictyol in which the hydroxy group at position 7 has been converted to the corresponding beta-D-glucopyranoside. Found in Viscum coloratum, an evergreen hemiparasitic plant whose stems and leaves are used in traditional Chinese medicine for the treatment of rheumatism. It has a role as a plant metabolite. It is a flavanone glycoside, a trihydroxyflavanone, a beta-D-glucoside and a member of 4'-hydroxyflavanones. It derives from a homoeriodictyol and a beta-D-glucopyranose. \n",
      " The molecule is a flavanone glycoside that is eriodictyol substituted by a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as a plant metabolite. It is a flavanone glycoside, a monomethoxyflavanone, a trihydroxyflavanone, a monosaccharide derivative and a member of 4'-methoxyflavanones. It derives from an eriodictyol.\n",
      "\n",
      "1887 0.2141000690911926 0.23117411291141818 0.3685634240068098 \n",
      " CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\\\\C)/C=C/C=C(\\\\C)/C=C/C=C(\\\\C)/CCC=C(C)C)/C)/C\n",
      "The molecule is a carotenol that is a natural xanthophyll pigment. It was formerly used as a food colourant (E161d), but approval for this purpose has been withdrawn throughout the European Union. It has a role as a food colouring and a plant metabolite. It derives from a hydride of a gamma-carotene.\n",
      "The molecule is a carotenol, the structure of which is (6'R)-beta,epsilon-carotene hydroxy-substituted at C-3 with R-stereochemistry. It derives from a hydride of a (6'R)-beta,epsilon-carotene.\n",
      " The molecule is a carotenol that is beta,beta-carotene carrying two hydroxy substituents at positions 3 and 3' (the 3R,3'S-diastereomer). It has a role as a marine metabolite and a biological pigment. It is a carotenol and a diol. \n",
      " The molecule is a carotenol. It has a role as a food colouring and a plant metabolite. It derives from a hydride of a (6'R)-beta,epsilon-carotene.\n",
      "\n",
      "1909 0.4074592882423866 0.4179922720360426 0.5634508795795925 \n",
      " C[C@@]12CCC[C@@]([C@H]1[C@@H]([C@]34[C@H]2CC[C@H](C3)C(=C)C4)C(=O)O)(C)C(=O)O\n",
      "The molecule is a C20-gibberellin, initially identified in Gibberella fujikuroi, in which the gibbane skeleton carries 1beta- and 4aalpha-methyl groups, 1alpha- and 10beta-carboxy substituents, and a methylene group at C-8 (all gibbane numberings). It is a C20-gibberellin and a dicarboxylic acid. It is a conjugate acid of a gibberellin A12(2-).\n",
      "The molecule is a C20-gibberellin that is gibberellin A12 carrying an additional carboxy substituent at the 7alpha-position It has a role as a plant metabolite. It is a C20-gibberellin and a dicarboxylic acid. It is a conjugate acid of a gibberellin A53(2-).\n",
      " The molecule is a C20-gibberellin that is a pentacyclic diterpenoid responsible for promoting growth and elongation of cells in plants. It has a role as a plant metabolite. It is a dicarboxylic acid, a C20-gibberellin and a gibberellin monocarboxylic acid. It is a conjugate acid of a gibberellin A12(2-). \n",
      " The molecule is a C20-gibberellin, initially identified in Gibberella fujikuroi. It differs from gibberellin A12 in the presence of a beta-OH at C-2 (gibbane numbering). It is a dicarboxylic acid, a C20-gibberellin and a gibberellin monocarboxylic acid. It is a conjugate acid of a gibberellin A14(2-).\n",
      "\n",
      "1911 0.2825018934878223 0.6340277728289405 0.8402988975300489 \n",
      " CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)NC(=O)C)O)O)O)O\n",
      "The molecule is an amino trisaccharide consisting of N-acetyl-alpha-D-glucosamine, beta-D-galactose and N-acetyl-beta-D-glucosamine residues linked sequentially (1->6) and (1->4). It has a role as an epitope. It is an amino trisaccharide and a glucosamine oligosaccharide.\n",
      "The molecule is an amino trisaccharide consisting of 2-acetamido-2-deoxy-beta-D-glucopyranose, beta-D-galactopyranose and 2-acetamido-2-deoxy-beta-D-glucopyranose residues joined in sequence by (1->6) and (1->4) glycosidic bonds. It is an amino trisaccharide and a member of acetamides. It derives from a beta-D-GlcpNAc-(1->6)-beta-D-Galp and a beta-D-GlcpNAc-(1->6)-beta-D-Galp.\n",
      " The molecule is a linear amino tetrasaccharide comprised of beta-D-galactose, N-acetyl-alpha-D-glucosamine, beta-D-galactose and N-acetyl-beta-D-glucosamineresidues linked sequentially (1->4), (1->6) and (1->4). It has a role as an epitope. It is an amino tetrasaccharide and a glucosamine oligosaccharide. \n",
      " The molecule is an amino trisaccharide consisting of N-acetyl-alpha-D-glucosamine, beta-D-galactose and N-acetyl-D-glucosamine residues all linked sequentially (1->4). It has a role as an epitope. It is an amino trisaccharide and a glucosamine oligosaccharide.\n",
      "\n",
      "1915 0.15687990497065038 0.05570175329765345 0.5164521928419908 \n",
      " C1CCC2(CC1)OCC(O2)CN=C(N)N\n",
      "The molecule is a spiroketal resulting from the formal condensation of the keto group of cyclohexanone with the hydroxy groups of 1-(2,3-dihydroxypropyl)guanidine. A postganglionic adrenergic blocking agent formerly used (generally as the sulfate salt) for the management of hypertension, it has been largely superseded by other drugs less likely to cause orthostatic hypotension (dizzy spells on standing up or stretching). It has a role as an antihypertensive agent and an adrenergic antagonist. It is a member of guanidines and a spiroketal. It is a conjugate base of a guanadrel(1+).\n",
      "The molecule is a member of the class of guanidines that is guanidine in which one of the hydrogens of the amino group is replaced by a cyclohexyl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus. It has a role as a hypoglycemic agent and an EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor. It is a member of guanidines and a member of guanidines.\n",
      " The molecule is a member of the class of guanidines resulting from the formal condensation of guanidine with guanidyloxyacetic acid. It is a guanidine derivative, a member of guanidines and an organic heterobicyclic compound. \n",
      " The molecule is a member of the class of guanidines that is guanidine in which the hydrogen attached to the nitrogen at position 2 is substituted by a guanidino group. A postganglionic adrenergic blocking agent formerly used for the management of hypertension, it has been largely superseded by other drugs less likely to cause orthostatic hypotension (dizzy spells on standing up or stretching). It has a role as an adrenergic antagonist and an antihypertensive agent. It is a member of guanidines and a member of guanidines.\n",
      "\n",
      "1933 0.24248063612525264 0.31624821067613446 0.4698491110969027 \n",
      " COC1=CC=C(C=C1)C2COC3=CC(=CC(=C3C2=O)[O-])O\n",
      "The molecule is conjugate base of 2,3-dihydrobiochanin A arising from selective deprotonation of the 7-hydroxy group. It is a conjugate base of a 2,3-dihydrobiochanin A.\n",
      "The molecule is a flavonoid oxoanion that is the conjugate base of kievitone, obtained by deprotonation of the 7-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). It has a role as an anticoagulant and a plant metabolite. It is a conjugate base of a kievitone.\n",
      " The molecule is a hydroxyisoflavanone anion that is the conjugate base of 2,3-dihydro-2'-hydroxyisoflavanone, obtained by deprotonation of the carboxy group at position 5'. Major microspecies at pH 7.3. It is a conjugate base of a 2,3-dihydro-2'-hydroxyisoflavanone. \n",
      " The molecule is a flavonoid oxoanion that is the conjugate base of 2,3-dihydrobiochanin A, obtained by deprotonation of the 7-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). It is a conjugate base of a 2,3-dihydrobiochanin A.\n",
      "\n",
      "1974 0.4558778148420755 0.38238318203022376 0.599436050297482 \n",
      " CC[NH+](CCCC1=CC=CC=C1)CCCC2=CC=CC=C2\n",
      "The molecule is an ammonium ion resulting from the protonation of the nitrogen of alvarine. It is a conjugate acid of an alverine.\n",
      "The molecule is an organic cation obtained by protonation of the tertiary amino function of alverine. It is an ammonium ion derivative and an organic cation. It is a conjugate acid of an alverine.\n",
      " The molecule is an organic cation that is the conjugate acid of alverine, obtained by protonation of the tertiary amino group. It is an ammonium ion derivative and an organic cation. It is a conjugate acid of an alverine. \n",
      " The molecule is an ammonium ion derivative resulting from the protonation of the nitrogen of alverine. It is the major species at pH 7.3. It is a conjugate acid of an alverine.\n",
      "\n",
      "1975 0.8644804733192484 0.6973539289176829 1.0 \n",
      " CCCCCCCCCCCCCCC[C@H]([C@H](COC1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)NC(=O)CCCCCCCCCCCCCCC)O\n",
      "The molecule is a glycodihydroceramide that is a sphinganine derivative having a D-galactosyl group at the 1-position and a hexadecanoyl group attached to the nitrogen. It has a role as a hapten.\n",
      "The molecule is a glycodihydroceramide that is a sphinganine derivative having a D-galactosyl group at the 1-position and an hexadecanoyl group attached to the nitrogen. It has a role as an epitope.\n",
      " The molecule is a glycodihydroceramide that is a sphinganine derivative having a D-galactosyl group at the 1-position and a hexacosanoyl group attached to the nitrogen. \n",
      " The molecule is a glycodihydroceramide that is a sphinganine derivative having a D-galactosyl group at the 1-position and a hexadecanoyl group attached to the nitrogen. It has a role as a hapten.\n",
      "\n",
      "1981 0.699829256555126 0.5445178846139404 0.8819694855922414 \n",
      " CSCCC/C(=N\\\\O)/SC[C@@H](C(=O)NCC(=O)[O-])NC(=O)CC[C@@H](C(=O)[O-])[NH3+]\n",
      "The molecule is an S-substituted glutathione(1-) obtained by deprotonation of the the two carboxy groups and protonation of the amino group of any (E)-1-(glutathione-S-yl)-omega-(methylthio)alkylhydroximate; major species at pH 7.3.\n",
      "The molecule is a peptide anion obtained by deprotonation of both carboxy groups and protonation of the glutamyl amino group of any (E)-1-(glutathion-S-yl)-omega-(methylthio)alkylhydroximate; major species at pH 7.3.\n",
      " The molecule is an S-substituted glutathione(1-) obtained by deprotonation of the two carboxy groups and protonation of the glutamyl alpha-amino group of (E)-1-(glutathion-S-yl)-L-hydroximate. Major microspecies at pH 7.3. It derives from a glutathionate(1-). \n",
      " The molecule is an S-substituted glutathione(1-) obtained by deprotonation of the the two carboxy groups and protonation of the glutamyl amino group of any (E)-1-(glutathion-S-yl)-omega-(methylthio)alkylhydroximate; major species at pH 7.3.\n",
      "\n",
      "1996 0.18282417008112528 0.1516587527976781 0.2874179287832174 \n",
      " CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C\n",
      "The molecule is a 20-oxo steroid obtained by acetylation of the 17-hydroxy group of (11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-ol (ulipristal). A selective progesterone receptor modulator, which is employed as an emergency contraceptive. It has a role as a contraceptive drug, a progestin and a progesterone receptor modulator. It is a 3-oxo-Delta(4) steroid, a steroid ester, an acetate ester, a 20-oxo steroid and a tertiary amino compound. It derives from an estradiol.\n",
      "The molecule is a 3-oxo-Delta(4) steroid, a steroid ester, an acetate ester and a tertiary amino compound. It has a role as an abortifacient, a contraceptive drug, a synthetic oral contraceptive and a hormone antagonist. It derives from a hydride of a pregnane.\n",
      " The molecule is a 3-oxo Delta(4)-steroid, an acetate ester, a tertiary amino compound and an organic heterotetracyclic compound. It has a role as an abortifacient, a progestin, a synthetic oral contraceptive and a hormone antagonist. It derives from a hydride of an androstane. \n",
      " The molecule is a steroid ester that is pregn-4-en-17beta-yl acetate substituted by an acetyl group at position 3 and a p-(dimethylamino)phenyl group at position 17. It is used in the treatment of inflammatory and pruritic (itching) skin disorders. It has a role as an anti-inflammatory drug and a prodrug. It is a steroid ester, an acetate ester, a steroid ester, a 3-oxo-Delta(4) steroid and a corticosteroid. It derives from a clomithocholic acid.\n",
      "\n",
      "2009 0.6225624692722199 0.22497958200435098 0.8484613486716333 \n",
      " C1=CC=C(C=C1)NN.Cl\n",
      "The molecule is a hydrochloride resulting from the reaction of equimolar amounts of phenylhydrazine and hydrogen chloride. It contains a phenylhydrazine.\n",
      "The molecule is a hydrochloride resulting from the reaction of phenylhydrazine with 1 mol eq. of hydrogen chloride. It contains a phenylhydrazine and a phenylhydrazine.\n",
      " The molecule is a hydrochloride salt resulting from the reaction of 1,2-diphenylhydrazine with one equivalent of hydrogen chloride. It has a role as a hyperglycemic agent and an alpha-adrenergic agonist. It contains a 1,2-diphenylhydrazine. \n",
      " The molecule is a hydrochloride resulting from the reaction of equimolar amounts of phenylhydrazine and hydrogen chloride. It contains a phenylhydrazine(1+).\n",
      "\n",
      "2033 0.32097685343658805 0.3240947241362838 0.5126018301413161 \n",
      " C1=COC(=C1)CO\n",
      "The molecule is a furan bearing a hydroxymethyl substituent at the 2-position. It has a role as a Maillard reaction product. It is a primary alcohol and a member of furans.\n",
      "The molecule is a furan carrying a single hydroxymethyl substituent at position 2. It has a role as a human xenobiotic metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a member of furans and a primary alcohol. It derives from a hydride of a furan.\n",
      " The molecule is a furan carrying two carbonyl substituents at the 2- and 5-positions. It is a member of furans and a member of carbonyl compounds. \n",
      " The molecule is a furan carrying a single hydroxymethyl substituent at the 2-position. It is a member of furans and a benzyl alcohol. It derives from a hydride of a furan.\n",
      "\n",
      "2037 0.3517555868134284 0.31461791561954944 0.48807301612847365 \n",
      " C1CN2CC3=CCO[C@H]4CC(=O)N5[C@H]6[C@H]4[C@H]3C[C@H]2[C@@]61C7=CC=CC=C75.Cl\n",
      "The molecule is a hydrochloride obtained by combining strychnine with one molar equivalent of hydrogen chloride. It has a role as an avicide, a cholinergic antagonist, a glycine receptor antagonist, a rodenticide and a neurotransmitter agent. It is a hydrochloride and an organoammonium salt. It contains a strychnine(1+).\n",
      "The molecule is a hydrochloride resulting from the reaction of equimolar amounts of strychnine and hydrogen chloride. It has a role as an antiplasmodial drug, a muscarinic antagonist and a serotonergic antagonist. It contains a strychnine(1+).\n",
      " The molecule is a hydrochloride resulting from the reaction of equimolar amounts of quipazine and hydrogen chloride. It has a role as an antidote to curare poisoning, a NMDA receptor antagonist and a cholinergic antagonist. It is a monoterpenoid indole alkaloid and a hydrochloride. It contains a quipazine(1+). \n",
      " The molecule is a hydrochloride obtained by combining strychnine with one molar equivalent of hydrochloric acid. It has a role as an anti-nicotinic antagonist, a serotonergic antagonist, a dopaminergic antagonist and a serotonergic antagonist. It contains a strychnine(1+).\n",
      "\n",
      "2038 0.08080108278052613 0.07040391092540038 0.22449125311311235 \n",
      " OO\n",
      "The molecule is an inorganic peroxide consisting of two hydroxy groups joined by a covalent oxygen-oxygen single bond. It has a role as an oxidising agent, a disinfectant, an explosive, an antimicrobial agent, a cofactor, a human xenobiotic metabolite, an apoptosis inducer, a GABA antagonist, a neurotoxin, a genotoxin, a biomarker, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite, a bleaching agent and an emetic. It is an inorganic peroxide and a member of reactive oxygen species. It is a conjugate acid of a hydrogenperoxide(1-).\n",
      "The molecule is the peracid of hydroxylamine. It has a role as an EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor, an EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor, an EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor, an EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor, an EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor, an EC 3.1.1.7 (acetylcholinesterase) inhibitor, an EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor, an EC 3.1.1.7 (acetylcholinesterase) inhibitor, an EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor, an EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor and an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a member of reactive oxygen species and a peroxynucleoside.\n",
      " The molecule is a diatomic oxygen, an inorganic radical, an oxygen radical and a member of reactive oxygen species. It has a role as a human metabolite, an Escherichia coli metabolite and a mouse metabolite. \n",
      " The molecule is a member of the class of reactive oxygen species obtained by removal of a proton from peroxylic acid. It has a role as a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a member of reactive oxygen species, a nitrogen oxoacid and an inorganic hydroxy compound. It is a conjugate acid of a peroxylate.\n",
      "\n",
      "2040 0.7480506936285954 0.5878441130823592 0.8585737982604738 \n",
      " CC(=CCC1=CC2=C(C3=C1OC(C=C3)(C)C)O[C@@H](CC2=O)C4=CC(=C(C=C4)OC)OC)C\n",
      "The molecule is an extended flavonoid that consists of (2S)-flavanone substituted methoxy groups at positions 3' and 4', a prenyl group at position 6 and a gem-dimethylpyran ring fused across positions 7 and 8. Isolated from Lonchocarpus utilis and Lonchocarpus urucu, it acts as a NADH:ubiquinone reductase inhibitor. It has a role as an EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor and a plant metabolite. It is a dimethoxyflavanone, an extended flavonoid, a pyranochromane, a member of 4'-methoxyflavanones and a member of 3'-methoxyflavanones.\n",
      "The molecule is an extended flavonoid that consists of (2S)-flavanone substituted by a 3,4-dimethoxyphenyl group at position 5, a methyl group at position 3' and a prenyl group at position 8. Isolated from Lonchocarpus utilis and Lonchocarpus urucu, it acts as a NADH:ubiquinone reductase inhibitor. It has a role as an EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor and a plant metabolite. It is an extended flavonoid, a dimethoxyflavanone, a dihydroxyflavanone, a pyranochromane and a member of 4'-methoxyflavanones.\n",
      " The molecule is an extended flavonoid that consists of 3,4-dihydro-2H,12H-pyrano[2,3-f]chromen-12-one substituted by a hydroxy group at position 5, geminal methyl groups at position 6, a methoxy group at position 8 and a prenyl group at position 3. Isolated from Lonchocarpus utilis and Lonchocarpus urucu, it acts as a NADH:ubiquinone reductase inhibitor. It has a role as an EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor and a plant metabolite. It is an extended flavonoid, a member of phenanthrenes and an organic heterotricyclic compound. \n",
      " The molecule is an extended flavonoid that consists of (2S)-flavanone substituted by a 3,4-dimethoxyphenyl group at position 5, a prenyl group at position 6 and a gem-dimethylpyran ring fused across positions 7 and 8. Isolated from Lonchocarpus utilis and Lonchocarpus urucu, it acts as a NADH:ubiquinone reductase inhibitor. It has a role as an EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor and a plant metabolite. It is an extended flavonoid, a dimethoxyflavanone, a monohydroxyflavanone, a pyranochromane, a member of 4'-methoxyflavanones and a member of 3'-methoxyflavanones.\n",
      "\n",
      "2041 0.6036449559012615 0.6916363183734594 1.0 \n",
      " CC/C=C\\\\C/C=C\\\\C/C=C\\\\C/C=C\\\\C/C=C\\\\C/C=C\\\\CCCCCCCCCCCC/C=C/C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O\n",
      "The molecule is a 2,3-trans-enoyl CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (2E,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontaheptaenoyl-CoA; major species at pH 7.3. It is a conjugate base of a (2E,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontaheptaenoyl-CoA.\n",
      "The molecule is a 2,3-trans-enoyl CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (2E,14Z,17Z,20Z,23Z,26Z,29Z)-dotriacontaheptaenoyl-CoA; major species at pH 7.3. It is a conjugate base of a (2E,14Z,17Z,20Z,23Z,26Z,29Z)-dotriacontaheptaenoyl-CoA.\n",
      " The molecule is a 2,3-trans-enoyl CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (2E,12Z,15Z,18Z,21Z,24Z,27Z)-triacontaheptaenoyl-CoA; major species at pH 7.3. It is a conjugate base of a (2E,12Z,15Z,18Z,21Z,24Z,27Z)-triacontaheptaenoyl-CoA. \n",
      " The molecule is a 2,3-trans-enoyl CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (2E,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontaheptaenoyl-CoA; major species at pH 7.3. It is a conjugate base of a (2E,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontaheptaenoyl-CoA.\n",
      "\n",
      "2044 0.32269242013685395 2.726425827213694e-78 0.44978162254475623 \n",
      " CCCCCCCCCCCCCCCC(=O)OCCC(C)CC/C=C(/C)\\\\CC/C=C(\\\\C)/CC/C=C(\\\\C)/CCC=C(C)C\n",
      "The molecule is an acyldolichol obtained by formal condensation of the hydroxy group of dolichol with the carboxy group of palmitic (hexadecanoic) acid. It has a role as a mammalian metabolite. It is an acyldolichol and a hexadecanoate ester.\n",
      "The molecule is a hexadecanoate ester obtained by formal condensation of the carboxy group of hexadecanoic acid with the hydroxy group of geranylgeraniol. It has a role as a human metabolite. It derives from a hexadecanoic acid and an all-trans-hexadeca-2,6,10,14-tetraen-1-ol.\n",
      " The molecule is a wax ester formed between all-trans-retinol and octadecanoic acid. It is a wax ester and a retinoid. It derives from an all-trans-retinol and an octadecanoic acid. \n",
      " The molecule is a palmitate ester obtained by formal condensation of the carboxy group of palmitic acid with the hydroxy group of hexadecanol. It has a role as a bacterial metabolite. It is a hexadecanoate ester and a wax ester. It derives from a hexadecanol.\n",
      "\n",
      "2096 0.391818228379534 0.32530991779487045 0.6958682535018921 \n",
      " CC(=O)CC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C\n",
      "The molecule is an O-acyl-L-carnitine in which the acyl group is specified as acetoacetyl. It is an O-acyl-L-carnitine and an oxo-fatty acyl-L-carnitine. It derives from an acetoacetic acid.\n",
      "The molecule is an O-acyl-L-carnitine in which the acyl group is specified as 3-oxobutanoyl. It has a role as a human metabolite. It derives from a 3-oxobutanoic acid.\n",
      " The molecule is an O-acyl-L-carnitine in which the acyl group specified is pimeloyl. It has a role as a human metabolite. It derives from a pimelic acid. \n",
      " The molecule is an O-acyl-L-carnitine in which the acyl group is specified as 3-oxobutanoyl. It is an O-acyl-L-carnitine and a saturated fatty acyl-L-carnitine. It derives from a 3-oxobutanoic acid.\n",
      "\n",
      "2099 0.0499375831213352 0.0708243398785118 0.19991669447903512 \n",
      " [Be+2].[F-].[F-]\n",
      "The molecule is the fluoride salt of beryllium (+2 oxidation state). In the solid state it exists as a glass, with four-coordinate Be(2+) tetrahedral centres and two-coordinate fluoride centres. As a gas it adopts a linear triatomic structure and in the liquid state a fluctuating tetrahedral structure. In protein crystallography it is used as a mimic of phosphate. It is a beryllium molecular entity and a fluoride salt.\n",
      "The molecule is a halide anion and a fluoride salt. It has a role as a carcinogenic agent and a genotoxin. It is a fluoride salt and a fluoride salt.\n",
      " The molecule is a fluoride salt having Be(2+) as the counterion. It has a role as a carcinogenic agent and a mutagen. It is a fluoride salt and a Be molecular entity. \n",
      " The molecule is a compound of beryllium (+2 oxidation state) and is the most common carcinogen in tobacco smoke. It has a role as a carcinogenic agent and a genotoxin. It is a beryllium molecular entity and a metal oxide.\n",
      "\n",
      "2101 0.3584612214883631 0.32008850869460337 0.5537412023101327 \n",
      " C([C@@H]1[C@H]([C@H]([C@@H](O1)NC2=C(C(=O)NC(=O)N2)N)O)O)OP(=O)(O)O\n",
      "The molecule is an N-glycosyl compound that consists of 5,6-diaminouracil in which one of the hydrogens on the 6-amino function is substituted by a 5-phospho-beta-D-ribosyl residue. It has a role as an Escherichia coli metabolite. It is a N-glycosyl compound, a ribose monophosphate and an aminouracil. It is a conjugate acid of a 5-amino-6-(5-phospho-D-ribosylamino)uracil(2-).\n",
      "The molecule is a 5-amino-6-(5-phospho-D-ribosylamino)uracil in which the anomeric centre of the pyranose fragment has alpha-configuration. It is a conjugate acid of a 5-amino-6-(5-phospho-beta-D-ribosylamino)uracil(2-).\n",
      " The molecule is a N-glycosyl compound, a ribose monophosphate, an aminopyrimidine and an oxopurine. It is a conjugate acid of a 5-amino-6-(5-phospho-D-ribosylamino)uracil(2-). \n",
      " The molecule is a 5-amino-6-(5-phospho-D-ribosylamino)uracil in which the hydroxy group at position 5 is substituted by the 6-amino group of 5,6-diaminopyrimidine-2,4(1H,3H)-dione. It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a ribose monophosphate, a pyrimidine ribonucleoside 5'-monophosphate and an aminouracil. It is a conjugate acid of a 5-amino-6-(5-phospho-beta-D-ribosylamino)uracil(2-).\n",
      "\n",
      "2113 0.41336703537446695 0.44144303831267745 0.5536442851680289 \n",
      " COC1=CC(=C2C(=C1)OC(=CC2=O)C3=CC(=C(C=C3OC)OC)OC)O\n",
      "The molecule is a monohydroxyflavone that is flavone with a hydroxy substituent at position 5 and methoxy groups at positions 7, 2', 4' and 5'. Isolated from Calliandra californica, it exhibits antibacterial activity. It has a role as a metabolite and an antibacterial agent. It is a monohydroxyflavone and a tetramethoxyflavone.\n",
      "The molecule is a pentamethoxyflavone that is flavone substituted by methoxy groups at positions 5, 7, 3' and 5' and a hydroxy group at position 5'. It has been isolated from Mimosa diplotricha. It has a role as a plant metabolite. It is a pentamethoxyflavone and a monohydroxyflavone. It derives from a flavone.\n",
      " The molecule is a dihydroxyflavone that is flavone substituted by hydroxy groups at positions 5 and 2' and methoxy groups at positions 7, 4' and 5'. It has been isolated from Mimosa diplotricha. It has a role as a plant metabolite. It is a trimethoxyflavone and a dihydroxyflavone. It derives from a flavone. \n",
      " The molecule is a monohydroxyflavone that is flavone substituted by a hydroxy group at position 5 and methoxy groups at positions 7, 4' and 5'. It has been isolated from Mimosa diplotricha. It has a role as a plant metabolite. It is a trimethoxyflavone and a monohydroxyflavone. It derives from a flavone.\n",
      "\n",
      "2125 0.14705223098363224 0.12472544322293314 0.3009685888082179 \n",
      " CC1=CC(=O)CC([C@]1(/C=C/C(=C/C=O)/C)O)(C)C\n",
      "The molecule is an enal that is (+)-abscisic aldehyde in which the double bonds at position 2 and 4 have trans-configuration. It is an enal, an apo carotenoid sesquiterpenoid, a member of cyclohexenones and an enone.\n",
      "The molecule is the naturally occurring (1'S)-(+) enantiomer of abscisic acid. It is an important sesquiterpenoid plant hormone which acts as a regulator of plant responses to environmental stresses such as drought and cold. It has a role as a plant hormone and a plant metabolite. It is a conjugate acid of a (+)-abscisate. It is an enantiomer of a (-)-abscisic acid.\n",
      " The molecule is an optically active form of dehydroabscisic acid having (2S,3E,4R)-configuration. It has a role as a plant metabolite. It is an enantiomer of a (2R,3E,4S)-dehydroabscisic acid. \n",
      " The molecule is the naturally occurring (1'S)-(+) enal. It is an enal, a sesquiterpenoid and an enal. It derives from a (+)-abscisic acid. It is an enantiomer of a (-)-abscisic acid.\n",
      "\n",
      "2130 0.312052477484831 0.5908400404640393 0.892585231474153 \n",
      " CC/C=C\\\\C[C@H](/C=C/C=C\\\\C/C=C\\\\C/C=C\\\\CCCC(=O)O)O\n",
      "The molecule is a 15-HEPE that consists of (5Z,8Z,11Z,13E,17Z)-icosapentaenoic acid in which the 15-hydroxy group has R-configuration. It has a role as a mouse metabolite, an anti-inflammatory agent and a human xenobiotic metabolite. It is a conjugate acid of a 15(R)-HEPE(1-). It is an enantiomer of a 15(S)-HEPE.\n",
      "The molecule is an optically active form of 15-HEPE having 15(R)-configuration. It is a conjugate acid of a 15(R)-HEPE(1-). It is an enantiomer of a 15(S)-HEPE.\n",
      " The molecule is an optically active form of 15-HEPE having 15(R)-configuration. It has a role as a mouse metabolite, an anti-inflammatory agent and a human xenobiotic metabolite. It is a conjugate acid of a 15(R)-HEPE(1-). It is an enantiomer of a 15(S)-HEPE. \n",
      " The molecule is an 18-HEPE that consists of (5Z,8Z,11Z,13E,17Z)-icosapentaenoic acid in which the 15-hydroxy group has R-configuration. It has a role as a mouse metabolite and a human xenobiotic metabolite. It is a conjugate acid of a 15(R)-HEPE(1-). It is an enantiomer of a 15(S)-HEPE.\n",
      "\n",
      "2154 0.29911290772661797 0.29920431919176527 0.5222807188410639 \n",
      " CC1(C2CCC1(C(=O)C2)C)C\n",
      "The molecule is a cyclic monoterpene ketone that is bornane bearing an oxo substituent at position 2. A naturally occurring monoterpenoid. It has a role as a plant metabolite. It is a bornane monoterpenoid and a cyclic monoterpene ketone.\n",
      "The molecule is a bornane monoterpenoid that is bicyclo[2.2.1]heptane substituted by methyl groups at positions 1, 7 and 7 and oxo groups at positions 2 and 3. It is a bornane monoterpenoid and a carbobicyclic compound.\n",
      " The molecule is a bornane monoterpenoid that is bicyclo[2.2.1]heptane substituted by acetyl groups at positions 1 and 7 and oxo groups at positions 2 and 3. It is a bornane monoterpenoid and a carbobicyclic compound. \n",
      " The molecule is a cyclic monoterpene ketone that is camphor bearing two methyl substituents at position 3. It is a bornane monoterpenoid and a cyclic monoterpene ketone. It derives from a camphor.\n",
      "\n",
      "2174 0.15464160708861793 0.18875477652449735 0.6867334030987956 \n",
      " CC(C)C1=CC2=CC[C@@H]3[C@@]([C@H]2CC1)(CCC[C@@]3(C)C(=O)O)C\n",
      "The molecule is an abietane diterpenoid that is abieta-7,13-diene substituted by a carboxy group at position 18. It has a role as a plant metabolite. It is an abietane diterpenoid and a monocarboxylic acid. It is a conjugate acid of an abietate.\n",
      "The molecule is an aldehyde resulting from the addition of water to the aldehyde group of abietal. It derives from a hydride of an abieta-7,13-diene.\n",
      " The molecule is a dicarboxylic acid monoester having abieta-7,13-diene as the carboxylic acid group. It derives from a hydride of an abieta-7,13-diene. \n",
      " The molecule is an abietane diterpenoid that is abieta-7,13-diene substituted by a carboxy group at position 28. It has been isolated from the leaves of Rosa laevigata. It has a role as a plant metabolite. It is an abietane diterpenoid, a carbotricyclic compound and a monocarboxylic acid.\n",
      "\n",
      "2193 0.6350368347073829 0.6391198576290681 0.8932475280858814 \n",
      " CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O)OCCN\n",
      "The molecule is a 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as pentadecanoyl and docosanoyl respectively. It has a role as a mouse metabolite and a rat metabolite. It is a 1,2-diacyl-sn-glycero-3-phosphoethanolamine and a phosphatidylethanolamine 37:0. It derives from a docosanoic acid and a pentadecanoic acid.\n",
      "The molecule is a 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as pentadecanoyl and docosanoyl respectively. It has a role as a mouse metabolite and a rat metabolite. It derives from a pentadecanoic acid and a pentadecanoic acid.\n",
      " The molecule is a 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are both specified as octadecanoyl (stearoyl). It has a role as a mouse metabolite and a rat metabolite. It is a 1,2-diacyl-sn-glycero-3-phosphoethanolamine and a phosphatidylethanolamine 36:0. It derives from an octadecanoic acid. It is a tautomer of a 1,2-dioctadecanoyl-sn-glycero-3-phospho \n",
      " The molecule is a 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as tetradecanoyl and docosanoyl respectively. It has a role as a mouse metabolite and a rat metabolite. It is a 1,2-diacyl-sn-glycero-3-phosphoethanolamine and a phosphatidylethanolamine 36:0. It derives from a tetradecanoic acid and a docosanoic acid.\n",
      "\n",
      "2198 0.5862079986039928 0.516086732676307 0.7477747719117864 \n",
      " CCC[C@H](CCCCCCCC1=C(C(=CC(=C1)O)O)C(=O)O[C@H](CCC)CCCCCCCC2=CC(=CC(=C2)O)O)OC(=O)C\n",
      "The molecule is a benzoate ester obtained by the formal condensation of the hydroxy group of 5-(8-hydroxyundecyl)benzene-1,3-diol with 4,6-dihydroxy benzoic acid which is also substituted by a 8-(acetoxy)undecyl group at position 2. It is isolated from Cytonaema sp. and has anti-HIV-1 activity. It has a role as a metabolite and a HIV-1 integrase inhibitor. It is a member of resorcinols and a benzoate ester.\n",
      "The molecule is a benzoate ester obtained by the formal condensation of the hydroxy group of 5-(acetyloxy)-2,4-dihydroxybenzoic acid with the 8-hydroxy group of 8-(8-hydroxyundecyl)benzene-1,3-diol. Isolated from the dried fruits of Cytonaema sp., it exhibits anti-HIV-1 activity. It has a role as a metabolite and an anti-HIV-1 agent. It is a member of resorcinols, a benzoate ester and a member of resorcinols.\n",
      " The molecule is a benzoate ester obtained by the formal condensation of the hydroxy group of 5,6-dihydroxy-3,4-dihydro-2H-1-benzopyran-2-one with the carboxy group of 4,4-dimethyluracil-1,6-dicarboxylic acid. Isolated from Cytonaema sp. and Spongia sp. it exhibits anti-HIV-1 activity. It has a role as a metabolite and a HIV-1 integrase inhibitor. It is a member of resorcinols, a benzoate ester and a member of uracils. It derives \n",
      " The molecule is a benzoate ester obtained by the formal condensation of the hydroxy group of 5-(8-hydroxyundecyl)benzene-1,3-diol with the carboxy group of acetic acid which is also substituted by an acetoxy group at position 4. It is isolated from Cytonaema sp. and has anti-HIV-1 activity. It has a role as a metabolite and a HIV-1 integrase inhibitor. It is a member of resorcinols, a benzoate ester and a monohydroxybenzoic acid. It derives from an olivetol.\n",
      "\n",
      "2199 0.4006127223164664 0.5484162480804929 0.7013015456199698 \n",
      " C1=CC(=C(C=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O\n",
      "The molecule is a C-glycosyl compound that is luteolin substituted by beta-D-glucopyranosyl moieties at positions 6 and 8 respectively. It is a C-glycosyl compound and a tetrahydroxyflavone. It derives from a luteolin.\n",
      "The molecule is a C-glycosyl compound that is isoorientin in which the hydrogen at position 8 is replaced by a beta-D-glucosyl residue. It has a role as a metabolite. It is a trihydroxyflavone and a C-glycosyl compound. It derives from an isoorientin.\n",
      " The molecule is a C-glycosyl compound that is luteolin substituted at positions 8 and 6 by beta-D-glucosyl residues. It has a role as a radical scavenger and an antineoplastic agent. It is a tetrahydroxyflavone and a C-glycosyl compound. It derives from a luteolin. \n",
      " The molecule is a C-glycosyl compound that is luteolin substituted at positions 6 and 8 by beta-D-glucosyl groups. It has a role as a metabolite. It is a C-glycosyl compound and a trihydroxyflavone. It derives from a luteolin.\n",
      "\n",
      "2261 0.8865168578990577 0.8540199842757134 1.0 \n",
      " CCCCCCCCCCCCCCCCCCOCC(=O)COP(=O)([O-])[O-]\n",
      "The molecule is a 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-octadecylglycerone 3-phosphate; major species at pH 7.3. It is a conjugate base of a 1-octadecylglycerone 3-phosphate.\n",
      "The molecule is a 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-heptadecylglycerone 3-phosphate; major species at pH 7.3. It is a conjugate base of a 1-heptadecylglycerone 3-phosphate.\n",
      " The molecule is a 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-dodecylglycerone 3-phosphate; major species at pH 7.3. It is a conjugate base of a 1-dodecylglycerone 3-phosphate. \n",
      " The molecule is a 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-octadecylglycerone 3-phosphate; major species at pH 7.3. It is a conjugate base of a 1-octadecylglycerone 3-phosphate.\n",
      "\n",
      "2283 0.10952472986228172 0.27952477202361653 0.39927791268585966 \n",
      " C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN\n",
      "The molecule is a 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups. It has a role as an EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor and a bone density conservation agent. It is a 1,1-bis(phosphonic acid) and a primary amino compound. It is a conjugate acid of an alendronate(1-).\n",
      "The molecule is a phosphonic acid having a 3-aminopropyl group attached to the phosphorus. It derives from a phosphonic acid. It is a conjugate acid of a gamma-aminobutyl diphosphate(1-).\n",
      " The molecule is a phosphonic acid in which the hydrogen attached to the phosphorus of 1,1-bis(phosphonic acid) is substituted by a 3-amino-3-oxopropyl group. It has a role as a proton donor and an EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor. It is a primary amino compound and a member of phosphonic acids. It derives from a phosphonic acid. It is a tautomer of a (3-amino-3-oxopropyl)phosphonate zwitterion. \n",
      " The molecule is a tertiary alcohol that is ethane-1,1-diylbis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces. It has a role as a bone density conservation agent, a chelator and an antineoplastic agent. It is a tertiary alcohol, a member of phosphonic acids and a primary amino compound. It is a conjugate acid of an alendronate(1-).\n",
      "\n",
      "2284 0.644852991743225 0.5456092794807179 0.8906377170337078 \n",
      " CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1C(=O)O)[O-]\n",
      "The molecule is a hydroxy monocarboxylic acid anion that is the conjugate base of Delta(9)-tetrahydrocannabinolic acid, obtained by deprotonation of the carboxy group. It is a conjugate base of a Delta(9)-tetrahydrocannabinolic acid.\n",
      "The molecule is a hydroxy monocarboxylic acid anion that is the conjugate base of Delta(9)-tetrahydrocannabinol, obtained by deprotonation of the carboxy group. Major species at pH 7.3. It is a hydroxy monocarboxylic acid anion and a phenolate anion. It is a conjugate base of a Delta(9)-tetrahydrocannabinol.\n",
      " The molecule is a benzochromenone anion that is the conjugate base of 16alpha-hydroxy-Delta(9)-tetrahydrocannabinol, obtained by deprotonation of the carboxy group. Major microspecies at pH 7.3. It is a conjugate base of a 16alpha-hydroxy-Delta(9)-tetrahydrocannabinol. \n",
      " The molecule is a hydroxy monocarboxylic acid anion that is the conjugate base of Delta(9)-tetrahydrocannabinol, obtained by deprotonation of the carboxy group. It is a conjugate base of a Delta(9)-tetrahydrocannabinol.\n",
      "\n",
      "2289 0.37527800943760453 0.39161578827806975 0.5630420634034394 \n",
      " CCCCCCCC/C=C\\\\CCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O\n",
      "The molecule is an acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (17Z)-hexacosenoyl-CoA It is a conjugate base of a (17Z)-hexacosenoyl-CoA.\n",
      "The molecule is a C24:1-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (15Z)-tetracosenoyl-CoA. It is a C24:1-CoA(4-) and a 3-substituted propionyl-CoA(4-). It is a conjugate base of a (15Z)-tetracosenoyl-CoA.\n",
      " The molecule is a C24:1-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (2E)-tricosenoyl-CoA. It is a C24:1-CoA(4-) and a 3-substituted propionyl-CoA(4-). It is a conjugate base of a (2E)-tricosenoyl-CoA. \n",
      " The molecule is a C24:1-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (17Z)-hexacosenoyl-CoA. It is a C24:1-CoA(4-) and a 3-substituted propionyl-CoA(4-). It is a conjugate base of a (17Z)-hexacosenoyl-CoA.\n",
      "\n",
      "2294 0.5906039317552653 0.4861017604270708 0.8667738772233501 \n",
      " C1=CC=C(C=C1)COC2=CC3=C(C=C2)NC=C3CC(=O)C(=O)[O-]\n",
      "The molecule is the anion of 3-(5-benzyloxyindol-3-yl)pyruvic acid. It derives from a pyruvate. It is a conjugate base of a 3-(5-benzyloxyindol-3-yl)pyruvic acid.\n",
      "The molecule is a 2-oxo monocarboxylic acid anion that is the conjugate base of 3-(5-benzyloxyindol-3-yl)pyruvic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. It derives from a pyruvate. It is a conjugate base of a 3-(5-benzyloxyindol-3-yl)pyruvic acid.\n",
      " The molecule is the conjugate base of 5-(4-hydroxyphenyloxy)pyruvic acid. It derives from a pyruvate. It is a conjugate base of a 5-(4-hydroxyphenyloxy)pyruvic acid. \n",
      " The molecule is a pyruvate that is the conjugate base of 3-(5-benzyloxyindol-3-yl)pyruvic acid. It derives from a pyruvate. It is a conjugate base of a 3-(5-benzyloxyindol-3-yl)pyruvic acid.\n",
      "\n",
      "2295 0.27674513687802116 3.798701938484373e-78 0.39725756313574173 \n",
      " C[NH3+].[Cl-]\n",
      "The molecule is the hydrochloride formed from methylamine. It is a hydrochloride, an organoammonium salt and a one-carbon compound. It contains a methylammonium.\n",
      "The molecule is the hydrochloride salt of methylamine. It has a role as an allergen. It contains a methylamine.\n",
      " The molecule is an organic chloride salt that is the monochloride salt of ethylamine. It has a role as a mutagen. It contains an ethylaminium. \n",
      " The molecule is an organic chloride salt and a one-carbon compound. It has a role as a protein denaturant. It contains a methylamine and a chloride.\n",
      "\n",
      "2297 0.7281555816542453 0.7266532531628946 0.8338542560892604 \n",
      " [C-]#[N+]S\n",
      "The molecule is a hydracid and a one-carbon compound. It is a conjugate acid of a thiofulminate. It is a tautomer of a thiofulminic acid.\n",
      "The molecule is a hydracid and a one-carbon compound. It is a conjugate acid of a thiocyanate. It is a tautomer of an isothiocyanic acid.\n",
      " The molecule is a nitrile sulfide, a hydracid and a one-carbon compound. It is a conjugate acid of a thiofulminate. It is a tautomer of an isothiofulminic acid. \n",
      " The molecule is a hydracid and a one-carbon compound. It is a conjugate acid of a thiofulminate. It is a tautomer of an isothiofulminic acid.\n",
      "\n",
      "2310 0.30341593099311187 0.2510992879507367 0.5249578753550506 \n",
      " CC1=NN(C(=O)N1C(F)F)C2=C(C=C(C(=C2)NS(=O)(=O)C)Cl)Cl\n",
      "The molecule is a member of the class of triazoles that is 5-oxo-1,2,4-triazole which is substituted at positions 1, 3, and 4 by 2,4-dichloro-5-[(methylsulfonyl)amino]phenyl, methyl, and difluoromethyl groups, respectively. A protoporphyrinogen oxidase inhibitor, it is used as a herbicide to control broad-leaved weeds in soya and tobacco crops. Not approved for use within the European Union. It has a role as an EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor, a herbicide and an agrochemical. It is a sulfonamide, a dichlorobenzene, an organofluorine compound and a member of triazoles.\n",
      "The molecule is a member of the class of triazoles that is 2,4-dihydro-3H-1,2,4-triazol-3-one which is substituted at positions 2, 4, and 5 by 5-(methanesulfonylamino)-4-chloro-2-fluorophenyl, difluoromethyl, and methyl groups, respectively. It is a member of triazoles, a dichlorobenzene, a member of pyrazoles, an organofluorine compound and a sulfonamide.\n",
      " The molecule is a member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one which is substituted at positions 1, 3, and 5 by trifluoromethyl, methylsulfonyl, and 2,4-dichlorophenyl groups, respectively. It has a role as a herbicide, an agrochemical and a synthetic auxin. It is a dichlorobenzene, a sulfone, a member of benzimidazoles and a member of monochlorobenzenes. \n",
      " The molecule is a member of the class of triazoles that is 2,4-dichloro-5-methyl-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-3-one which is substituted at positions 2, 4, and 5 by 2,6-dichloro-4-(methylsulfonyl)phenyl, difluoromethyl, and methyl groups, respectively. A protoporphyrinogen oxidase inhibitor, it is used (usually as the corresponding ethyl ester proherbicide, pyraflufen-ethyl) for the control of broad-leaved weeds and grasses in a variety of crops. It has a role as an EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor, a herbicide and an agrochemical. It is a member of triazoles, a sulfonamide, a dichlorobenzene, a member of monochlorobenzenes and a sulfonamide.\n",
      "\n",
      "2323 0.20958474374504202 0.3154399905413281 0.4204660525238324 \n",
      " CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O\n",
      "The molecule is a substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group. It has a role as a bronchodilator agent, a beta-adrenergic agonist and a sympathomimetic agent. It is a member of ethanolamines, a primary arylamine, a secondary amino compound, an amino alcohol, a substituted aniline and a dichlorobenzene. It is a conjugate base of a clenbuterol(1+).\n",
      "The molecule is a member of the class of ethanolamines that is 4-aminophenol substituted by a 2-(tert-butylamino)-1-hydroxyethyl group at position 2. It is a member of ethanolamines, a dichlorobenzene and a primary amino compound.\n",
      " The molecule is a member of the class of clenbuters that is dichlorobenzene substituted by an amino group at position 2 and by chloro groups at positions 3, 4 and 5. It has a role as a bronchodilator agent, a beta-adrenergic agonist and a sympathomimetic agent. It is a member of clenbuters, a dichlorobenzene and a member of monochlorobenzenes. \n",
      " The molecule is a member of the class of phenylethanolamines that is catechol in which the hydrogens at positions 2 and 5 are replaced by chlorines, while the hydrogens at position 4 are replaced by a 2-(tert-butylamino)-1-hydroxyethyl group. It has a role as a beta-adrenergic agonist, an anti-asthmatic drug and a bronchodilator agent. It is a member of phenylethanolamines, a member of trichlorobenzenes and a secondary amino compound.\n",
      "\n",
      "2349 0.21755753574515563 0.10879795726917288 0.3836812372154901 \n",
      " CC(C)CC1=CC=C(C=C1)C(C)C(=O)O\n",
      "The molecule is a monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a cyclooxygenase 2 inhibitor, a cyclooxygenase 1 inhibitor, an antipyretic, a xenobiotic, an environmental contaminant, a radical scavenger and a drug allergen. It derives from a propionic acid. It is a conjugate acid of an ibuprofen(1-).\n",
      "The molecule is a monocarboxylic acid that is propionic acid substituted by a 4-isopropylphenyl group at position 2. It is a metabolite of the drug ibuprofen. It has a role as a marine xenobiotic metabolite. It derives from a propionic acid.\n",
      " The molecule is a ibuprofen. It has a role as a non-steroidal anti-inflammatory drug and a drug allergen. It is a conjugate acid of an ibuprofenate. \n",
      " The molecule is a monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is replaced by a 4-isobutylphenyl group. Although it was shown to be effective in treatment of rheumatoid arthritis, the clinical use of ibufenac was discontinued due to hepatotoxic side-effects. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a hepatotoxic agent and an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor. It derives from an acetic acid.\n",
      "\n",
      "2366 0.3918018729289882 0.3918018729289882 0.8561729204918195 \n",
      " COC1=C(C=C(C=C1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[C@@H]3CCC4=C(O3)C=C(C=C4)O)O\n",
      "The molecule is a flavan glycoside that is (2S)-flavan substituted by a methoxy group at position 4', hydroxy groups at positions 7 and 5' and a beta-D-glucopyranosyloxy group at position 3 respectively. It has a role as a plant metabolite. It is a hydroxyflavan, a methoxyflavan, a beta-D-glucoside, a monosaccharide derivative and a flavan glycoside. It derives from a (2S)-flavan.\n",
      "The molecule is a monosaccharide derivative that is 4'-O-methylrobinetinidol attached to a beta-D-glucopyranosyl residue at position 3'. Isolated from Acacia mearnsii, it exhibits inhibitory activity against alpha-amylase. It has a role as a metabolite and an EC 3.2.1.1 (alpha-amylase) inhibitor. It is a catechin, a monosaccharide derivative, a beta-D-glucoside, a methoxyflavan and a flavan glycoside. It derives from a robinetinidol.\n",
      " The molecule is a monosaccharide derivative that is 4'-O-methylrobinetinidol attached to a beta-D-glucopyranosyl residue at position 3'. Isolated from Acacia mearnsii, it exhibits inhibitory activity against alpha-amylase. It has a role as a metabolite and an EC 3.2.1.1 (alpha-amylase) inhibitor. It is a catechin, a monosaccharide derivative, a beta-D-glucoside, a methoxyflavan and a flavan glycoside. It derives from a robinetinidol. \n",
      " The molecule is a flavan glycoside that is (2S)-flavan substituted by hydroxy groups at positions 7 and 3', a methoxy group at position 4' and a beta-D-glucopyranosyloxy group at position 5' respectively. It has a role as a plant metabolite. It is a flavan glycoside, a methoxyflavan, a hydroxyflavan, a monosaccharide derivative and a beta-D-glucoside. It derives from a (2S)-flavan.\n",
      "\n",
      "2369 0.3343372102951986 0.3014502730756701 0.6065306597126334 \n",
      " C1[C@H](NCC1O)C(=O)O\n",
      "The molecule is the L-stereoisomer of 4-hydroxyproline. It is a 4-hydroxyproline, a L-proline derivative and a non-proteinogenic L-alpha-amino acid. It is a conjugate acid of a 4-hydroxy-L-prolinate. It is an enantiomer of a 4-hydroxy-D-proline. It is a tautomer of a 4-hydroxy-L-proline zwitterion.\n",
      "The molecule is the L-stereoisomer of 4-hydroxyproline. It is a L-proline derivative and a 4-hydroxyproline. It is an enantiomer of a 4-hydroxy-D-proline.\n",
      " The molecule is the D-stereoisomer of 4-hydroxyproline. It is a D-proline derivative and a 4-hydroxyproline. It is an enantiomer of a 4-hydroxy-L-proline. \n",
      " The molecule is the L-stereoisomer of 4-hydroxyproline. It is a 4-hydroxyproline, a L-proline derivative and a non-proteinogenic L-alpha-amino acid. It is a tautomer of a 4-hydroxy-L-proline zwitterion.\n",
      "\n",
      "2382 0.5354242140620307 0.489796212032952 0.6724238253698834 \n",
      " C(CC(=O)[O-])[C@@H](C(=O)[O-])[NH+]=CN\n",
      "The molecule is conjugate base of N-formimidoyl-L-glutamic acid having both carboxy groups in anionic form and the imine nitrogen protonated. It is an alpha-amino-acid anion and a dicarboxylic acid anion. It is a conjugate base of a N-formimidoyl-L-glutamic acid.\n",
      "The molecule is conjugate base of N-formimidoyl-L-glutamic acid arising from deprotonation of the carboxy groups and protonation of the secondary amino group; major species at pH 7.3. It is a conjugate base of a N-formimidoyl-L-glutamic acid.\n",
      " The molecule is a dicarboxylic acid anion resuting from removal of a proton from both carboxy groups and protonation of the imino group of N-formimidoyl-L-glutamic acid. It has a role as a human metabolite. It is an alpha-amino-acid anion and a dicarboxylic acid dianion. It derives from a L-glutamate(2-). It is a conjugate base of a N-formimidoyl-L-glutamic acid. \n",
      " The molecule is conjugate base of N-formimidoyl-L-glutamic acid having anionic carboxy groups and a protonated secondary amino group; major species at pH 7.3. It is a L-alpha-amino acid anion and a dicarboxylic acid anion. It is a conjugate base of a N-formimidoyl-L-glutamic acid.\n",
      "\n",
      "2391 0.3454867582344682 0.3454867582344682 0.669369530104576 \n",
      " CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OC[C@H](CO)O)OC(=O)CCCCCCCCCCC\n",
      "The molecule is a 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) obtained by deprotonation of the phosphate group of 1-palmitoyl-2-lauroyl-sn-glycero-3-phospho-(1'-sn-glycerol); major species at pH 7.3. It is a conjugate base of a 1-palmitoyl-2-lauroyl-sn-glycero-3-phospho-(1'-sn-glycerol).\n",
      "The molecule is a 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) that is the conjugate base of dimyristoyl phosphatidylglycerol; major species at pH 7.3. It is a conjugate base of a ditetradecanoyl phosphatidylglycerol.\n",
      " The molecule is a 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) that is the conjugate base of dimyristoyl phosphatidylglycerol; major species at pH 7.3. It is a conjugate base of a ditetradecanoyl phosphatidylglycerol. \n",
      " The molecule is a 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) in which the phosphatidyl acyl groups at positions 1 and 2 are specified as palmitoyl and lauroyl respectively; major species at pH 7.3. It is a conjugate base of a 1-palmitoyl-2-lauroyl-sn-glycero-3-phospho-(1'-sn-glycerol).\n",
      "\n",
      "2420 0.8492372354788985 0.6730140330541496 0.979629900343721 \n",
      " CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]2[C@H](OC([C@@H]([C@H]2O)NC(=O)C)O)CO)CO)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O)O)O)O)NC(=O)C)O)O)O)O\n",
      "The molecule is a linear amino hexasaccharide comprised of beta-D-galactose, N-acetyl-beta-D-glucosamine, alpha-D-mannose, beta-D-mannose, N-acetyl-beta-D-glucosamine and N-acetyl-D-glucosamine residues linked sequentially (1->4), (1->2), (1->6), (1->4) and (1->4). It has a role as an epitope. It is an amino hexasaccharide and a glucosamine oligosaccharide.\n",
      "The molecule is an amino hexasaccharide comprised of beta-D-galactose, N-acetyl-beta-D-glucosamine, alpha-D-mannose, beta-D-mannose, and two N-acetyl-D-glucosamine residues linked sequentially (1->4), (1->2), (1->3), (1->4) and (1->4). It has a role as an epitope. It is an amino hexasaccharide and a glucosamine oligosaccharide.\n",
      " The molecule is a branched amino heptasaccharide consisting of a sequence of beta-D-galactose, N-acetyl-beta-D-glucosamine, alpha-D-mannose, beta-D-mannose, and two N-acetyl-beta-D-glucosamine residues linked (1->4), (1->2), (1->6), (1->4) and (1->4), with an N-acetyl-beta-D-glucosaminyl residue linked (1->2) to the beta-D-mannose \n",
      " The molecule is a linear amino hexasaccharide comprised of beta-D-galactose, N-acetyl-beta-D-glucosamine, alpha-D-mannose, beta-D-mannose, N-acetyl-beta-D-glucosamine and N-acetyl-D-glucosamine residues linked sequentially (1->4), (1->2), (1->3), (1->4) and (1->4). It has a role as an epitope. It is an amino hexasaccharide and a glucosamine oligosaccharide.\n",
      "\n",
      "2424 0.29984508655515363 0.3134718994085877 0.46531368464411343 \n",
      " C(C(C(=O)[O-])[S-])C(=O)[O-].[Au+]\n",
      "The molecule is a C4-dicarboxylate which is a dianion obtained by the deprotonation of the two carboxy OH groups of aurothiomalic acid. It is a conjugate base of an aurothiomalic acid.\n",
      "The molecule is a dicarboxylic acid dianion resulting from the removal of a proton from both of the carboxylic acid groups of gold thiomalic acid. It is a gold coordination entity and a dicarboxylic acid dianion. It derives from a gold(2-). It is a conjugate base of an aurothiomalic acid.\n",
      " The molecule is a sulfur-containing carboxylic acid anion obtained by deprotonation of the three carboxy groups of thiomalic acid. It is a conjugate base of a thiomalic acid. It is a conjugate acid of a thiomalate(3-). \n",
      " The molecule is a sulfur-containing carboxylic acid anion obtained by the deprotonation of the carboxy groups of gold thiomalic acid. It is a gold coordination entity and a sulfur-containing carboxylic acid anion. It is a conjugate base of an aurothiomalic acid.\n",
      "\n",
      "2458 0.7864476341202712 0.8993657334643944 1.0 \n",
      " CCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@@H](/C=C/CCCCCCCCC(C)CC)O\n",
      "The molecule is a ceramide obtained by formal condensation of the carboxy group of henicosanoic acid with the amino group of 14-methylhexadecasphingosine. It is a metabolite of the nematode Caenorhabditis elegans. It has a role as a Caenorhabditis elegans metabolite. It is a ceramide and a Cer(d38:1). It derives from a 14-methylhexadecasphingosine and a henicosanoic acid.\n",
      "The molecule is a ceramide obtained by formal condensation of the carboxy group of icosanoic acid with the amino group of 14-methylhexadecasphingosine. It is a metabolite of the nematode Caenorhabditis elegans. It has a role as a Caenorhabditis elegans metabolite. It is a ceramide and a Cer(d38:1). It derives from an icosanoic acid.\n",
      " The molecule is a ceramide obtained by formal condensation of the carboxy group of heptadecanoic acid with the amino group of 14-methylhexadecasphingosine. It is a metabolite of the nematode Caenorhabditis elegans. It has a role as a Caenorhabditis elegans metabolite. It is a ceramide and a Cer(d34:1). It derives from a 14-methylhexadecasphingosine and a heptadecanoic acid. \n",
      " The molecule is a ceramide obtained by formal condensation of the carboxy group of henicosanoic acid with the amino group of 14-methylhexadecasphingosine. It is a metabolite of the nematode Caenorhabditis elegans. It has a role as a Caenorhabditis elegans metabolite. It is a ceramide and a Cer(d38:1). It derives from a 14-methylhexadecasphingosine and a henicosanoic acid.\n",
      "\n",
      "2474 0.4254999135407971 0.3054146074947832 0.663937512647381 \n",
      " CC1=C(C(=O)C2=CC=CC=C2C1=O)C/C=C(/C)\\\\CCC(=O)O\n",
      "The molecule is a member of the class of naphthoquinones that is 2-methyl-1,4-naphthoquinone which is substituted at position 3 by a (2E)-5-carboxy-3-methylpent-2-en-1-yl group. A urinary metabolite of vitamin K1. It has a role as a human urinary metabolite. It is a member of 1,4-naphthoquinones and a monocarboxylic acid.\n",
      "The molecule is a monocarboxylic acid that is 1,4-naphthoquinone substituted at position 2 by a (2Z)-5-carboxy-3-methylpent-2-en-1-yl group. It is a natural product found in Streptomyces sp. KORDI-3238 and exhibits cytotoxic activity. It has a role as a metabolite, an antineoplastic agent and an antimicrobial agent. It is a monocarboxylic acid, a member of p-quinones and an olefinic compound.\n",
      " The molecule is a monocarboxylic acid that is 1,4-naphthoquinone substituted at position 3 by a 2-carboxyethenyl group and at position 2 by a methyl group. It is a monocarboxylic acid, an enone and a member of 1,4-naphthoquinones. \n",
      " The molecule is a monocarboxylic acid that is 2-methyl-4-oxo-1,4-naphthoquinone which is substituted at position 3 by a (2Z)-5-carboxy-3-methylpent-2-en-1-yl group. It is a natural product found in Aspergillus niger. It has a role as an Aspergillus metabolite. It is a monocarboxylic acid, a member of 1,4-naphthoquinones and a monocarboxylic acid.\n",
      "\n",
      "2480 0.17880760055896686 0.35544530722015777 0.5423792215884728 \n",
      " CNC.C1=CC(=C(C2=NC=C(C=C21)Cl)C(=O)O)Cl\n",
      "The molecule is an organic salt resulting from the formal condensation of equimolar amounts of quinclorac and dimethylamine. It is used as a (rather persistent) herbicide for the post-emergence control of weeds in rice, grass and turf. It is not approved for use within the European Union. It has a role as an agrochemical, a herbicide and a synthetic auxin. It contains a quinclorac(1-) and a dimethylaminium.\n",
      "The molecule is a quinolinemonocarboxylic acid salt that is the monohydrochloride salt of quinclorac. Used as an agricultural herbicide. It has a role as a herbicide and an agrochemical. It contains a quinclorac.\n",
      " The molecule is a quinolinemonocarboxylic acid that is quinoline-8-carboxylic acid in which all three hydrogens attached to the nitrogen are replaced by methyl groups. It is used as a (synthetic) herbicide for the post-emergence control of weeds in rice. It has a role as a herbicide, an agrochemical and a synthetic auxin. It contains a 3,5-dichloro-6-(methylamino)quinolin-8-yl group. \n",
      " The molecule is an organochlorine compound that is quinoline-8-carboxylic acid in which the hydrogens at positions 3 and 7 have been replaced by chlorines. It is used (particularly as its dimethylamine salt, known as quinclorac-dimethylammonium) as a (rather persistent) herbicide for the post-emergence control of weeds in rice, grass and turf. It is not approved for use within the European Union. It has a role as a herbicide, an agrochemical and a synthetic auxin. It contains a quinclorac(1+).\n",
      "\n",
      "2484 0.41204256484431806 0.3050931117807202 0.6115930943538099 \n",
      " C=CCNC1=NC=NC2=C1C=C(C=C2)Br\n",
      "The molecule is a member of the class of quinazolines that is quinazoline which is substituted by a prop-2-en-1-ylnitrilo group and a bromo group at positions 4 and 6, respectively. It is a modulator of mammalian autophagy. It has a role as an autophagy inducer. It is a member of quinazolines, a secondary amino compound and an organobromine compound.\n",
      "The molecule is a member of the class of quinazolines carrying a bromo substituent at position 4 on the phenyl ring. It has a role as a tyrosine kinase inhibitor and an antineoplastic agent. It is a member of quinazolines, an organobromine compound and a secondary amino compound. It derives from a quinazoline.\n",
      " The molecule is a member of the class of quinazolines carrying a bromo substituent at position 4. It has a role as an epidermal growth factor receptor antagonist. It is a member of quinazolines, a member of bromobenzenes and an olefinic compound. \n",
      " The molecule is a member of the class of quinazolines that is quinazoline which is substituted by a bromo group at position 4 and a prop-2-en-1-ylamino group at position 6 respectively. It is a member of quinazolines, an organobromine compound, a secondary amino compound and a substituted aniline.\n",
      "\n",
      "2485 0.13899892322977897 0.044183140395002936 0.3900630289572713 \n",
      " CC(C)(CCCCCCCCCCC(C)(C)CC(=O)O)CC(=O)O\n",
      "The molecule is an alpha,omega-dicarboxylic acid that is hexadecanedioic acid carrying methyl groups at positions 3 and 14. It is a free fatty acid 1 (FFA1/GPR40) receptor agonist and an ATP citrate lyase inhibitor, and exhibits hypolipidemic and antidiabetogenic properties. It has a role as an antilipemic drug, an EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor, an EC 2.3.3.8 (ATP citrate synthase) inhbitor, a G-protein-coupled receptor agonist and a hypoglycemic agent.\n",
      "The molecule is an alpha,omega-dicarboxylic acid that is azelaic acid substituted by methyl groups groups at positions 2 and 14, and by a methyl group at position 4. It has a role as a plant metabolite. It is an alpha,omega-dicarboxylic acid and a methyl ester.\n",
      " The molecule is a branched dodecanedioic acid in which the two carboxy groups are located at positions 2 and 12 and are substituted by methyl groups at positions 2 and 11, respectively. It is a fatty acid derivative, a monocarboxylic acid and a branched dodecanedioic acid. \n",
      " The molecule is an alpha,omega-dicarboxylic acid that is pentadecanedioic acid which is substituted by methyl groups groups at positions 2 and 14, and by a methyl group at position 13. It is a drug used for the treatment of high LDL cholesterol, which is sometimes referred to as 'bad cholesterol'. It has a role as an antilipemic drug, an EC 2.3.3.8 (ATP citrate synthase) inhbitor and a prodrug.\n",
      "\n",
      "2517 0.5570493951272191 0.4520518228326671 0.6827173734606571 \n",
      " CC/C=C\\\\CC/C=C/CO\n",
      "The molecule is a primary allylic alcohol that is (2E,6Z)-nona-2,6-diene in which a hydrogen at position 1 has been replaced by a hydroxy group. It has a role as a flavouring agent, a plant metabolite and a fragrance. It is an alkenyl alcohol, a volatile organic compound, a primary allylic alcohol and a medium-chain primary fatty alcohol.\n",
      "The molecule is a medium-chain primary fatty alcohol that is (Z)-nona-2,6-diene substituted by a hydroxy group at position 1. It has a role as a flavouring agent, a fragrance, a plant metabolite and a pheromone. It is a medium-chain primary fatty alcohol, an alkenyl alcohol and a volatile organic compound.\n",
      " The molecule is a medium-chain primary fatty alcohol that is (E,E)-oct-2-ene carrying two oxo substituents at positions 1 and 3. It has a role as a flavouring agent, a plant metabolite and a pheromone. It is an alkenyl alcohol, a medium-chain primary fatty alcohol and a volatile organic compound. \n",
      " The molecule is a medium-chain primary fatty alcohol that is (2E,6Z)-nona-2,6-diene substituted by a hydroxy group at position 1. It has a role as a flavouring agent, a plant metabolite and a fragrance. It is a medium-chain primary fatty alcohol, an alkenyl alcohol and a primary allylic alcohol.\n",
      "\n",
      "2519 0.8876419388203219 0.8090001850697197 1.0 \n",
      " CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC1[C@@H]([C@H](C([C@H]([C@H]1O)O)O)O)O)OC(=O)CCCCCCC\n",
      "The molecule is a 1-phosphatidyl-1D-myo-inositol in which the two phosphatidyl acyl groups are specified as octanoyl. It is a 1-phosphatidyl-1D-myo-inositol and an octanoate ester. It is a conjugate acid of a 1,2-dioctanoyl-sn-glycero-3-phospho-1D-myo-inositol(1-).\n",
      "The molecule is a 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are both specified as octanoyl. It is a 1-phosphatidyl-1D-myo-inositol and an octanoate ester. It is a conjugate acid of a 1,2-dioctanoyl-sn-glycero-3-phospho-1D-myo-inositol(1-).\n",
      " The molecule is a 1-phosphatidyl-1D-myo-inositol in which both phosphatidyl acyl groups are specified as heptanoyl. It is a 1-phosphatidyl-1D-myo-inositol and a heptanoate ester. It is a conjugate acid of a 1,2-diheptanoyl-sn-glycero-3-phospho-1D-myo-inositol(1-). \n",
      " The molecule is a 1-phosphatidyl-1D-myo-inositol in which the two phosphatidyl acyl groups are specified as octanoyl. It is a 1-phosphatidyl-1D-myo-inositol and an octanoate ester. It is a conjugate acid of a 1,2-dioctanoyl-sn-glycero-3-phospho-1D-myo-inositol(1-).\n",
      "\n",
      "2524 0.7673327806100262 0.6830293574217832 0.8765059950339735 \n",
      " C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)OC2=CC=C(C=C2)[N+](=O)[O-])O)O)O\n",
      "The molecule is an alpha-L-fucoside that is alpha-L-fucopyranose in which the anomeric hydroxy hydrogen is replaced by a 4-nitrophenyl group. It has a role as a chromogenic compound. It is an alpha-L-fucoside and a C-nitro compound. It derives from a 4-nitrophenol.\n",
      "The molecule is an alpha-L-fucoside in which the anomeric hydroxy hydrogen is replaced by a 4-nitrophenyl group. It has a role as a chromogenic compound. It is a C-nitro compound and an alpha-L-fucoside. It derives from a 4-nitrophenol.\n",
      " The molecule is an alpha-L-fucoside having a 4-nitrophenyl substituent at the anomeric position. It has a role as a chromogenic compound. It is an alpha-L-fucoside and a C-nitro compound. It derives from a 4-nitrophenol. \n",
      " The molecule is an alpha-L-fucoside that is alpha-L-fucopyranose in which the anomeric hydroxy hydrogen is replaced by a 4-nitrophenyl group. It has a role as a chromogenic compound. It is a beta-L-fucoside and a C-nitro compound. It derives from an alpha-L-fucose.\n",
      "\n",
      "2540 0.14334024282524116 0.0657235403654718 0.2896202069722313 \n",
      " C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O\n",
      "The molecule is a xanthene dye that is highly fluorescent, detectable even when present in minute quantities. Used forensically to detect traces of blood, in analytical chemistry as an indicator in silver nitrate titrations and in microscopy. It has a role as a radioopaque medium and a fluorescent dye. It is a xanthene dye, a gamma-lactone, a polyphenol, an oxaspiro compound, a member of 2-benzofurans and an organic heteropentacyclic compound. It derives from a fluoran.\n",
      "The molecule is a perylene that consists of dibenzo[b,d]furan-1(3H)-one substituted by hydroxy groups at positions 4 and 7 and oxo groups at positions 4 and 9. It is a member of dibenzofurans, an organic heteropentacyclic compound and a gamma-lactone.\n",
      " The molecule is a fluorene-based fluorescent dye that is fluorescein in which the hydrogen at position 8 has been replaced by a 5-hydroxy-2-oxo-2H-benzo[g][1,3]dioxole. It derives from a fluorescein. \n",
      " The molecule is an organic heteropentacyclic compound that is fluoran carrying two hydroxy substituents at positions 3 and 4'. It has a role as a fluorochrome. It is an organic heteropentacyclic compound, a member of 2-benzofurans, a polyphenol and a delta-lactone. It derives from a fluoran.\n",
      "\n",
      "2544 0.8606388910477158 0.8606388910477158 1.0 \n",
      " CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)[C@@H](/C=C/CCCCCCCCCCCCC)O\n",
      "The molecule is a beta-D-galactosyl-N-acylsphingosine in which the acyl group is specified as octadecanoyl. It has a role as a mouse metabolite. It derives from an octadecanoic acid.\n",
      "The molecule is a D-galactosyl-N-acylsphingosine in which the ceramide N-acyl group is specified as octadecanoyl. It has a role as a mouse metabolite. It derives from an octadecanoic acid.\n",
      " The molecule is a D-galactosyl-N-acylsphingosine in which the ceramide N-acyl group is specified as octadecanoyl. It has a role as a mouse metabolite. It derives from an octadecanoic acid. \n",
      " The molecule is a beta-D-galactosyl-N-acylsphingosine in which the acyl group is specified as octadecanoyl. It has a role as a mouse metabolite. It derives from an octadecanoic acid.\n",
      "\n",
      "2546 0.37013798687669963 0.27243703831351995 0.5578092617446941 \n",
      " CCCCCCC(C/C=C/CCCCCCCC(=O)O)OP(=O)(O)O\n",
      "The molecule is a carboxyalkyl phosphate that is (9E)-octadecenoic acid carrying a phosphonooxy substituent at position 12. It derives from an elaidic acid. It is a conjugate acid of a (9E)-12-(phosphonooxy)octadecenoate(3-).\n",
      "The molecule is an olefinic phospholipid that is (9E)-octadec-9-enoic (elaidic) acid substituted by a phosphonooxy group at position 10. It has a role as a human metabolite. It is an olefinic phospholipid, a monounsaturated fatty acid and a long-chain fatty acid. It derives from an elaidic acid. It is a conjugate acid of a (9E)-12-(phosphonatooxy)octadec-9-enoate.\n",
      " The molecule is a monounsaturated fatty acid that is (2E)-oct-2-enoic acid substituted at positions 1 and 12 by phosphono and carboxy groups respectively. It is a monounsaturated fatty acid and a member of phosphonic acids. It derives from an oct-2-enoic acid. It is a conjugate acid of a (2E)-12-(phosphonatooxy)octadec-2-enoate(1-). \n",
      " The molecule is a phospholipid that is the phosphate ester of 12-phosphonooxy-(9E)-octadecenoic acid. It derives from an oleic acid. It is a conjugate acid of a 12-phosphonatooxy-(9E)-octadecenoate(3-).\n",
      "\n",
      "2588 0.0963139079456538 0.1277395429425412 0.41162875677311317 \n",
      " C[N+](C)(C)CCCC[C@@H](C(=O)O)N\n",
      "The molecule is an alpha-amino-acid cation that is the N(6)-trimethyl derivative of L-lysine. It has a role as a human metabolite and a mouse metabolite. It is a tautomer of a N(6),N(6),N(6)-trimethyl-L-lysine zwitterion.\n",
      "The molecule is a L-lysine derivative that is L-lysine in which the hydrogen attached to the nitrogen is replaced by a trimethylammonio group. It is a L-lysine derivative and a non-proteinogenic L-alpha-amino acid.\n",
      " The molecule is an L-lysine derivative comprising L-lysine having a 3-carboxy-3-(trimethylammonio)propyl group at the 6-position. It is a L-lysine derivative, a non-proteinogenic L-alpha-amino acid and a quaternary ammonium ion. \n",
      " The molecule is a L-lysine derivative that is L-lysine having three methyl substituents attached to the side-chain amino group. It is a L-lysine derivative and a non-proteinogenic L-alpha-amino acid. It is a conjugate acid of a N(6),N(6),N(6)-trimethyl-L-lysinate.\n",
      "\n",
      "2594 0.29472850735417616 0.29472850735417616 0.5975707415981633 \n",
      " C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O)O)NC(=O)NC2=O\n",
      "The molecule is trianion of xanthosine 5'-triphosphate arising from deprotonation of three of the four free triphosphate OH groups. It is a xanthosine 5'-phosphate and a ribonucleoside triphosphate oxoanion. It is a conjugate base of a XTP. It is a conjugate acid of a XTP(4-).\n",
      "The molecule is a nucleoside triphosphate(4-) obtained by global deprotonation of the triphosphate OH groups of XTP; major species present at pH 7.3. It is a conjugate base of a XTP(3-).\n",
      " The molecule is a nucleoside triphosphate(4-) obtained by global deprotonation of the triphosphate OH groups of XTP; major species present at pH 7.3. It is a conjugate base of a XTP(3-). \n",
      " The molecule is trianion of xanthosine 5'-triphosphate arising from deprotonation of three of the four phosphate OH groups; major species at pH 7.3. It is a conjugate base of a XTP. It is a conjugate acid of a XTP(4-).\n",
      "\n",
      "2609 0.476212855565173 0.44299955576450084 0.671054265000698 \n",
      " C1=CC=C(C=C1)CC2=C(N3C=C(N=C(C3=N2)CC4=CC=CC=C4)C5=CC=C(C=C5)O)OS(=O)(=O)[O-]\n",
      "The molecule is an organosulfate oxoanion that is the conjugate base of Renilla luciferyl sulfate; major species at pH 7.3. It is a conjugate base of a Renilla luciferyl sulfate.\n",
      "The molecule is an organosulfonate oxoanion obtained by deprotonation of the sulfo group of Watasenia luciferin; major species at pH 7.3. It is a conjugate base of a Watasenia luciferin.\n",
      " The molecule is a heterocyclyl sulfate oxoanion. It derives from a Renilla luciferin(1-). It is a conjugate base of a Renilla luciferyl sulfate. \n",
      " The molecule is a organosulfate oxoanion that is the conjugate base of Renilla luciferin, obtained by deprotonation of the sulfo group; major species at pH 7.3. It is a conjugate base of a Renilla luciferin.\n",
      "\n",
      "2617 0.16874280150349338 0.1738653001111386 0.27933391194309953 \n",
      " CCC(C)C(CC)C(=O)NC(=O)N\n",
      "The molecule is an N-acylurea in which the acyl substituent is 2-ethyl-3-methylpentanoyl. A monoureide sedative, it has a duration of hypnotic effect similar to that of the short-acting barbiturates. It has a role as a sedative.\n",
      "The molecule is an N-acylurea that is urea in which one of the hydrogens is replaced by a 2,3-diethylpentanoyl group. It is a N-acylurea and a member of ureas.\n",
      " The molecule is a member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by two methyl groups at position 3 and a carbamoyl group at position 2. It has a role as a drug allergen. \n",
      " The molecule is an N-acylurea that is urea in which one of the hydrogens is replaced by a 2-ethyl-3-methylpentanoyl group. It is a N-acylurea and a monocarboxylic acid amide.\n",
      "\n",
      "2644 0.45645564604340816 0.6016532616660615 0.7257405247667091 \n",
      " CC(=CCC1=C(C(=CC=C1)[C@@H]2CC(=O)C3=C(C=C(C(=C3O2)CC=C(C)C)O)O)O)C\n",
      "The molecule is a trihydroxyflavanone that is (2S)-5,7,2'-trihydroxyflavanone substituted by prenyl groups at positions 8 and 3'. Isolated from Dalea boliviana, it exhibits inhibitory activity against tyrosinase. It has a role as an EC 1.14.18.1 (tyrosinase) inhibitor and a plant metabolite.\n",
      "The molecule is a trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7 and 3' and prenyl groups at positions 8 and 3'. Isolated from Dalea boliviana, it exhibits inhibitory activity against breast cancer resistance protein. It has a role as a metabolite and a breast cancer resistance protein inhibitor. It is a trihydroxyflavanone and a member of 4'-hydroxyflavanones. It derives from a (2S)-flavanone.\n",
      " The molecule is a trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7 and 3', a prenyl group at position 8 and a double bond between positions 4' and 5'. Isolated from Dalea boliviana, it exhibits inhibitory activity against tyrosinase. It has a role as an EC 1.14.18.1 (tyrosinase) inhibitor and a plant metabolite. It is a trihydroxyflavanone and a member of 4'-hydroxyflavanones. \n",
      " The molecule is a trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7 and 3', prenyl groups at positions 8 and 2' and a prenyl group at position 5'. Isolated from Dalea boliviana, it exhibits inhibitory activity against tyrosinase. It has a role as an EC 1.14.18.1 (tyrosinase) inhibitor and a plant metabolite.\n",
      "\n",
      "2647 0.09319231105222744 0.2967148927935949 0.5489456385507601 \n",
      " CC[C@H](C)CC/C=C/C=C(\\\\C)/[C@H](C/C=C/C=C/C(=O)O[C@H]1[C@@H]([C@H](O[C@]2([C@@H]1O)C3=C(CO2)C=C(C=C3O)O)CO)O)O\n",
      "The molecule is a papulacandin that is papulacandin A in which the 6-O-acylgalactosyl group is replaced by a hydrogen. It is a carbohydrate-containing antibiotic from the deuteromycetous fungus Papularia sphaerosperma which shows potent antifungal activity against Candida albicans. It has a role as an antifungal agent and a metabolite. It is a papulacandin, a monosaccharide derivative and an organic heterotricyclic compound.\n",
      "The molecule is a member of the class of hydroxyisoflavans that is (2E,4E,8E,10E,12E)-dodeca-2,4,8,10-tetraenoate substituted by hydroxy groups at positions 2, 5 and 8 and a (2E,4E,8E,10E,12S,14S)-12-hydroxy-8,14-dimethylicosa-2,4,8,10-tetraenoyl moiety at position 3. It is a metabolite of the nematode Caenorhabditis elegans. It has a role as a Caenorhabditis elegans metabolite. It is a member of hydroxyisoflavans, a (2E,4E,8E,10E,12E)-dodeca-2,4,8,10-tetraenoate and an organic heterotricyclic compound. It derives from a (2E,4E,8E,10E,12S,14S)-12-hydroxy-8,14-dimethylicosa-2,4,8,10-tetraenoic acid.\n",
      " The molecule is a papulacandin substituted by a (2E,4E)-deca-2,4-dienoyl chain at the O-(6') position and a (2E,4E,7S,8E,10E,14S)-7-hydroxy-8,14-dimethylhexadeca-2,4,8,10-tetraenoyl chain at the O-(3) position. It is a carbohydrate-containing antibiotic from the deuteromycetous fungus Papularia sphaerosperma which shows potent antifungal activity \n",
      " The molecule is a papulacandin that is papulacandin A in which the (2E,4E,8E,10E,14S)-3,15-dihydroxy-2,4,6,8,10-pentamethylhexadeca-2,4,8,10-tetraenoyl chain. It is a carbohydrate-containing antibiotic from the deuteromycetous fungus Papularia sphaerosperma which shows potent antifungal activity against Candida albicans. It has a role as an antifungal agent and a metabolite. It is a papulacandin, a disaccharide derivative and an organic heterotricyclic compound. It derives from an alpha-lactose.\n",
      "\n",
      "2669 0.555801916655416 0.4441870510052531 0.8417933126961473 \n",
      " CCCCCCCCCCCCCCCCCCCCCCC(C(=O)N[C@@H](COP(=O)([O-])O[C@@H]1[C@@H]([C@@H]([C@H]([C@@H]([C@H]1O[C@H]2[C@H]([C@H]([C@@H]([C@H](O2)COP(=O)([O-])OC3[C@@H]([C@H](C([C@H]([C@H]3O)O)O)O)O)O)O)O)O)O)O)O)[C@@H](CCCCCCCCCCCCCCC)O)O\n",
      "The molecule is an inositol phosphomannosylinositol phosphophytoceramide(2-) having an inositol 1-phosphoryl group attached to the mannose residue and a tetracosanoyl group attached to the ceramide nitrogen, with no hydroxylation at C-4 of the long-chain base, and hydroxylation at C-2 of the very-long-chain fatty acid. Major species at pH 7.3 It is a conjugate base of an Ins-1-P-6-Man-beta1-2-Ins-1-P-Cer(d18:0/2-OH-24:0).\n",
      "The molecule is an inositol phosphomannosylinositol phosphophytoceramide(2-) having a tetracosanoyl group attached to the ceramide nitrogen. Major species at pH 7.3. It is a conjugate base of an Ins-1-P-6-Man-beta1-2-Ins-1-P-Cer(d18:0/2-OH-24:0).\n",
      " The molecule is an inositol phosphomannosylinositol phosphophytoceramide(2-) having a hexacosanoyl group attached to the ceramide nitrogen. Major species at pH 7.3. It is a conjugate base of an Ins-1-P-6-Man-beta1-2-Ins-1-P-Cer(t18:0/26:0). \n",
      " The molecule is an inositol phosphomannosylinositol phosphophytoceramide(2-) having a tetracosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and hydroxylation at C-2 of the very-long-chain fatty acid. Major species at pH 7.3. It is a conjugate base of an Ins-1-P-6-Man-beta1-2-Ins-1-P-Cer(d18:0/2-OH-24:0).\n",
      "\n",
      "2672 0.7843654614341745 0.4025553215248429 0.8852528613357351 \n",
      " CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O)CO[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O)O)O)NC(=O)C)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)COS(=O)(=O)[O-])O)O)O\n",
      "The molecule is a doubly-charged organosulfate oxoanion arising from deprotonation of the sulfate OH groups of 6-O-sulfo-beta-D-glucosyl-(1->3)-[6-O-sulfo-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->6)]-N-acetyl-beta-D-galactosamine It is a conjugate base of a 6-O-sulfo-beta-D-glucosyl-(1->3)-[6-O-sulfo-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->6)]-N-acetyl-beta-D-galactosamine.\n",
      "The molecule is an organosulfate oxoanion that is the conjugate base of N-acetyl-beta-D-galactosaminyl-(1->3)-[6-O-sulfo-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->6)]-N-acetyl-beta-D-galactosamine, arising from deprotonation of the sulfate OH groups; major species at pH 7.3. It is a conjugate base of a N-acetyl-beta-D-galactosaminyl-(1->3)-[6-O-sulfo-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->6)]-N-acetyl-beta-D-galactosamine.\n",
      " The molecule is a dimeric branched amino tetrasaccharide consisting of 6-O-sulfo-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosamine, having a further 6-O-sulfo-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl moiety attached at the 6-position of the galactosamine. It is an oligosaccharide sulfate and an amino tetrasaccharide. It is a conjugate acid of a 6-O-sulfonato-beta-D \n",
      " The molecule is an organosulfate oxoanion that is the conjugate base of 6-O-sulfo-beta-D-glucosyl-(1->3)-[6-O-sulfo-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->6)]-N-acetyl-beta-D-galactosamine, arising from deprotonation of the sulfate OH groups; major species at pH 7.3. It is a conjugate base of a 6-O-sulfo-beta-D-glucosyl-(1->3)-[6-O-sulfo-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->6)]-N-acetyl-beta-D-galactosamine.\n",
      "\n",
      "2728 0.3294528520427618 0.3961045644703544 0.6031386863770972 \n",
      " C#CCC(=O)[O-]\n",
      "The molecule is a monocarboxylic acid anion that is the conjugate base of 3-butynoic acid; major species at pH 7.3. It is a conjugate base of a 3-butynoic acid.\n",
      "The molecule is an acetylenic fatty acid anion and the conjugate base of butynoic acid, arising from deprotonation of the carboxylic acid group. It is a monocarboxylic acid anion, an acetylenic fatty acid anion and a short-chain fatty acid anion. It is a conjugate base of a butynoic acid.\n",
      " The molecule is a terminal acetylenic compound that is the conjugate base of pentynoic acid, obtained by deprotonation of the carboxy group. It is a monocarboxylic acid anion and a terminal acetylenic compound. It is a conjugate base of a pentynoic acid. \n",
      " The molecule is a monocarboxylic acid anion that is the conjugate base of butynoic acid, obtained by deprotonation of the carboxy group. It is a conjugate base of a butynoic acid.\n",
      "\n",
      "2751 0.3637541151546371 0.365957860304005 0.4846443370434705 \n",
      " C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=N4)C(=O)[O-]\n",
      "The molecule is a steroid acid anion, that is the conjugate base of pyridinestrone-3-carboxylic acid. An abiotic metabolite in the 4,5-seco pathway of aerobic estrogen degradation by the bacterium Sphingomonas sp. strain KC8. It is a conjugate base of a pyridinestrone-3-carboxylic acid.\n",
      "The molecule is a steroid acid anion that is the conjugate base of estrone-3-carboxylic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a conjugate base of an estrone-3-carboxylic acid.\n",
      " The molecule is an aza-steroid anion resulting from the removal of a proton from the carboxy group of 3-amino-17-oxoestra-1,3,5(10)-triene-17-carboxylic acid. An abiotic metabolite in the 4,5-seco pathway of aerobic estrogen degradation by the bacterium Sphingomonas sp. strain KC8. It has a role as a bacterial metabolite. It is a conjugate base of a 3-amino-17-oxoestra-1,3,5(10)-triene-17-carboxylic acid. \n",
      " The molecule is an oxo monocarboxylic acid anion that is the conjugate base of pyridinestrone-3-carboxylic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a conjugate base of a pyridinestrone-3-carboxylic acid.\n",
      "\n",
      "2764 0.09607814826854548 0.10190020582031253 0.22752045497593698 \n",
      " CC(=C)C1CCC(OC(=O)C1)(C)O\n",
      "The molecule is a terpene lactone that is oxepan-2-one bearing an isopropenyl substituent at position 4 as well as hydroxy and methyl substituents at position 7. It is an epsilon-lactone, a monoterpenoid and a terpene lactone.\n",
      "The molecule is a butenolide that is furan-2(5H)-one substituted by a hydroxy group at position 3 and a methyl group at position 4. It has a role as a plant metabolite. It is a butenolide and a tertiary alcohol.\n",
      " The molecule is a p-menthane monoterpenoid that is (4R)-7-oxabicyclo[4.1.0]hept-2-ene carrying two additional methyl substituents at positions 3 and 8. It derives from a (4R)-7-oxabicyclo[4.1.0]hept-2-ene. \n",
      " The molecule is a butenolide that is 7-hydroxy-4-isopropenyl-7-methyloxepan-2-one carrying additional hydroxy and methyl substituents at positions 3 and 6 respectively. It has a role as a plant metabolite.\n",
      "\n",
      "2792 0.1651458042834275 0.3010106526110202 0.4357258623892004 \n",
      " C[C@H]1C[C@H](CC(=O)O[C@H](C/C(=C/C=C\\\\C(=O)O[C@@H](CC2=NC1=CS2)/C=C(\\\\C)/C=C/C(=C/CN(C)C)/C)/C)C)N\n",
      "The molecule is a marine macrodiolide that is isolated from the sponge Mycale hentscheli and exhibits anticancer and antiviral properties It has a role as a marine metabolite, an antiviral agent, an antineoplastic agent and a eukaryotic initiation factor 4F inhibitor. It is a member of 1,3-thiazoles, a tertiary amino compound, a primary amino compound, an olefinic compound and a macrodiolide.\n",
      "The molecule is a leukotriene that is leukotriene B4 in which the terminal methyl group has been oxidised to the corresponding dimethyl ether. It is a leukotriene, a macrocycle, an olefinic compound and a tertiary amino compound. It derives from a tetrahydrofuran.\n",
      " The molecule is a macrolide antibiotic isolated from the marine sponge Latrunculia magnifica and exhibits antifungal and cytotoxic activity. It has a role as a metabolite, an antimicrobial agent, an antineoplastic agent and an EC 2.7.11.13 (protein kinase C) inhibitor. It is a macrolide antibiotic, a cyclic ketone, an enone, a tertiary amino compound and a bridged compound. \n",
      " The molecule is a macrolide antibiotic that is isolated from Streptomyces hygroscopicus and exhibits antitumour activity. It has a role as a bacterial metabolite, an antineoplastic agent and a bacterial metabolite. It is a macrolide antibiotic, a member of 1,3-thiazoles, an olefinic compound and a tertiary amino compound.\n",
      "\n",
      "2795 0.25676375293941867 0.3976975191903291 0.5378028315402493 \n",
      " CCCCCCCCCC1=CC=C(C=C1)O\n",
      "The molecule is a member of the class of phenols that is phenol which is para-substituted with a nonyl group. It has a role as an environmental contaminant.\n",
      "The molecule is a phenol having the structure of p-octylphenol with a hydroxy function at C-4 of one of the phenyl rings. It has a role as an allergen.\n",
      " The molecule is a member of the class of phenols that is phenol in which the hydrogen at position 4 has been replaced by a octyl group. It is a member of phenols and an aromatic ether. \n",
      " The molecule is a member of the class of phenols that is phenol substituted by a decyl group at position 4. It has a role as an antibacterial agent and a fungal metabolite.\n",
      "\n",
      "2796 0.17529444387396134 0.1544059603628072 0.551571074392751 \n",
      " C[N@@+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C=C6)OC)OC)OC)OC)C\n",
      "The molecule is a diester that is the (1R,1'R,2R,2'R)-diastereoisomer of atracurium, a quaternary ammonium ion consisting of pentane-1,5-diol with both hydroxy functions bearing 3-[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium-2(1H)-yl]propanoyl groups. The active species in the skeletal muscle relaxant cisatracurium besylate. It has a role as a muscle relaxant and a nicotinic antagonist. It is a diester and a quaternary ammonium ion.\n",
      "The molecule is the (1R,2S,1'R,2'R)-diastereoisomer of doxacurium. It is a quaternary ammonium ion, a diester and a succinate ester. It is an enantiomer of a (1S,2R,1'S,2'S)-doxacurium.\n",
      " The molecule is the diester compound of 1,2-dibenzyl-1,2,3,3a,8,8a-hexahydronaphthalen-5,6,8-tricarboxylic acid. It has a role as a muscle relaxant and a nicotinic antagonist. It is a quaternary ammonium ion and a diester. \n",
      " The molecule is a diester compound consisting of pentane-1,5-diol with both hydroxyls bearing 3-[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium-2(1H)-yl]propanoyl groups. It has a role as a muscle relaxant and a nicotinic antagonist. It is a quaternary ammonium ion and a diester.\n",
      "\n",
      "2803 0.06557877454586612 0.08491018929628229 0.24596516910532396 \n",
      " C[C@@]1(CC(=O)C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O\n",
      "The molecule is a methyl ester derived from (1R,2S)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylic acid. It has a role as a bacterial metabolite. It is a member of tetracenes, a methyl ester, a tertiary alcohol, a polyketide, a member of tetracenequinones and a member of p-quinones. It is a conjugate acid of a nogalaviketone(1-).\n",
      "The molecule is the methyl ester of nogalaviketone. It is a methyl ester, a polyketide, a polyphenol and a tertiary alcohol. It derives from a nogalaviketone.\n",
      " The molecule is a phenolate anion obtained by deprotonation of the 5-OH group of nogalaviketone. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). It is a conjugate base of a nogalaviketone. \n",
      " The molecule is a methyl ester resulting from the formal condensation of the carboxy group of nogalaviketone with methanol. Isolated from the culture broth of Nocardia sp. MJ896-43F17. It has a role as a metabolite. It is a methyl ester, a polyketide, a member of phenols, a tertiary alcohol and a tetracenomycin. It derives from a nogalaviketone.\n",
      "\n",
      "2825 0.14717457187103342 0.18707471467519882 0.36662936900151955 \n",
      " CCCCCCOC1=CC=CC=C1C(=O)N\n",
      "The molecule is an arenecarboxamide that is salicylamide in which the phenolic hydroxy group has been converted into the corresponding hexyl ether. It has been used as a topical antifungal agent. It has a role as an antifungal agent. It is an arenecarboxamide and an aromatic ether. It derives from a salicylamide.\n",
      "The molecule is a monocarboxylic acid amide that is benzamide substituted by a hexyloxy group at position 2. It has a role as a metabolite. It is an aromatic ether and a member of benzamides.\n",
      " The molecule is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of pent-2-enoic acid with ammonia. It has a role as an apoptosis inducer, a neuroprotective agent and an antineoplastic agent. It is a member of benzamides and a monocarboxylic acid amide. It derives from a pent-2-enoic acid. \n",
      " The molecule is a benzamide that is salicylanilide in which the hydrogen of the phenolic hydroxy group is replaced by a hexyl group. It has a role as a non-steroidal anti-inflammatory drug. It is a member of benzamides and an aromatic ether. It derives from a salicylanilide.\n",
      "\n",
      "2833 0.2655870367649045 0.331784773375349 0.440266778202054 \n",
      " CC(=CCC1=C(C(=CC(=C1)C2=C(C(=O)C3=C(O2)C=C(C(=C3O)CC=C(C)C)O)O)O)O)C\n",
      "The molecule is a pentahydroxyflavone that is flavone substituted with hydroxy groups at positions 3, 5, 7, 3' and 4' and prenyl groups at positions 6 and 5'. Isolated from Broussonetia papyrifera, it exhibits inhibitory activity against phospholipase A2 and tyrosinase. It has a role as a metabolite, an EC 3.1.1.4 (phospholipase A2) inhibitor and an EC 1.14.18.1 (tyrosinase) inhibitor. It is a member of flavonols, a pentahydroxyflavone and a 3'-hydroxyflavonoid.\n",
      "The molecule is a 7-hydroxyflavonol substituted by additional hydroxy groups at positions 3, 5, 3' and 5' and prenyl groups at positions 6, 8 and 4'. Isolated from the leaves of Dorstenia psilurus, it exhibits alpha-glucosidase inhibitory activity. It has a role as a metabolite and an EC 3.2.1.20 (alpha-glucosidase) inhibitor.\n",
      " The molecule is a pentahydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 7, 3', 4' and 5' and prenyl groups at positions 6 and 2'. Isolated from the roots of Dorstenia psilurus, it exhibits alpha-glucosidase inhibitory activity. It has a role as a metabolite and an EC 3.2.1.20 (alpha-glucosidase) inhibitor. \n",
      " The molecule is a pentahydroxyflavone that is flavone substituted by hydroxy groups at positions 3, 5, 7, 3' and 4' and prenyl groups at positions 6, 8 and 3'. Isolated from the leaves of Macaranga sampsonii, it exhibits cytotoxicity against several human cancer cell lines. It has a role as a metabolite and an antineoplastic agent. It is a member of flavonols and a pentahydroxyflavone. It derives from a flavone.\n",
      "\n",
      "2834 0.17613473592661116 0.3270473779601329 0.4319404494779805 \n",
      " CC1=CC=C(C=C1)CN2C(=CC(=N2)C(=O)N[C@H]3[C@]4(CC[C@H](C4)C3(C)C)C)C5=CC(=C(C=C5)Cl)C\n",
      "The molecule is a secondary carboxamide resulting from the formal condensation of the carboxy group of 5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-1H-pyrazole-3-carboxylic acid with the amino group of (1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-amine. A potent and selective cannabinoid receptor type 2 (CB2 receptor) inverse agonist (Ki = 0.6 nM). It has a role as a CB2 receptor antagonist and an EC 2.3.1.26 (sterol O-acyltransferase) inhibitor. It is a member of pyrazoles, a secondary carboxamide, a member of monochlorobenzenes and a bridged compound.\n",
      "The molecule is a member of the class of pyrazoles that is 1H-pyrazole which is substituted at positions 1, 3, and 5 by 4-chlorobenzyl, p-tolyl, and methyl groups, respectively. It is a potent inhibitor of protein kinase C. It has a role as a protein kinase inhibitor. It is a member of pyrazoles, a member of monochlorobenzenes, a biaryl, an aromatic amide and a member of benzamides.\n",
      " The molecule is a monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 3-(2,4-dichlorophenyl)-1-(pyrazin-2-yl)pyrazole-4-carboxylic acid with the amino group of (1R,3R,4S)-3,5,5-trimethylbicyclo[3.1.1]hept-2-ene-1-carboxamide. An insecticide used to control sucking and chewing pests. It has a role as an insecticide, a cannabinoid receptor agonist and an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a monocarboxylic acid amide, a member of \n",
      " The molecule is an aromatic amide obtained by formal condensation of the carboxy group of [1-(4-chlorobenzyl)-1-(3,4-dimethylphenyl)-3,4-dimethylbicyclo[2.2.1]heptan-2-yl]carbamic acid with the amino group of (1R,2S,4R)-1-(4-chlorophenyl)-3,4-dimethylbicyclo[2.2.1]heptan-2-amine. It is a potent inhibitor of p38alpha mitogen-activated protein kinase. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of morpholines, a member of pyrazoles, an aromatic amide, a monocarboxylic acid amide and a member of monochlorobenzenes.\n",
      "\n",
      "2856 0.20734411435449351 0.3510763437611822 0.5117946631999386 \n",
      " C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)OS(=O)(=O)O)C)O)C\n",
      "The molecule is a bile acid glycine conjugate that is glycodeoxycholic acid in which the hydroxy hydrogen at position 3 has been replaced by a sulfo group. It is a bile acid glycine conjugate, a 12alpha-hydroxy steroid and a steroid sulfate. It derives from a glycodeoxycholic acid.\n",
      "The molecule is the 3-O-sulfo derivative of glycolithocholic acid. It is a steroid sulfate and a bile acid glycine conjugate. It derives from a glycolithocholic acid. It is a conjugate acid of a sulfoglycolithocholate(2-) and a sulfoglycolithocholate anion.\n",
      " The molecule is a steroid sulfate that is the 3-O-sulfo derivative of glycodeoxycholic acid. It has a role as a human metabolite. It is a bile acid glycine conjugate, a steroid sulfate, a 12alpha-hydroxy steroid, a 23-hydroxy steroid and an 11beta-hydroxy steroid. It derives from a glycodeoxycholic acid. It is a conjugate acid of a sulfoglycodeoxycholate(1-) and a sulfoglycodeoxycholate anion. \n",
      " The molecule is a steroid sulfate that is the 3-O-sulfo derivative of glycodeoxycholic acid. It has a role as a metabolite. It is a bile acid glycine conjugate, a steroid sulfate and a 7alpha-hydroxy steroid. It derives from a glycodeoxycholic acid.\n",
      "\n",
      "2864 0.2767320296876916 0.27441292016029323 0.4043323317997106 \n",
      " CC/C=C\\\\C/C=C\\\\C/C=C\\\\CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O\n",
      "The molecule is an octadecatrienoyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of alpha-linolenoyl-CoA. It is a conjugate base of an alpha-linolenoyl-CoA.\n",
      "The molecule is a polyunsaturated fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (9Z,12Z,15Z)-octadecatrienoyl-CoA; major species at pH 7.3. It is a polyunsaturated fatty acyl-CoA(4-), an (11Z)-Delta(11)-fatty acyl-CoA(4-) and a 3-substituted propionyl-CoA(4-). It is a conjugate base of a (9Z,12Z,15Z)-octadecatrienoyl-CoA.\n",
      " The molecule is a polyunsaturated fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (7Z,10Z,13Z)-hexadecatrienoyl; major species at pH 7.3. It is a polyunsaturated fatty acyl-CoA(4-), a very long-chain acyl-CoA(4-) and a 3-substituted propionyl-CoA(4-). It is a conjugate base of a (7Z,10Z,13Z)-hexadecatrienoyl-CoA. \n",
      " The molecule is a polyunsaturated fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of alpha-linolenoyl-CoA. It has a role as a human metabolite and a Saccharomyces cerevisiae metabolite. It is a polyunsaturated fatty acyl-CoA(4-), an (11Z)-Delta(11)-fatty acyl-CoA(4-) and a 3-substituted propionyl-CoA(4-). It is a conjugate base of an alpha-linolenoyl-CoA.\n",
      "\n",
      "2875 0.21470671177520176 0.14088762401993457 0.36410755916958926 \n",
      " C(C[NH3+])C[NH2+]CCC[NH2+]CCC[NH2+]CCCN\n",
      "The molecule is an organic cation obtained by protonation of four of the five amino groups of caldopentamine. It has a role as a marine metabolite. It is an ammonium ion derivative and an organic cation. It is a conjugate base of a caldopentamine(5+). It is a conjugate acid of a caldopentamine.\n",
      "The molecule is dication of N(1),N(12)-diaminopropylspermine. It has a role as a human metabolite. It is a conjugate acid of a N(1),N(12)-diaminopropylspermine.\n",
      " The molecule is the ammonium ion resulting from deprotonation of all four amino groups of bis(3-aminopropyl)amine; major species at pH 7.3. It is a conjugate acid of a bis(3-aminopropyl)amine. \n",
      " The molecule is a triply-charged organic cation obtained by protonation of all three amino groups of aminopropylcadaverine; major species at pH 7.3. It is an ammonium ion derivative and an organic cation. It is a conjugate acid of an aminopropylcadaverine.\n",
      "\n",
      "2891 0.678336407110281 0.7021204507207348 0.9525618205602057 \n",
      " C1=CC2=C(C=C1O)C(=O)C3=C(C=C(C=C3O2)O)O\n",
      "The molecule is a member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3 and 7. It has a role as a plant metabolite. It is a member of xanthones and a polyphenol.\n",
      "The molecule is a member of the class of xanthones that is 9H-xanthen-9-one substituted bybhydroxy groups at positions 1, 3 and 5. It is isolated from Garcinia subelliptica. It has a role as a metabolite. It is a member of xanthones and a polyphenol.\n",
      " The molecule is a member of the class of xanthones that is xanthone substituted by hydroxy groups at positions 1, 3 and 7. It has been isolated from Cratoxylum cochinchinense. It has a role as a plant metabolite. It is a member of xanthones and a polyphenol. \n",
      " The molecule is a member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3 and 5. It has a role as a plant metabolite. It is a member of xanthones and a polyphenol.\n",
      "\n",
      "2895 0.6084086518078277 0.5590356066638503 0.7097319784064754 \n",
      " CCCCCCCC(=O)OCCCCCC\n",
      "The molecule is an octanoate ester obtained by the formal condensation of octanoic acid with hexan-1-ol. It has a role as a plant metabolite. It derives from a hexan-1-ol.\n",
      "The molecule is an octanoate ester obtained by the formal condensation of the carboxy group of octanoic acid with the hydroxy group of hexan-1-ol. It has a role as a metabolite. It is a fatty acid ester and an octanoate ester. It derives from a hexan-1-ol.\n",
      " The molecule is a hexanoate ester obtained by the formal condensation of the carboxy group of hexanoic acid with the hydroxy group of butan-1-ol. It has a role as a metabolite. It derives from a butan-1-ol. \n",
      " The molecule is an octanoate ester obtained by the formal condensation of the carboxy group of octanoic acid with the hydroxy group of hexanol. It has a role as a metabolite. It derives from a hexan-1-ol.\n",
      "\n",
      "2936 0.22458639604997774 0.2238960827605055 0.43171531761558524 \n",
      " [C@@H]([C@@H]([C@H](C(=O)[O-])O)O)([C@H](C(=O)[O-])O)O\n",
      "The molecule is the L-enantiomer of altrarate(2-). It is a conjugate base of a L-altrarate(1-). It is an enantiomer of a D-altrarate(2-).\n",
      "The molecule is a dicarboxylic acid dianion that is the conjugate base of galactarate(1-). It has a role as a human metabolite. It is a galactaric acid anion and a dicarboxylic acid dianion. It is a conjugate base of a galactarate(1-).\n",
      " The molecule is an allaric acid anion that is the dianion resulting from the deprotonation of both the carboxy groups of allaric acid. It is a conjugate base of an allarate(1-). \n",
      " The molecule is a mannarate(2-) that is the dianion obtained by the deprotonation of the carboxy groups of L-mannaric acid. It is a conjugate base of a L-mannarate(1-). It is an enantiomer of a D-mannarate(2-).\n",
      "\n",
      "2950 0.5201082253927247 0.49922516068421136 0.9686391926502761 \n",
      " CCCCCCCC/C=C\\\\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\\\\C/C=C\\\\CCCCC)COP(=O)([O-])OCC(COP(=O)([O-])OC[C@@H](COC(=O)CCCCCCC/C=C\\\\C/C=C\\\\CCCCC)OC(=O)CCCCCCC/C=C\\\\C/C=C\\\\CCCCC)O\n",
      "The molecule is a cardiolipin 72:7(2-) obtained by deprotonation of the phosphate OH groups of 1,1',2-trilinoleoyl-2'-oleoyl cardiolipin; major species at pH 7.3. It is a conjugate base of a 1,1',2-trilinoleoyl-2'-oleoyl cardiolipin.\n",
      "The molecule is a cardiolipin 72:8(2-) obtained by deprotonation of the phosphate OH groups of tetralinoleoyl cardiolipin; major species at pH 7.3. It is a conjugate base of a tetralinoleoyl cardiolipin.\n",
      " The molecule is a cardiolipin 70:6(2-) obtained by deprotonation of the phosphate OH groups of tetralinoleoyl cardiolipin; major species at pH 7.3. It is a conjugate base of a tetralinoleoyl cardiolipin. \n",
      " The molecule is a cardiolipin 72:8(2-) obtained by deprotonation of the phosphate OH groups of 1,1',2-trilinoleoyl-2'-oleoyl cardiolipin; major species at pH 7.3. It is a conjugate base of a 1,1',2-trilinoleoyl-2'-oleoyl cardiolipin.\n",
      "\n",
      "2958 0.5540800293551466 0.6493820384836164 0.8653582101046644 \n",
      " CCCCCC(=O)CC[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)[O-])O\n",
      "The molecule is a prostaglandin carboxylic acid anion that is the conjugate base of 13,14-dihydro-15-oxoprostaglandin E1, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a conjugate base of a 13,14-dihydro-15-oxoprostaglandin E1.\n",
      "The molecule is conjugate base of 13,14-dihydro-15-oxoprostaglandin E1. It has a role as a human metabolite. It is a conjugate base of a 13,14-dihydro-15-oxoprostaglandin E1.\n",
      " The molecule is a prostaglandin carboxylic acid anion that is the conjugate base of 13,14-dihydro-15-keto-PGF2alpha, obtained by deprotonation of the carboxy group; major species at pH 7.3. It has a role as a human xenobiotic metabolite. It is a conjugate base of a 13,14-dihydro-15-keto-PGF2alpha. \n",
      " The molecule is a prostaglandin carboxylic acid anion that is the conjugate base of 13,14-dihydro-15-oxo-prostaglandin E1, obtained by deprotonation of the carboxy group; major species at pH 7.3. It is a conjugate base of a 13,14-dihydro-15-oxo-prostaglandin E1.\n",
      "\n",
      "2966 0.51352751182934 0.11743044236161476 0.6262731360202444 \n",
      " C[C@H]1/C=C/C=C(\\\\C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C\n",
      "The molecule is a member of the class of rifamycins that exhibits antibiotic and antitubercular properties. It has a role as a bacterial metabolite, an antimicrobial agent and an antitubercular agent. It is a member of rifamycins, an acetate ester, a cyclic ketal, a lactam, a macrocycle, a polyphenol and an organic heterotetracyclic compound. It is a conjugate acid of a rifamycin SV(1-).\n",
      "The molecule is a member of the class of rifamycins that is rifamycin SV lacking the O-methyl group at position 27. It has a role as a bacterial metabolite. It is a lactam, a macrocycle, a polyphenol and an acetate ester. It derives from a rifamycin SV. It is a conjugate acid of a rifamycin SV(1-).\n",
      " The molecule is a phenolate anion obtained by deprotonation of the 5-hydroxy group of rifamycin SV. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). It is a conjugate base of a rifamycin SV. \n",
      " The molecule is a member of the class of rifamycins that is rifamycin SV lacking the O-methyl group at position 27. It has a role as a bacterial metabolite. It is an acetate ester, a cyclic ketal, a lactam, a macrocycle, a polyphenol and a member of rifamycins. It derives from a rifamycin SV. It is a conjugate acid of a rifamycin SV(1-).\n",
      "\n",
      "2971 0.4531740880264922 0.3142582803585133 0.7910599183862032 \n",
      " CCCCCCCCCCCCC/C=C\\\\C(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\\\\CCCCCCCC\n",
      "The molecule is a phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as (2Z)-hexadecenoyl and (9Z)-octadecenoyl respectively. It has a role as a mouse metabolite. It derives from an oleic acid.\n",
      "The molecule is a phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as (1Z)-hexadecenoyl (palmitoyl) and 9Z-octadecenoyl (oleoyl) respectively. It has a role as a mouse metabolite. It is a phosphatidylcholine 34:1 and a 1-acyl-2-oleoyl-sn-glycero-3-phosphocholine betaine. It derives from an oleic acid and a palmitoleic acid.\n",
      " The molecule is a 1,2-di-octadecenoyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are (1Z)-octadecenoyl and (2Z,6Z)-hexadecadienoyl respectively. It derives from a (Z,Z)-hexadecadienoic acid and an oleic acid. \n",
      " The molecule is a phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as (1Z)-hexadecenoyl and (9Z)-octadecenoyl respectively. It has a role as a mouse metabolite. It derives from a cis-vaccenic acid and an oleic acid.\n",
      "\n",
      "2980 0.36348050600882553 0.1887577115537257 0.5530702055023214 \n",
      " C[C@H](CN)OP(=O)(O)O\n",
      "The molecule is a 1-aminopropan-2-yl phosphate. It is a conjugate acid of a (R)-1-ammoniopropan-2-yl phosphate(1-). It is an enantiomer of a (S)-1-aminopropan-2-yl phosphate.\n",
      "The molecule is an optically active phosphonic acid having (S)-configuration. It has a role as a mouse metabolite. It is a 2-phosphonic acid and a primary amino compound. It is a conjugate acid of a (S)-(1-aminoethyl)phosphonate(1-). It is an enantiomer of a (R)-(1-aminoethyl)phosphonic acid.\n",
      " The molecule is the N-phospho derivative of L-alanine. It has a role as a bacterial metabolite. It is a conjugate acid of a N-phosphonato-L-alaninate(1-). \n",
      " The molecule is the (R)-enantiomer of 2-aminoimidazole 1-phosphate. It is a conjugate acid of a (R)-2-aminoimidazole 1-phosphate(1-). It is an enantiomer of a (S)-2-aminoimidazole 1-phosphate.\n",
      "\n",
      "2991 0.5201315471186941 0.49963888724242533 0.6713911905512749 \n",
      " CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@H]2[C@H]([C@@H]([C@H](O[C@@H]2O[C@H]3[C@@H]([C@H](O[C@H]([C@H]3O)O[C@@H]4[C@H](O[C@H]([C@@H]([C@H]4O)NC(=O)C)O[C@@H]5[C@H](OC([C@@H]([C@H]5O)NC(=O)C)O)CO)CO)CO[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H]([C@H]([C@H](O8)CO)O)O)O)O)NC(=O)C)O)CO)O)O)CO)O)O\n",
      "The molecule is a branched amino oligosaccharide comprising a linear trisaccharide of beta-D-mannosyl, N-acetyl-beta-D-glucosaminyl and N-acetyl-D-glucosaminyl residues all linked in sequence (1->4), to the mannosyl residue of which are connected branches consisting of N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl and beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl via (1->3) and (1->6) linkages respectively. It is an amino sugar, an amino oligosaccharide and a glucosamine oligosaccharide.\n",
      "The molecule is a branched amino octasaccharide comprised of a hexasaccharide chain of beta-D-galactose, N-acetyl-beta-D-glucosamine, alpha-D-mannose, beta-D-mannose, and two N-acetyl-beta-D-glucosamine residues linked sequentially (1->4), (1->2), (1->3), (1->4) and (1->4), to the beta-D-mannose residue of which is (1->6)-linked a beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-alpha-D-mannosyl trisaccharide branch. It has a role as an epitope. It is an amino octasaccharide and a glucosamine oligosaccharide.\n",
      " The molecule is an amino octasaccharide consisting of a tetrasaccharide chain of N-acetyl-beta-D-glucosamine, beta-D-mannose, N-acetyl-beta-D-glucosamine and N-acetyl-D-glucosamine residues, all linked sequentially (1->4), to the beta-D-mannose residue of which are also linked beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl and beta-D-galactosyl-( \n",
      " The molecule is an amino octasaccharide in which an N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl disaccharide chain and a beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl chain are linked (1->6) and (1->3) respectively to the mannose residue of a beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-D-glucosamine trisaccharide. It is a glucosamine oligosaccharide and an amino octasaccharide.\n",
      "\n",
      "3018 0.5798997460011005 0.44304813152023653 0.9609949206919333 \n",
      " CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\\\\C/C=C\\\\CCCCC\n",
      "The molecule is a phosphatidylcholine 32:2 in which the acyl groups specified at positions 1 and 2 are tetradecanoyl and (9Z,12Z)-octadecadienoyl respectively. It is a phosphatidylcholine 32:2 and a tetradecanoate ester. It derives from a linoleic acid.\n",
      "The molecule is a phosphatidylcholine 30:2 in which the acyl groups at positions 1 and 2 are myristoyl and linoleoyl respectively. It has a role as a mouse metabolite. It is a phosphatidylcholine 30:2 and a tetradecanoate ester. It derives from a linoleic acid.\n",
      " The molecule is a phosphatidylcholine 34:2 in which the acyl groups specified at positions 1 and 2 are (2Z,4Z)-octadecadienoyl and (5Z,11Z)-octadecadienoyl respectively. It is a phosphatidylcholine 34:2 and a 1-acyl-2-linoleoyl-sn-glycero-3-phosphocholine betaine. \n",
      " The molecule is a phosphatidylcholine 32:2 in which the acyl groups at positions 1 and 2 are tetradecanoyl and (9Z,12Z)-octadecadienoyl respectively. It is a phosphatidylcholine 32:2 and a tetradecanoate ester. It derives from a linoleic acid.\n",
      "\n",
      "3046 0.12312605268173563 0.14794832427906587 0.36327917785688607 \n",
      " C1=CC=C2C(=C1)C=CC=C2CC(=O)O\n",
      "The molecule is a naphthylacetic acid substituted by a carboxymethyl group at position 1. It has a role as a synthetic auxin.\n",
      "The molecule is a monocarboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a 1-naphthyl group. It has a role as a bacterial xenobiotic metabolite and a fungal xenobiotic metabolite. It is a monocarboxylic acid and a member of naphthalenes. It derives from an acetic acid. It is a conjugate acid of a 1-naphthylacetate.\n",
      " The molecule is a naphthoic acid carrying a carboxy substituent at position 3. It has a role as a bacterial xenobiotic metabolite and a fungal xenobiotic metabolite. It is a member of naphthalenes and a naphthoic acid. It derives from an anthranilic acid. It is a conjugate acid of a 3-naphthoate. \n",
      " The molecule is a naphthylacetic acid carrying a carboxy group at position 1. It has a role as a fungal xenobiotic metabolite and a bacterial xenobiotic metabolite. It is a conjugate acid of a 1-naphthylacetate.\n",
      "\n",
      "3055 0.5183342689886544 0.4219508769327427 0.6584693869621252 \n",
      " CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC\n",
      "The molecule is a 2-acyl-1-alkyl-sn-glycero-3-phosphocholine betaine where the alkyl and the acyl groups at position 1 and 2 are octadecyl and palmitoyl respectively. It derives from a 1-O-octadecyl-sn-glycero-3-phosphocholine and a hexadecanoic acid.\n",
      "The molecule is a phosphatidylcholine O-36:0 in which the alkyl and acyl groups specified at positions 1 and 2 are octadecyl and penttadecanoyl respectively. It is a 2-acyl-1-alkyl-sn-glycero-3-phosphocholine and a phosphatidylcholine O-36:0. It derives from a pentadecanoic acid.\n",
      " The molecule is a phosphatidylcholine O-30:0 in which the alkyl and acyl groups specified at positions 1 and 2 are (2-ethyl-1-alkyl) and octanoyl respectively. It is a 2-acyl-1-alkyl-sn-glycero-3-phosphocholine and a phosphatidylcholine O-30:0. It derives from an octanoic acid. \n",
      " The molecule is a phosphatidylcholine O-36:0 in which the alkyl and acyl groups specified at positions 1 and 2 are octadecyl and palmitoyl respectively. It is a 2-acyl-1-alkyl-sn-glycero-3-phosphocholine and a phosphatidylcholine O-36:0. It derives from a 1-O-octadecyl-sn-glycero-3-phosphocholine.\n",
      "\n",
      "3065 0.6159508780559902 0.33913820991914784 0.7388702349580054 \n",
      " CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC\n",
      "The molecule is a triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by capric (decanoic) acid. It is a triglyceride and a decanoate ester.\n",
      "The molecule is a triglyceride obtained by acylation of the three hydroxy groups of glycerol by lauric (dodecanoic) acid. It is a triglyceride and a dodecanoate ester.\n",
      " The molecule is a triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by tricarboxylic acid. Used as an alternative energy source to glucose for patients with mild to moderate Alzheimer's disease. It has a role as an anticonvulsant and a plant metabolite. It is a triglyceride and a tricarboxylic acid. \n",
      " The molecule is a triglyceride obtained by acylation of the three hydroxy groups of glycerol by lauric (dodecanoic) acid. It is a triglyceride and a decanoate ester.\n",
      "\n",
      "3067 0.8187642879667328 0.8187642879667328 1.0 \n",
      " C[C@H]\\\\1C/C=C/[C@H]2C=C([C@H]([C@@H]3[C@@]2(C(=O)/C=C\\\\CC/C(=C1)/C)C(=O)N[C@H]3CC4=CNC5=CC=CC=C54)C)C\n",
      "The molecule is a cytochalasan alkaloid found in Chaetomium globosum and Chaetomium subaffine. It has a role as a Chaetomium metabolite. It is a cytochalasan alkaloid, a member of indoles and a macrocycle.\n",
      "The molecule is a cytochalasan alkaloid found in Chaetomium globosum. It has a role as a Chaetomium metabolite and an antineoplastic agent. It is a cytochalasan alkaloid, a member of indoles and a macrocycle.\n",
      " The molecule is a cytochalasan alkaloid found in Chaetomium globosum. It has a role as an antineoplastic agent and a Chaetomium metabolite. It is a cytochalasan alkaloid, a member of indoles and a macrocycle. \n",
      " The molecule is a cytochalasan alkaloid found in Chaetomium globosum and Chaetomium subaffine. It has a role as a Chaetomium metabolite. It is a cytochalasan alkaloid, a member of indoles and a macrocycle.\n",
      "\n",
      "3084 0.38800532004220323 0.41169053949101486 0.5681244576331271 \n",
      " CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4\n",
      "The molecule is a phenothiazine substituted on the nitrogen by a 3-(morpholin-4-yl)propanoyl group, and at position 2 by an (ethoxycarbonyl)amino group. It has a role as an anti-arrhythmia drug. It is a member of phenothiazines, a member of morpholines and a carbamate ester.\n",
      "The molecule is a member of the class of phenothiazines that is 10H-phenothiazine substituted by a ethoxycarbonyl group at position 2 and a 3-(morpholin-4-yl)propanoyl group at position 10. It has a role as a phenothiazine antipsychotic drug, a dopaminergic antagonist, a serotonergic antagonist, a muscarinic antagonist, a histamine antagonist and a sedative. It is a member of phenothiazines, a member of morpholines and an ethyl ester. It derives from a 10H-phenothiazine.\n",
      " The molecule is a member of the class of phenothiazines that is phenothiazine substituted by a carbamoylcarbonyl group at position 2 and a [2-(morpholin-4-yl)-1,3-dioxolan-2-yl]carbonyl group at position 10. It has a role as a phenothiazine antipsychotic drug. It is a member of phenothiazines, a carbamate ester, a member of morpholines and an organic heterotricyclic compound. \n",
      " The molecule is a member of the class of phenothiazines that is 10H-phenothiazine substituted by a (ethoxycarbonyl)amino group at position 2 and a 3-(morpholin-4-yl)propanoyl group at position 10. It has a role as a phenothiazine antipsychotic drug. It is a member of morpholines, a carbamate ester and a member of phenothiazines.\n",
      "\n",
      "3107 0.34862670227373926 0.40079210239191965 0.5150367516588704 \n",
      " CC(=O)[C@H]([C@@H](C(=O)COP(=O)(O)O)O)O\n",
      "The molecule is a ketohexose monophosphate having keto groups at the 2- and 5-positions, hydroxy groups at the 3- and 4-positions and the phosphate group at the 6-position. It is a conjugate acid of a 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate(2-).\n",
      "The molecule is a deoxyketohexose phosphate consisting of 1-deoxy-D-threo-hexo-2,5-diulose having a phospho group at the 3-position. It has a role as an Escherichia coli metabolite. It is a deoxyketohexose phosphate and a deoxyhexose phosphate. It derives from a D-threo-hexo-2,5-diulose. It is a conjugate acid of a 1-deoxy-D-threo-hexo-2,5-diulose 5-phosphate(2-).\n",
      " The molecule is the dianion resulting from the removal of a proton from the phosphate group of 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate. It is a conjugate base of a 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate. \n",
      " The molecule is a deoxyketohexose phosphate consisting of 1-deoxy-D-threo-hexo-2,5-diulose having a phosphate group at the 3-position. It is a deoxyketohexose phosphate and a deoxyglucose phosphate. It is a conjugate acid of a 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate(2-).\n",
      "\n",
      "3110 0.27520508034743607 0.3347770073519107 0.6169776861763092 \n",
      " C[C@H](CCC[C@H](C)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O)[C@H]4CC[C@@H]5[C@@]4(CC[C@H]6[C@H]5CCC7=CC(=O)CC[C@]67C)C\n",
      "The molecule is an acyl-CoA(4-) resulting from the removal of all four protons from the phosphate and diphosphate groups of (25S)-3-oxocholest-4-en-26-oyl-CoA; major species at pH 7.3. It is a steroidal acyl-CoA(4-) and a (2S)-2-methylacyl-CoA(4-). It is a conjugate base of a (25S)-3-oxocholest-4-en-26-oyl-CoA.\n",
      "The molecule is an acyl-CoA oxoanion resulting from the removal of all four protons from the phosphate groups of (25S)-3-oxocholest-4-en-26-oyl-CoA; major species at pH 7.3.\n",
      " The molecule is an acyl-CoA(4-) resulting from the removal of all four protons from the phosphate and diphosphate groups of (25R)-3-oxocholest-4-en-26-oyl-CoA; major species at pH 7.3. \n",
      " The molecule is an acyl-CoA oxoanion resulting from the removal of all four protons from the phosphate groups of (25S)-3-oxocholest-4-en-26-oyl-CoA; major species at pH 7.3. It is a conjugate base of a (25S)-3-oxocholest-4-en-26-oyl-CoA.\n",
      "\n",
      "3120 0.40019352176611545 0.4960097886523622 0.9312457603037672 \n",
      " CC(C)(COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCSC(=O)/C=C/C4=CC=C(C=C4)O)O\n",
      "The molecule is tetraanion of 4-coumaroyl-CoA arising from deprotonation of phosphate and diphosphate functions. It has a role as a human metabolite. It is a conjugate base of a 4-coumaroyl-CoA.\n",
      "The molecule is an acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of 4-coumaric acid; major species at pH 7.3. It is a conjugate base of a 4-coumaric acid.\n",
      " The molecule is tetraanion of acetyl-CoA arising from deprotonation of phosphate and diphosphate functions. It is a conjugate base of an acetyl-CoA. \n",
      " The molecule is tetraanion of 4-coumaroyl-CoA arising from deprotonation of phosphate and diphosphate functions. It has a role as a Saccharomyces cerevisiae metabolite. It is a conjugate base of a 4-coumaroyl-CoA.\n",
      "\n",
      "3128 0.5440258941807921 0.2025488486655342 0.6917064852075834 \n",
      " C1=C(O[C@H]([C@@H]([C@H]1O)OS(=O)(=O)O)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)NS(=O)(=O)O)O[C@H]3[C@@H]([C@H]([C@@H](O[C@H]3C(=O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)NS(=O)(=O)O)O[C@H]5[C@@H]([C@H]([C@@H](O[C@H]5C(=O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)NS(=O)(=O)O)O[C@H]7[C@@H]([C@H]([C@@H](O[C@H]7C(=O)O)O[C@@H]8[C@H](O[C@@H]([C@@H]([C@H]8O)NS(=O)(=O)O)O[C@H]9[C@@H]([C@H]([C@@H](O[C@@H]9C(=O)O)O[C@@H]1[C@H](O[C@@H]([C@@H]([C@H]1O)NS(=O)(=O)O)O)COS(=O)(=O)O)O)O)COS(=O)(=O)O)OS(=O)(=O)O)O)COS(=O)(=O)O)OS(=O)(=O)O)O)COS(=O)(=O)O)OS(=O)(=O)O)O)COS(=O)(=O)O)C(=O)O\n",
      "The molecule is a heparin decasaccharide consisting of 4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, beta-D-glucopyranuronosyl, and 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DUA2S-GlcNS6S-IdoA2S-GlcNS6S-IdoA2S-GlcNS6S-IdoA2S-GlcNS6S-GlcA-GlcNS6S. It is a heparin decasaccharide, an amino decasaccharide and an oligosaccharide sulfate.\n",
      "The molecule is a heparin hexadecasaccharide consisting of 4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, and 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DUAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a\n",
      " The molecule is a heparin decasaccharide consisting of 4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyran \n",
      " The molecule is a heparin decasaccharide consisting of 4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, beta-D-glucopyranuronosyl, 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl, 2-O-sulfo-alpha-L-idopyranuronosyl, and 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose units joined in sequence by (1->4) linkages. Sequence: DUAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S-(1-4)-b-D-GlcAp-(1-4)-a-D-GlcNpS6S-(1-4)-a-L-IdoAp2S-(1-4)-a-D-GlcNpS6S. It is a heparin decasaccharide, an oligosaccharide sulfate and\n",
      "\n",
      "3131 0.19199833489515705 0.22154676349179123 0.33333269065588766 \n",
      " C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC(=CC3=NC=C2)Cl\n",
      "The molecule is a carboxylic ester that is 2,3-dihydroxypropyl anthranilate in which the amino group is substituted by a 7-chloroquinolin-4-yl group. A non-steroidal anti-inflammatory drug, glafenine and its hydrochloride salt were used for the relief of all types of pain, but high incidence of anaphylactic reactions resulted in their withdrawal from the market. It has a role as a non-narcotic analgesic, a non-steroidal anti-inflammatory drug and an inhibitor. It is an organochlorine compound, a secondary amino compound, a glycol, a carboxylic ester and an aminoquinoline. It derives from a glycerol and an anthranilic acid.\n",
      "The molecule is a carboxylic ester obtained by formal condensation of the carboxy group of 2-[(7-chloroquinolin-4-yl)amino]phenoxyacetic acid with the hydroxy group of glycerol. It is an aromatic amine, an organochlorine compound, a secondary amino compound, a carboxylic ester and a member of quinolines. It derives from a glycerol.\n",
      " The molecule is a carboxylic ester obtained by formal condensation of the carboxy group of 4-{[(6-chloroquinoxalin-2-yl)nitrilo]carbonyl}-2-carboxylic acid with one of the hydroxy groups of propane-1,2-diol. It is a prodrug for the active metabolite quinoxaline-1,4-bis(carboxylic acid). It has a role as a prodrug. It is an organochlorine compound, a quinoxaline derivative, a secondary amino compound and a carboxylic ester. It derives from a propane-1,2-diol. \n",
      " The molecule is an acetate ester obtained by the formal condensation of the carboxy group of clodinafen with the hydroxy group of 3-hydroxypropanoic acid. It is a prodrug for clodinafenib and is used for the treatment of rheumatoid arthritis and osteoarthritis and rheumatoid arthritis. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, an antirheumatic drug, a prodrug and an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor. It is a benzoate ester, an organochlorine compound, a secondary amino compound, a primary alcohol and a monocarboxylic acid amide. It derives from a clodinafenib.\n",
      "\n",
      "3147 0.180857419547277 0.20098339913206323 0.32128023503098063 \n",
      " C[C@]12CC[C@H]3[C@H]([C@H]1CC[C@@H]2C4=CC(=O)OC4)CCC5[C@@]3(CCCC5)C\n",
      "The molecule is a steroid lactone that is a C23 steroid with methyl groups at C-10 and C-13 and a butenolide ring at C-17. It is a steroid fundamental parent and a member of cardenolides.\n",
      "The molecule is a steroid lactone and a butenolide. It derives from a hydride of a 5beta-cardanolide.\n",
      " The molecule is a steroid lactone that is 5alpha-cardanolide with a double bond between positions 12 and 13 and with a keto group at the 3beta-position. It is a 17beta-hydroxy steroid and a steroid lactone. It derives from a hydride of a 5alpha-cardanolide. \n",
      " The molecule is a steroid lactone that is card-20(22)-enolide substituted by a hydroxy group at position 3. It has a role as a metabolite. It is a steroid lactone and a butenolide.\n",
      "\n",
      "3165 0.21374934317740793 0.17831039056726838 0.3556009998361983 \n",
      " CCC#CC#CC#CC(=O)N\n",
      "The molecule is a triyne amide produced by the Brazilian fungus Agrocybe perfecta (Basidiomycota). It has a role as a metabolite. It is a triyne, a ynamide and a primary carboxamide.\n",
      "The molecule is a fatty amide of octadecane with a double bond at position 2 and triple bonds at positions 4, 6, and 8. It has a role as an EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor. It is an acetylenic fatty amide and a primary carboxamide.\n",
      " The molecule is a pyrrolecarboxamide that is pyrrole-2-carboxylic acid substituted by acetyl groups at positions 1 and 3. It has a role as an EC 1.4.3.4 (monoamine oxidase) inhibitor and an antifungal agent. It is a pyrrolecarboxamide, a terminal acetylenic compound and a secondary carboxamide. \n",
      " The molecule is an acetylenic compound that is heptadecane which is substituted by a carbamoyl group at position 1. It has a role as a metabolite. It is an acetylenic compound and a primary carboxamide.\n",
      "\n",
      "3168 0.2508399786549228 0.2014852342468353 0.355411258023712 \n",
      " CCCCCCCCCCCCCCCCCC(=O)N[C@@H](COP(=O)(O)OCCN)[C@@H](/C=C/CCCCCCCCCC)O\n",
      "The molecule is a ceramide phosphoethanolamine (33:1) in which the sphingoid and acyl components are pentadecasphing-4-enine and octadecanoyl respectively. It derives from an octadecanoic acid.\n",
      "The molecule is a N-acyltetradecasphingosine-1-phosphoethanolamine in which the acyl group specified is heptadecanoyl. It is a ceramide phosphoethanolamine (35:1) and a N-acyltetradecasphingosine-1-phosphoethanolamine. It derives from a heptadecanoic acid.\n",
      " The molecule is a N-acyltetradecasphingosine-1-phosphoethanolamine in which the acyl group specified is (3E)-hexadecenoyl. It is a ceramide phosphoethanolamine (35:1) and a N-acyltetradecasphingosine-1-phosphoethanolamine. It derives from a hexadec-3-enoic acid. \n",
      " The molecule is a N-acyltetradecasphingosine-1-phosphoethanolamine in which the acyl group specified is octadecanoyl. It is a ceramide phosphoethanolamine (35:1) and a N-acyltetradecasphingosine-1-phosphoethanolamine. It derives from an octadecanoic acid.\n",
      "\n",
      "3176 0.26388493964926385 0.40102710943457076 0.5668388513239532 \n",
      " C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CC[C@@]3(C2)O)O)C6=CC(=O)OC6)C)C=O)O)O)O\n",
      "The molecule is a cardenolide glycoside that consists of strophanthidin having a 6-deoxy-alpha-L-mannopyranosyl (L-rhamnosyl) group attached at position 3. It has a role as a vasodilator agent and a metabolite. It is an alpha-L-rhamnoside, a 19-oxo steroid, a 14beta-hydroxy steroid, a 5beta-hydroxy steroid, a steroid lactone and a steroid aldehyde. It derives from a strophanthidin.\n",
      "The molecule is a cardenolide glycoside that is 3,5,11,14-tetrahydroxy-19-oxocard-20(22)-enolide glycosylated at position 3 by a beta-allosyl-(1->4)-beta-6-deoxyallosyl group. Isolated from Elaeodendron alluaudianum, it exhibits antiproliferative activity against human ovarian cancer and human histiocytic lymphoma cell lines. It has a role as a metabolite and an antineoplastic agent. It is a cardenolide glycoside, a hydroxy steroid, a steroid lactone and a steroid aldehyde.\n",
      " The molecule is a cardenolide glycoside that is strophanthidin attached to a 4,6-dideoxy-3-O-(beta-D-glucopyranosyl)-2-O-methyl-alpha-L-rhamnopyranosyl residue at position 3 via a glycosidic linkage. Isolated from Crossosoma bigelovii, it exhibits cytotoxic activity. It has a role as a metabolite and an antineoplastic agent. It is a cardenolide glycoside, a 19-oxo steroid, a 5beta-hydroxy steroid, a disaccharide derivative and a steroid aldehyde. It derives from a st \n",
      " The molecule is a cardenolide glycoside that consists of strophanthidin having an alpha-L-rhamnosyl moiety attached at position 3. It is a 14beta-hydroxy steroid, a 19-oxo steroid, a 5beta-hydroxy steroid, a cardenolide glycoside, a steroid saponin and a steroid aldehyde. It derives from a strophanthidin.\n",
      "\n",
      "3178 0.10666449422634507 0.12769225140933574 0.4511969171609554 \n",
      " C(C(=O)O)(N)O\n",
      "The molecule is a hydroxy-amino acid that is glycine substituted by a hydroxy group at the alpha-position. It is a hydroxy-amino acid, a glycine derivative and a hemiaminal.\n",
      "The molecule is an alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2. It has a role as a fundamental metabolite. It derives from a propionic acid. It is a conjugate acid of a hydroxyalaninate. It is a tautomer of an oxamic acid zwitterion.\n",
      " The molecule is an alpha-amino acid that is malonic acid in which one of the methylene hydrogens has been replaced by an amino group. It has a role as a Daphnia magna metabolite. It derives from a malonic acid. It is a conjugate acid of an aminomalonate(1-). \n",
      " The molecule is a hydroxy-amino acid that is alanine substituted by a hydroxy group at position 2. It has a role as a Saccharomyces cerevisiae metabolite. It is a hydroxy-amino acid, a non-proteinogenic alpha-amino acid and an alanine derivative.\n",
      "\n",
      "3194 0.3424132895302073 0.2562056869349808 0.5332432296639402 \n",
      " CC1=C(C2=CC=CC=C2C(=C1)O)O\n",
      "The molecule is a naphthalene-1,4-diol having a methyl substituent at the 2-position. It is a member of naphthalenediols, a member of methylnaphthalenes and a naphthohydroquinone. It derives from a naphthalene-1,4-diol.\n",
      "The molecule is a naphthohydroquinone that is 2-methylnaphthalene-1,4-diol having a methyl substituent at position 2. It has a role as an Escherichia coli metabolite.\n",
      " The molecule is a member of the class of naphthalenediols that is 1,2-dihydronaphthalene substituted by hydroxy groups at positions 2 and 4 respectively. It has a role as an antibacterial agent and an antifungal agent. It derives from a 1,2-dihydronaphthalene. \n",
      " The molecule is a naphthohydroquinone that is 2-methylnaphthalene-1,4-diol substituted by a methyl group at position 2. It has a role as an Escherichia coli metabolite. It is a naphthohydroquinone and a member of naphthalenediols. It derives from a 2-methylnaphthalene-1,4-diol.\n",
      "\n",
      "3200 0.29505925045569475 0.29505925045569475 0.8957567894376306 \n",
      " CCCCCCCCC(=O)C\n",
      "The molecule is a methyl ketone that is decane in which the methylene hydrogens at position 2 are replaced by an oxo group. It has a role as a plant metabolite. It derives from a hydride of a decane.\n",
      "The molecule is a dialkyl ketone with methyl and nonyl as the two alkyl groups. It has a role as a rodenticide and a plant metabolite. It is a dialkyl ketone and a methyl ketone.\n",
      " The molecule is a dialkyl ketone with methyl and methylidene as the two alkyl groups. It has a role as a rodenticide and a plant metabolite. It is a dialkyl ketone and a methyl ketone. \n",
      " The molecule is a methyl ketone that is nonane in which the methylene hydrogens at position 2 are replaced by an oxo group. It has a role as a plant metabolite. It derives from a hydride of a nonane.\n",
      "\n",
      "3201 0.28687372828969165 0.2760560802321948 0.4360209046139378 \n",
      " CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N\n",
      "The molecule is a dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position. It has a role as an antineoplastic agent, an adrenergic agent, an EC 1.14.14.14 (aromatase) inhibitor and an anticonvulsant. It is a dicarboximide, a member of piperidones and a substituted aniline. It derives from a piperidine-2,6-dione.\n",
      "The molecule is a member of the class of piperidones that is piperidine-2,5-dione substituted at position 3 by a 1-(4-aminophenyl)propyl group. It is a potent and selective inhibitor of the delta- and epsilon-isoforms of casein kinase 1 (CK1delta and CK1epsilon). It has a role as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor. It is a member of piperidones and a substituted aniline.\n",
      " The molecule is a dicarboximide that is 1,3-dioxolane-2,5-dione in which one of the hydrogens at position 4 is substituted by a phenyl group, while the other is substituted by a cyclopropyl group. It has a role as an environmental contaminant, a xenobiotic, a central nervous system drug and an antineoplastic agent. It is a member of cyclopropanes and a dicarboximide. \n",
      " The molecule is a dicarboximide that is pyrrolidine-2,5-dione which is substituted at position 3 by a 1-(4-aminophenyl)propyl group. It is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures. It has a role as an anticonvulsant and a calcium channel blocker. It is a dicarboximide, a member of piperidones and a substituted aniline.\n",
      "\n",
      "3266 0.1660402383659602 0.1660402383659602 0.7869275908729413 \n",
      " O.[O-]S(=O)(=O)[O-].[Fe+2]\n",
      "The molecule is a hydrate that is the monohydrate form of iron(2+) sulfate. It is obtained from the heptahydrate by heating above 65Ã¢ÂÂ. It is used as a source of iron in the treatment of iron-deficiency anaemia (generally in solid-dosage treatments; for liquid-dosage treatments, the heptahydrate is normally used). It has a role as a nutraceutical, an anti-anaemic agent and a reducing agent. It is a hydrate and an iron molecular entity. It contains an iron(2+) sulfate (anhydrous).\n",
      "The molecule is a hydrate that is the monohydrate form of iron(2+) sulfate. It has a role as a mordant, a catalyst and an astringent. It contains an iron(2+) sulfate.\n",
      " The molecule is a hydrate that is the monohydrate form of iron(2+) sulfate. It has a role as a mordant, a catalyst and an astringent. It contains an iron(2+) sulfate. \n",
      " The molecule is a hydrate that is the monohydrate form of iron(2+) sulfate. It is used as a source of iron in the treatment of iron-deficiency anaemia (generally in liquid-dosage treatments; for solid-dosage treatments, the monohydrate is normally used). It has a role as a nutraceutical, an anti-anaemic agent and a reducing agent. It is a hydrate and an iron molecular entity. It contains an iron(2+) sulfate (anhydrous).\n",
      "\n",
      "3271 0.12327740413661996 0.19871804241340327 0.3968095058960314 \n",
      " C[C@H]1CC[C@@H]([C@@H]1C=O)C(=C)C=O\n",
      "The molecule is a dialdehyde that is cyclopentanecarbaldehyde substituted by a methyl group at position 2 and a 3-oxo-prop-1-en-2yl group at position 5. It has been found to occur in pheromones of insects such as aphids. It has a role as an animal metabolite, a plant metabolite and a volatile oil component. It is a dialdehyde, an olefinic compound and an iridoid monoterpenoid.\n",
      "The molecule is a cyclic ketone and an alicyclic ketone. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a conjugate acid of a (+)-jasmonic acid anion. It is an enantiomer of a (-)-jasmonic acid.\n",
      " The molecule is a sesquiterpenoid that is 1,2,3,4,4a,5,6,8a-octahydronaphthalen-5-one substituted by a formyl group at position 8 and methyl groups at positions 2 and 4a. It has a role as an Escherichia coli metabolite and a plant metabolite. It is a sesquiterpenoid, an aldehyde and a carbobicyclic compound. \n",
      " The molecule is a cyclic monoterpene ketone that is cyclohexanecarbaldehyde substituted by a methyl group at position 2 and a 3-oxoprop-1-en-2-yl group at position 5 (the 2R,5S,6S stereoisomer). It is isolated from the leaves of Eremophila mitchellii. It has a role as a plant metabolite. It is a dialdehyde, an enal and a cyclic monoterpene ketone.\n",
      "\n",
      "3283 0.2790185015472407 0.3708750637080502 0.51738952946473 \n",
      " CC[N+](=C1C=CC2=NC3=C(C=C(C(=C3)C)N)OC2=C1)CC\n",
      "The molecule is an organic cation that is phenoxazin-5-ium substituted by methyl, amino and diethylamino groups at positions 2, 3 and 7 respectively. The tetrachlorozincate salt salt is the histological dye 'brilliant cresyl blue'.\n",
      "The molecule is an organic cation that is phenoxazin-5-ium substituted by amino and diethyl groups at positions 3 and 7 respectively. An inhibitor of geranylgeranyltransferase type I. It has a role as an EC 2.5.1.59 (protein geranylgeranyltransferase type I) inhibitor, an antifungal agent and an antimicrobial agent. It is an organic cation and an ammonium ion derivative.\n",
      " The molecule is an organic cation consisting of 3-amino-7-(dimethylamino)phenoxazin-5-ium carrying additional methyl and dimethylamino substituents at positions 2 and 8 respectively. The chloride salt is the histological dye'methyl blue'. \n",
      " The molecule is an organic cation that is phenoxazin-5-ium substituted by amino and diethyl groups at positions 3 and 7 respectively. The chloride salt is the histological dye 'azure A'.\n",
      "\n",
      "3295 1.9552251842690608e-78 2.5781491834794375e-78 0.2819047150780413 \n",
      " [B]\n",
      "The molecule is a nonmetal atom, a boron group element atom and a metalloid atom. It has a role as a micronutrient.\n",
      "The molecule is the stable isotope of gold with relative atomic mass 196.966552, 100 atom percent natural abundance and nuclear spin 5/2.\n",
      " The molecule is the simplest borane, consisting of a single boron atom carrying three hydrogens. It is a member of boranes and a mononuclear parent hydride. \n",
      " The molecule is a divalent metal cation, a mercury cation and a monoatomic dication. It has a role as an Escherichia coli metabolite.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "from nltk.translate.bleu_score import corpus_bleu\n",
    "from transformers import BertTokenizerFast\n",
    "import json\n",
    "\n",
    "def apply_filter(seq):\n",
    "    seq = list(filter(('[PAD]').__ne__, seq))\n",
    "    seq = list(filter(('[CLS]').__ne__, seq))\n",
    "    seq = list(filter(('[SEP]').__ne__, seq))\n",
    "    return seq\n",
    "\n",
    "data1 = open(\"../assets/molcap/biot5-captions.txt\", \"r\").readlines()\n",
    "data2 = open(\"/mnt/luoyz_dair/code_reference/MolCA/all_checkpoints/chebi_evaluation/lightning_logs/version_4/predictions.txt\", \"r\").readlines()\n",
    "data3 = open(\"../assets/molcap/mvmol-captions.txt\", \"r\").readlines()\n",
    "tokenizer = BertTokenizerFast.from_pretrained(\"../ckpts/text_ckpts/scibert_scivocab_uncased\")\n",
    "for i in range(1, len(data1)):\n",
    "    pred1 = tokenizer.tokenize(data1[i].strip().split(\"\\t\")[-1], truncation=True, max_length=512, padding='max_length')\n",
    "    pred1 = apply_filter(pred1)\n",
    "\n",
    "    cur2 = json.loads(data2[i - 1])\n",
    "    pred2 = tokenizer.tokenize(cur2[\"prediction\"].strip(), truncation=True, max_length=512, padding='max_length')\n",
    "    pred2 = apply_filter(pred2)\n",
    "\n",
    "    pred3 = tokenizer.tokenize(data3[i].strip().split(\"\\t\")[-1], truncation=True, max_length=512, padding='max_length')\n",
    "    pred3 = apply_filter(pred3)\n",
    "\n",
    "    gt = tokenizer.tokenize(data1[i].strip().split(\"\\t\")[1], truncation=True, max_length=512, padding='max_length')\n",
    "    gt = [apply_filter(gt)]\n",
    "\n",
    "    bleu1 = corpus_bleu([gt], [pred1], weights=(0.25, 0.25, 0.25, 0.25))\n",
    "    bleu2 = corpus_bleu([gt], [pred2], weights=(0.25, 0.25, 0.25, 0.25))\n",
    "    bleu3 = corpus_bleu([gt], [pred3], weights=(0.25, 0.25, 0.25, 0.25))\n",
    "    if bleu3 - bleu1 > 0.1 and bleu3 - bleu2 > 0.1:\n",
    "        print(i, bleu1, bleu2, bleu3, \"\\n\", \"\\n\".join(data1[i].split(\"\\t\")), cur2[\"prediction\"], \"\\n\", data3[i].split(\"\\t\")[-1])"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3.9.18 ('biomedgpt')",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.18"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "3c386dc5421f1dd96397eecb598a9197c5d71697e6243c5da9a50f791998bfec"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
